WO2011072117A1 - Fabric and home care products - Google Patents
Fabric and home care products Download PDFInfo
- Publication number
- WO2011072117A1 WO2011072117A1 PCT/US2010/059669 US2010059669W WO2011072117A1 WO 2011072117 A1 WO2011072117 A1 WO 2011072117A1 US 2010059669 W US2010059669 W US 2010059669W WO 2011072117 A1 WO2011072117 A1 WO 2011072117A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protease
- variant
- group
- mutations
- seq
- Prior art date
Links
- 239000004744 fabric Substances 0.000 title claims abstract description 129
- 102000035195 Peptidases Human genes 0.000 claims abstract description 300
- 108091005804 Peptidases Proteins 0.000 claims abstract description 300
- 239000004365 Protease Substances 0.000 claims abstract description 298
- 239000000203 mixture Substances 0.000 claims abstract description 255
- 229910001868 water Inorganic materials 0.000 claims abstract description 137
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 136
- 102000004190 Enzymes Human genes 0.000 claims abstract description 92
- 108090000790 Enzymes Proteins 0.000 claims abstract description 92
- 238000004140 cleaning Methods 0.000 claims abstract description 71
- 238000000034 method Methods 0.000 claims abstract description 63
- 108090000787 Subtilisin Proteins 0.000 claims abstract description 46
- 238000006467 substitution reaction Methods 0.000 claims abstract description 45
- 238000012217 deletion Methods 0.000 claims abstract description 17
- 230000037430 deletion Effects 0.000 claims abstract description 17
- 238000003780 insertion Methods 0.000 claims abstract description 15
- 230000037431 insertion Effects 0.000 claims abstract description 15
- 239000002304 perfume Substances 0.000 claims description 174
- 230000035772 mutation Effects 0.000 claims description 110
- 229940088598 enzyme Drugs 0.000 claims description 89
- -1 pentosanases Proteins 0.000 claims description 81
- 239000003795 chemical substances by application Substances 0.000 claims description 77
- 229920000642 polymer Polymers 0.000 claims description 76
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 72
- 239000000463 material Substances 0.000 claims description 67
- 235000001014 amino acid Nutrition 0.000 claims description 51
- 238000010998 test method Methods 0.000 claims description 45
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 32
- 239000007844 bleaching agent Substances 0.000 claims description 28
- 239000004927 clay Substances 0.000 claims description 25
- 230000002797 proteolythic effect Effects 0.000 claims description 20
- 125000000539 amino acid group Chemical group 0.000 claims description 18
- 239000004094 surface-active agent Substances 0.000 claims description 18
- 239000004615 ingredient Substances 0.000 claims description 17
- 150000004965 peroxy acids Chemical class 0.000 claims description 17
- 239000012190 activator Substances 0.000 claims description 15
- 239000000049 pigment Substances 0.000 claims description 15
- 239000002904 solvent Substances 0.000 claims description 15
- 238000005406 washing Methods 0.000 claims description 15
- 239000002270 dispersing agent Substances 0.000 claims description 14
- 108090001060 Lipase Proteins 0.000 claims description 13
- 102000004882 Lipase Human genes 0.000 claims description 13
- 239000004367 Lipase Substances 0.000 claims description 13
- 239000002738 chelating agent Substances 0.000 claims description 13
- 235000019421 lipase Nutrition 0.000 claims description 13
- 108010056079 Subtilisins Proteins 0.000 claims description 12
- 102000005158 Subtilisins Human genes 0.000 claims description 12
- 108090000637 alpha-Amylases Proteins 0.000 claims description 11
- 230000003197 catalytic effect Effects 0.000 claims description 11
- 230000004075 alteration Effects 0.000 claims description 10
- 230000002401 inhibitory effect Effects 0.000 claims description 10
- 238000012546 transfer Methods 0.000 claims description 10
- 108010065511 Amylases Proteins 0.000 claims description 9
- 102000013142 Amylases Human genes 0.000 claims description 9
- 235000019418 amylase Nutrition 0.000 claims description 9
- 230000007935 neutral effect Effects 0.000 claims description 9
- 102200118280 rs33918343 Human genes 0.000 claims description 9
- 102220575769 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9_N62Q_mutation Human genes 0.000 claims description 8
- 102220542960 Eukaryotic peptide chain release factor GTP-binding subunit ERF3A_S236W_mutation Human genes 0.000 claims description 8
- 102000004316 Oxidoreductases Human genes 0.000 claims description 8
- 108090000854 Oxidoreductases Proteins 0.000 claims description 8
- 102220267408 rs1426083834 Human genes 0.000 claims description 8
- 239000002689 soil Substances 0.000 claims description 7
- 239000003381 stabilizer Substances 0.000 claims description 7
- 102220465972 Cilium assembly protein DZIP1_S24R_mutation Human genes 0.000 claims description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- 102220493582 HLA class II histocompatibility antigen, DR beta 3 chain_S89Y_mutation Human genes 0.000 claims description 6
- 239000006057 Non-nutritive feed additive Substances 0.000 claims description 6
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Chemical group OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 6
- 229940025131 amylases Drugs 0.000 claims description 6
- 239000002979 fabric softener Substances 0.000 claims description 6
- 239000003752 hydrotrope Substances 0.000 claims description 6
- 102220011563 rs150973053 Human genes 0.000 claims description 6
- 102100032487 Beta-mannosidase Human genes 0.000 claims description 5
- 102220566680 Cellular tumor antigen p53_S260P_mutation Human genes 0.000 claims description 5
- 102220551400 Cellular tumor antigen p53_V203E_mutation Human genes 0.000 claims description 5
- 102220579931 E3 ubiquitin-protein ligase RING2_Q185L_mutation Human genes 0.000 claims description 5
- 239000004471 Glycine Substances 0.000 claims description 5
- 235000004279 alanine Nutrition 0.000 claims description 5
- 108010055059 beta-Mannosidase Proteins 0.000 claims description 5
- 102220349156 c.233G>A Human genes 0.000 claims description 5
- 108010087558 pectate lyase Proteins 0.000 claims description 5
- 102220331596 rs863224613 Human genes 0.000 claims description 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 4
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 4
- 102220566656 Cellular tumor antigen p53_L257V_mutation Human genes 0.000 claims description 4
- 108010084185 Cellulases Proteins 0.000 claims description 4
- 102000005575 Cellulases Human genes 0.000 claims description 4
- 108010023736 Chondroitinases and Chondroitin Lyases Proteins 0.000 claims description 4
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 claims description 4
- 108090000371 Esterases Proteins 0.000 claims description 4
- 108010003272 Hyaluronate lyase Proteins 0.000 claims description 4
- 102000001974 Hyaluronidases Human genes 0.000 claims description 4
- 108010029541 Laccase Proteins 0.000 claims description 4
- 102000003820 Lipoxygenases Human genes 0.000 claims description 4
- 108090000128 Lipoxygenases Proteins 0.000 claims description 4
- 102100031688 N-acetylgalactosamine-6-sulfatase Human genes 0.000 claims description 4
- 108700020962 Peroxidase Proteins 0.000 claims description 4
- 102000003992 Peroxidases Human genes 0.000 claims description 4
- 108010064785 Phospholipases Proteins 0.000 claims description 4
- 102000015439 Phospholipases Human genes 0.000 claims description 4
- 108010059820 Polygalacturonase Proteins 0.000 claims description 4
- 108091007187 Reductases Proteins 0.000 claims description 4
- 102000003425 Tyrosinase Human genes 0.000 claims description 4
- 108060008724 Tyrosinase Proteins 0.000 claims description 4
- 108010084650 alpha-N-arabinofuranosidase Proteins 0.000 claims description 4
- 229960001230 asparagine Drugs 0.000 claims description 4
- 235000009582 asparagine Nutrition 0.000 claims description 4
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 claims description 4
- 102200123712 c.758C>G Human genes 0.000 claims description 4
- 108010005400 cutinase Proteins 0.000 claims description 4
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 4
- 108010002430 hemicellulase Proteins 0.000 claims description 4
- 229960002773 hyaluronidase Drugs 0.000 claims description 4
- 108010059345 keratinase Proteins 0.000 claims description 4
- 108010062085 ligninase Proteins 0.000 claims description 4
- 102200011002 rs1057517674 Human genes 0.000 claims description 4
- 102200148733 rs116840794 Human genes 0.000 claims description 4
- 102200104275 rs1555525465 Human genes 0.000 claims description 4
- 102200106066 rs1555525970 Human genes 0.000 claims description 4
- 102200002861 rs199474725 Human genes 0.000 claims description 4
- 102200029979 rs201824781 Human genes 0.000 claims description 4
- 102220011740 rs386833408 Human genes 0.000 claims description 4
- 102200089607 rs398123481 Human genes 0.000 claims description 4
- 102200158933 rs63749797 Human genes 0.000 claims description 4
- 102220285757 rs747302288 Human genes 0.000 claims description 4
- 102220058924 rs749212640 Human genes 0.000 claims description 4
- 102220214503 rs749545338 Human genes 0.000 claims description 4
- 102220062227 rs775515332 Human genes 0.000 claims description 4
- 102200124515 rs786205679 Human genes 0.000 claims description 4
- 102220094408 rs876658416 Human genes 0.000 claims description 4
- 102220215230 rs876658416 Human genes 0.000 claims description 4
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims description 4
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 claims description 4
- 108010038851 tannase Proteins 0.000 claims description 4
- 102220476899 ATPase family AAA domain-containing protein 3A_S101N_mutation Human genes 0.000 claims description 3
- 108010052085 cellobiose-quinone oxidoreductase Proteins 0.000 claims description 3
- 108010076363 licheninase Proteins 0.000 claims description 3
- 102220316056 rs1553351592 Human genes 0.000 claims description 3
- 102200108308 rs1555526631 Human genes 0.000 claims description 3
- 102220283192 rs397509301 Human genes 0.000 claims description 3
- 102220059233 rs63750817 Human genes 0.000 claims description 3
- 102200104216 rs745425759 Human genes 0.000 claims description 3
- 108010083879 xyloglucan endo(1-4)-beta-D-glucanase Proteins 0.000 claims description 3
- 102220584207 Cellular tumor antigen p53_A88T_mutation Human genes 0.000 claims description 2
- 102220566725 Cellular tumor antigen p53_D259E_mutation Human genes 0.000 claims description 2
- 102220566723 Cellular tumor antigen p53_D259H_mutation Human genes 0.000 claims description 2
- 102220566667 Cellular tumor antigen p53_D259P_mutation Human genes 0.000 claims description 2
- 102220566677 Cellular tumor antigen p53_D259S_mutation Human genes 0.000 claims description 2
- 102220573732 Cellular tumor antigen p53_S183P_mutation Human genes 0.000 claims description 2
- 102220566674 Cellular tumor antigen p53_S260A_mutation Human genes 0.000 claims description 2
- 102220566673 Cellular tumor antigen p53_S260C_mutation Human genes 0.000 claims description 2
- 102220583069 Cellular tumor antigen p53_S33T_mutation Human genes 0.000 claims description 2
- 102220563809 Cellular tumor antigen p53_T253A_mutation Human genes 0.000 claims description 2
- 102220573351 Cellular tumor antigen p53_V143A_mutation Human genes 0.000 claims description 2
- 102220573349 Cellular tumor antigen p53_V143E_mutation Human genes 0.000 claims description 2
- 102220573639 Cellular tumor antigen p53_V147A_mutation Human genes 0.000 claims description 2
- 102220551399 Cellular tumor antigen p53_V203A_mutation Human genes 0.000 claims description 2
- 102220551403 Cellular tumor antigen p53_V203W_mutation Human genes 0.000 claims description 2
- 102220608231 Hemoglobin subunit beta_N109K_mutation Human genes 0.000 claims description 2
- 101000922061 Homo sapiens Beta-catenin-like protein 1 Proteins 0.000 claims description 2
- 102220606466 Protein C19orf12_P40A_mutation Human genes 0.000 claims description 2
- 102220515621 Pterin-4-alpha-carbinolamine dehydratase 2_E156G_mutation Human genes 0.000 claims description 2
- 102220534416 Tyrosine-protein phosphatase non-receptor type 1_D181A_mutation Human genes 0.000 claims description 2
- 102220495682 Zinc finger protein 324B_S63G_mutation Human genes 0.000 claims description 2
- 102220532205 Zinc finger protein ZFPM2_D259A_mutation Human genes 0.000 claims description 2
- 102220419545 c.728A>G Human genes 0.000 claims description 2
- 102220220003 rs1060503161 Human genes 0.000 claims description 2
- 102200080102 rs121908643 Human genes 0.000 claims description 2
- 102220285980 rs1331273811 Human genes 0.000 claims description 2
- 102220120571 rs142918575 Human genes 0.000 claims description 2
- 102220221562 rs145132275 Human genes 0.000 claims description 2
- 102220015229 rs145518215 Human genes 0.000 claims description 2
- 102220215234 rs147342421 Human genes 0.000 claims description 2
- 102220276634 rs1553131563 Human genes 0.000 claims description 2
- 102220423008 rs1554039069 Human genes 0.000 claims description 2
- 102220278667 rs1554301463 Human genes 0.000 claims description 2
- 102200051375 rs1554625334 Human genes 0.000 claims description 2
- 102220325159 rs1555338628 Human genes 0.000 claims description 2
- 102200108569 rs1555526226 Human genes 0.000 claims description 2
- 102200108969 rs1555526241 Human genes 0.000 claims description 2
- 102220036704 rs193096019 Human genes 0.000 claims description 2
- 102220008867 rs193922322 Human genes 0.000 claims description 2
- 102200096987 rs199472876 Human genes 0.000 claims description 2
- 102220001605 rs267607055 Human genes 0.000 claims description 2
- 102200104233 rs28934577 Human genes 0.000 claims description 2
- 102200104236 rs28934577 Human genes 0.000 claims description 2
- 102200118308 rs34037627 Human genes 0.000 claims description 2
- 102220005182 rs35068498 Human genes 0.000 claims description 2
- 102200117964 rs35485099 Human genes 0.000 claims description 2
- 102220258303 rs371667663 Human genes 0.000 claims description 2
- 102220277598 rs572906317 Human genes 0.000 claims description 2
- 102220257095 rs587779102 Human genes 0.000 claims description 2
- 102220041685 rs587780689 Human genes 0.000 claims description 2
- 102220097486 rs62625285 Human genes 0.000 claims description 2
- 102220045802 rs63750102 Human genes 0.000 claims description 2
- 102200061268 rs63750812 Human genes 0.000 claims description 2
- 102200105632 rs730882003 Human genes 0.000 claims description 2
- 102200105633 rs730882003 Human genes 0.000 claims description 2
- 102220286106 rs746298214 Human genes 0.000 claims description 2
- 102220313230 rs764089231 Human genes 0.000 claims description 2
- 102220276545 rs765046399 Human genes 0.000 claims description 2
- 102200069858 rs786205857 Human genes 0.000 claims description 2
- 102220072465 rs794729068 Human genes 0.000 claims description 2
- 102200104320 rs876658916 Human genes 0.000 claims description 2
- 102220094069 rs876660914 Human genes 0.000 claims description 2
- 102220093346 rs876661018 Human genes 0.000 claims description 2
- 102220120839 rs886042672 Human genes 0.000 claims description 2
- 102220198384 rs942158624 Human genes 0.000 claims description 2
- 238000011144 upstream manufacturing Methods 0.000 claims description 2
- 102220572811 Cellular tumor antigen p53_A138S_mutation Human genes 0.000 claims 2
- 102220508459 E3 ubiquitin-protein ligase XIAP_S87E_mutation Human genes 0.000 claims 2
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims 2
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 claims 2
- 150000002333 glycines Chemical group 0.000 claims 2
- 102220572812 Cellular tumor antigen p53_A138T_mutation Human genes 0.000 claims 1
- 102220566672 Cellular tumor antigen p53_S260F_mutation Human genes 0.000 claims 1
- 102200094891 rs121913566 Human genes 0.000 claims 1
- 102220307898 rs142045411 Human genes 0.000 claims 1
- 102200163545 rs63749838 Human genes 0.000 claims 1
- 102220282676 rs892567748 Human genes 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 abstract description 21
- 241000193422 Bacillus lentus Species 0.000 abstract description 11
- 230000008569 process Effects 0.000 abstract description 9
- JSFUMBWFPQSADC-UHFFFAOYSA-N Disperse Blue 1 Chemical compound O=C1C2=C(N)C=CC(N)=C2C(=O)C2=C1C(N)=CC=C2N JSFUMBWFPQSADC-UHFFFAOYSA-N 0.000 description 125
- 239000000047 product Substances 0.000 description 118
- 239000003599 detergent Substances 0.000 description 68
- 238000003556 assay Methods 0.000 description 50
- 239000000975 dye Substances 0.000 description 45
- 229920002472 Starch Polymers 0.000 description 34
- 108090000623 proteins and genes Proteins 0.000 description 33
- 235000019698 starch Nutrition 0.000 description 33
- 150000001412 amines Chemical class 0.000 description 32
- 239000008107 starch Substances 0.000 description 31
- 239000002253 acid Substances 0.000 description 30
- 239000000243 solution Substances 0.000 description 24
- 238000005516 engineering process Methods 0.000 description 23
- 229940024606 amino acid Drugs 0.000 description 22
- 150000007523 nucleic acids Chemical group 0.000 description 22
- 235000018102 proteins Nutrition 0.000 description 21
- 102000004169 proteins and genes Human genes 0.000 description 21
- 239000007788 liquid Substances 0.000 description 19
- 230000008901 benefit Effects 0.000 description 17
- 239000011159 matrix material Substances 0.000 description 17
- 150000003839 salts Chemical class 0.000 description 16
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 15
- 241000193830 Bacillus <bacterium> Species 0.000 description 14
- 239000011162 core material Substances 0.000 description 14
- 239000000835 fiber Substances 0.000 description 14
- 108090000765 processed proteins & peptides Proteins 0.000 description 14
- 125000000217 alkyl group Chemical group 0.000 description 13
- 239000007795 chemical reaction product Substances 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 13
- 239000003094 microcapsule Substances 0.000 description 13
- 102000053602 DNA Human genes 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 12
- 150000001299 aldehydes Chemical class 0.000 description 12
- 238000004422 calculation algorithm Methods 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 102000039446 nucleic acids Human genes 0.000 description 12
- 108020004707 nucleic acids Proteins 0.000 description 12
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 11
- 239000002775 capsule Substances 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- DUYCTCQXNHFCSJ-UHFFFAOYSA-N dtpmp Chemical compound OP(=O)(O)CN(CP(O)(O)=O)CCN(CP(O)(=O)O)CCN(CP(O)(O)=O)CP(O)(O)=O DUYCTCQXNHFCSJ-UHFFFAOYSA-N 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 150000002576 ketones Chemical class 0.000 description 11
- 229960003330 pentetic acid Drugs 0.000 description 11
- 102220149217 rs886059904 Human genes 0.000 description 11
- 239000011257 shell material Substances 0.000 description 11
- VKZRWSNIWNFCIQ-WDSKDSINSA-N (2s)-2-[2-[[(1s)-1,2-dicarboxyethyl]amino]ethylamino]butanedioic acid Chemical compound OC(=O)C[C@@H](C(O)=O)NCCN[C@H](C(O)=O)CC(O)=O VKZRWSNIWNFCIQ-WDSKDSINSA-N 0.000 description 10
- MHOFGBJTSNWTDT-UHFFFAOYSA-M 2-[n-ethyl-4-[(6-methoxy-3-methyl-1,3-benzothiazol-3-ium-2-yl)diazenyl]anilino]ethanol;methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC(N(CCO)CC)=CC=C1N=NC1=[N+](C)C2=CC=C(OC)C=C2S1 MHOFGBJTSNWTDT-UHFFFAOYSA-M 0.000 description 10
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- 108091028043 Nucleic acid sequence Proteins 0.000 description 10
- 125000003277 amino group Chemical group 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- 125000004432 carbon atom Chemical group C* 0.000 description 10
- 229910052739 hydrogen Inorganic materials 0.000 description 10
- 125000003729 nucleotide group Chemical group 0.000 description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 10
- 229920001184 polypeptide Chemical group 0.000 description 10
- 229920001296 polysiloxane Polymers 0.000 description 10
- 102000004196 processed proteins & peptides Human genes 0.000 description 10
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 10
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 102000012479 Serine Proteases Human genes 0.000 description 9
- 108010022999 Serine Proteases Proteins 0.000 description 9
- 238000010790 dilution Methods 0.000 description 9
- 239000012895 dilution Substances 0.000 description 9
- 238000004851 dishwashing Methods 0.000 description 9
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 9
- 150000002500 ions Chemical class 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 239000002773 nucleotide Substances 0.000 description 9
- 239000013612 plasmid Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- LKDMKWNDBAVNQZ-WJNSRDFLSA-N 4-[[(2s)-1-[[(2s)-1-[(2s)-2-[[(2s)-1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-WJNSRDFLSA-N 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 101000740449 Bacillus subtilis (strain 168) Biotin/lipoyl attachment protein Proteins 0.000 description 8
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 8
- 229920000877 Melamine resin Polymers 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 125000005529 alkyleneoxy group Chemical group 0.000 description 8
- 125000003118 aryl group Chemical group 0.000 description 8
- 239000002585 base Substances 0.000 description 8
- 239000000969 carrier Substances 0.000 description 8
- 239000003054 catalyst Substances 0.000 description 8
- 239000013522 chelant Substances 0.000 description 8
- 239000004519 grease Substances 0.000 description 8
- 239000001257 hydrogen Substances 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 7
- 239000007995 HEPES buffer Substances 0.000 description 7
- 229920002873 Polyethylenimine Polymers 0.000 description 7
- 150000007513 acids Chemical class 0.000 description 7
- 102000004139 alpha-Amylases Human genes 0.000 description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 230000008021 deposition Effects 0.000 description 7
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 7
- 238000009792 diffusion process Methods 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 7
- 229910000271 hectorite Inorganic materials 0.000 description 7
- 230000002209 hydrophobic effect Effects 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 230000000813 microbial effect Effects 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 229910000275 saponite Inorganic materials 0.000 description 7
- 150000003384 small molecules Chemical class 0.000 description 7
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 7
- VRVDFJOCCWSFLI-UHFFFAOYSA-K trisodium 3-[[4-[(6-anilino-1-hydroxy-3-sulfonatonaphthalen-2-yl)diazenyl]-5-methoxy-2-methylphenyl]diazenyl]naphthalene-1,5-disulfonate Chemical compound [Na+].[Na+].[Na+].COc1cc(N=Nc2cc(c3cccc(c3c2)S([O-])(=O)=O)S([O-])(=O)=O)c(C)cc1N=Nc1c(O)c2ccc(Nc3ccccc3)cc2cc1S([O-])(=O)=O VRVDFJOCCWSFLI-UHFFFAOYSA-K 0.000 description 7
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 6
- 235000014469 Bacillus subtilis Nutrition 0.000 description 6
- 229920000858 Cyclodextrin Polymers 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 6
- 239000000981 basic dye Substances 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 6
- 238000010276 construction Methods 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- ZXJXZNDDNMQXFV-UHFFFAOYSA-M crystal violet Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1[C+](C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 ZXJXZNDDNMQXFV-UHFFFAOYSA-M 0.000 description 6
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 6
- 238000005538 encapsulation Methods 0.000 description 6
- IVJISJACKSSFGE-UHFFFAOYSA-N formaldehyde;1,3,5-triazine-2,4,6-triamine Chemical compound O=C.NC1=NC(N)=NC(N)=N1 IVJISJACKSSFGE-UHFFFAOYSA-N 0.000 description 6
- 230000000670 limiting effect Effects 0.000 description 6
- 229910052901 montmorillonite Inorganic materials 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 239000011368 organic material Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 239000010457 zeolite Substances 0.000 description 6
- MZZRKEIUNOYYDF-UHFFFAOYSA-N 2,4-dimethylcyclohex-3-ene-1-carbaldehyde Chemical compound CC1C=C(C)CCC1C=O MZZRKEIUNOYYDF-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical class OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 229920000881 Modified starch Polymers 0.000 description 5
- 239000004698 Polyethylene Substances 0.000 description 5
- 108010076504 Protein Sorting Signals Proteins 0.000 description 5
- 229910021536 Zeolite Inorganic materials 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 239000012228 culture supernatant Substances 0.000 description 5
- 229960004585 etidronic acid Drugs 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 238000002703 mutagenesis Methods 0.000 description 5
- 231100000350 mutagenesis Toxicity 0.000 description 5
- LEGWLJGBFZBZSC-UHFFFAOYSA-N n-[2-[(2,6-dicyano-4-nitrophenyl)diazenyl]-5-(diethylamino)phenyl]acetamide Chemical compound CC(=O)NC1=CC(N(CC)CC)=CC=C1N=NC1=C(C#N)C=C([N+]([O-])=O)C=C1C#N LEGWLJGBFZBZSC-UHFFFAOYSA-N 0.000 description 5
- 125000001624 naphthyl group Chemical group 0.000 description 5
- 102000040430 polynucleotide Human genes 0.000 description 5
- 108091033319 polynucleotide Proteins 0.000 description 5
- 239000002157 polynucleotide Substances 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 102220106373 rs879255289 Human genes 0.000 description 5
- 229910021647 smectite Inorganic materials 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 230000035882 stress Effects 0.000 description 5
- 108010082371 succinyl-alanyl-alanyl-prolyl-phenylalanine-4-nitroanilide Proteins 0.000 description 5
- 229910052723 transition metal Inorganic materials 0.000 description 5
- XEJGJTYRUWUFFD-FNORWQNLSA-N (e)-1-(2,6,6-trimethyl-1-cyclohex-3-enyl)but-2-en-1-one Chemical compound C\C=C\C(=O)C1C(C)C=CCC1(C)C XEJGJTYRUWUFFD-FNORWQNLSA-N 0.000 description 4
- CRIGTVCBMUKRSL-FNORWQNLSA-N 1-(2,6,6-trimethylcyclohex-2-en-1-yl)but-2-enone Chemical compound C\C=C\C(=O)C1C(C)=CCCC1(C)C CRIGTVCBMUKRSL-FNORWQNLSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 102220625453 Arylamine N-acetyltransferase 1_S78R_mutation Human genes 0.000 description 4
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 4
- 108010059892 Cellulase Proteins 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 101710176178 Kidney androgen-regulated protein Proteins 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 102000005741 Metalloproteases Human genes 0.000 description 4
- 108010006035 Metalloproteases Proteins 0.000 description 4
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 4
- 229930193140 Neomycin Natural products 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- CRIGTVCBMUKRSL-UHFFFAOYSA-N alpha-Damascone Natural products CC=CC(=O)C1C(C)=CCCC1(C)C CRIGTVCBMUKRSL-UHFFFAOYSA-N 0.000 description 4
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 4
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 4
- AKGGYBADQZYZPD-UHFFFAOYSA-N benzylacetone Chemical compound CC(=O)CCC1=CC=CC=C1 AKGGYBADQZYZPD-UHFFFAOYSA-N 0.000 description 4
- 239000001110 calcium chloride Substances 0.000 description 4
- 229910001628 calcium chloride Inorganic materials 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- ZBNARPCCDMHDDV-UHFFFAOYSA-N chembl1206040 Chemical compound C1=C(S(O)(=O)=O)C=C2C=C(S(O)(=O)=O)C(N=NC3=CC=C(C=C3C)C=3C=C(C(=CC=3)N=NC=3C(=CC4=CC(=CC(N)=C4C=3O)S(O)(=O)=O)S(O)(=O)=O)C)=C(O)C2=C1N ZBNARPCCDMHDDV-UHFFFAOYSA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- ZLRROLLKQDRDPI-UHFFFAOYSA-L disodium;4,5-dihydroxybenzene-1,3-disulfonate;hydrate Chemical compound O.[Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C1O ZLRROLLKQDRDPI-UHFFFAOYSA-L 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 125000005842 heteroatom Chemical group 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 150000002430 hydrocarbons Chemical class 0.000 description 4
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 4
- 125000005647 linker group Chemical group 0.000 description 4
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 4
- 235000019426 modified starch Nutrition 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- 229960004927 neomycin Drugs 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000011118 polyvinyl acetate Substances 0.000 description 4
- 229920002689 polyvinyl acetate Polymers 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 102220211862 rs144030074 Human genes 0.000 description 4
- 102200082937 rs33945546 Human genes 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 150000003624 transition metals Chemical class 0.000 description 4
- 230000001960 triggered effect Effects 0.000 description 4
- AAAQKTZKLRYKHR-UHFFFAOYSA-N triphenylmethane Chemical compound C1=CC=CC=C1C(C=1C=CC=CC=1)C1=CC=CC=C1 AAAQKTZKLRYKHR-UHFFFAOYSA-N 0.000 description 4
- 210000005239 tubule Anatomy 0.000 description 4
- 239000012224 working solution Substances 0.000 description 4
- ZFNVDHOSLNRHNN-UHFFFAOYSA-N xi-3-(4-Isopropylphenyl)-2-methylpropanal Chemical compound O=CC(C)CC1=CC=C(C(C)C)C=C1 ZFNVDHOSLNRHNN-UHFFFAOYSA-N 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 3
- KPVQNXLUPNWQHM-RBEMOOQDSA-N 3-acetylpyridine adenine dinucleotide Chemical compound CC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 KPVQNXLUPNWQHM-RBEMOOQDSA-N 0.000 description 3
- 102220470113 Aldo-keto reductase family 1 member C2_N43A_mutation Human genes 0.000 description 3
- 239000004382 Amylase Substances 0.000 description 3
- 102100028449 Arginine-glutamic acid dipeptide repeats protein Human genes 0.000 description 3
- 241001328119 Bacillus gibsonii Species 0.000 description 3
- 241000194108 Bacillus licheniformis Species 0.000 description 3
- 102220527632 Basigin_V26F_mutation Human genes 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- 239000005973 Carvone Substances 0.000 description 3
- 102220592774 Cellular tumor antigen p53_E271P_mutation Human genes 0.000 description 3
- 102220592780 Cellular tumor antigen p53_E271V_mutation Human genes 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 102220589215 DNA repair protein XRCC2_A16S_mutation Human genes 0.000 description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 3
- 239000005977 Ethylene Substances 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 102220599960 Inositol 1,4,5-trisphosphate receptor-interacting protein-like 1_Q59A_mutation Human genes 0.000 description 3
- 102220642080 Lipoma-preferred partner_N43R_mutation Human genes 0.000 description 3
- 101710122864 Major tegument protein Proteins 0.000 description 3
- 229920002774 Maltodextrin Polymers 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 102100031545 Microsomal triglyceride transfer protein large subunit Human genes 0.000 description 3
- 101710148592 PTS system fructose-like EIIA component Proteins 0.000 description 3
- 101710169713 PTS system fructose-specific EIIA component Proteins 0.000 description 3
- 229920001609 Poly(3,4-ethylenedioxythiophene) Polymers 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 102220485938 Probable ATP-dependent RNA helicase DHX34_K94R_mutation Human genes 0.000 description 3
- 102220558194 Ras association domain-containing protein 1_L75A_mutation Human genes 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 101710199973 Tail tube protein Proteins 0.000 description 3
- 241000223258 Thermomyces lanuginosus Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229920001807 Urea-formaldehyde Polymers 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 125000002947 alkylene group Chemical group 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000004002 angle-resolved photoelectron spectroscopy Methods 0.000 description 3
- 239000003945 anionic surfactant Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- VJDDAARZIFHSQY-UHFFFAOYSA-N basic black 2 Chemical compound [Cl-].C=1C2=[N+](C=3C=CC=CC=3)C3=CC(N(CC)CC)=CC=C3N=C2C=CC=1NN=C1C=CC(=O)C=C1 VJDDAARZIFHSQY-UHFFFAOYSA-N 0.000 description 3
- POIARNZEYGURDG-FNORWQNLSA-N beta-damascenone Chemical compound C\C=C\C(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-FNORWQNLSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- NNBFNNNWANBMTI-UHFFFAOYSA-M brilliant green Chemical compound OS([O-])(=O)=O.C1=CC(N(CC)CC)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](CC)CC)C=C1 NNBFNNNWANBMTI-UHFFFAOYSA-M 0.000 description 3
- 102220419264 c.223C>T Human genes 0.000 description 3
- 102220407719 c.224T>A Human genes 0.000 description 3
- 102220348394 c.266A>G Human genes 0.000 description 3
- 102220360915 c.811_812delGAinsTT Human genes 0.000 description 3
- 235000013877 carbamide Nutrition 0.000 description 3
- 239000012876 carrier material Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 230000001186 cumulative effect Effects 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000013024 dilution buffer Substances 0.000 description 3
- QCWPZYSLMIXIHM-UHFFFAOYSA-L disodium 4-amino-5-hydroxy-3-[(3-nitrophenyl)diazenyl]-6-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].Nc1c(N=Nc2cccc(c2)[N+]([O-])=O)c(cc2cc(c(N=Nc3ccccc3)c(O)c12)S([O-])(=O)=O)S([O-])(=O)=O QCWPZYSLMIXIHM-UHFFFAOYSA-L 0.000 description 3
- XPRMZBUQQMPKCR-UHFFFAOYSA-L disodium;8-anilino-5-[[4-[(3-sulfonatophenyl)diazenyl]naphthalen-1-yl]diazenyl]naphthalene-1-sulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC=CC(N=NC=2C3=CC=CC=C3C(N=NC=3C4=CC=CC(=C4C(NC=4C=CC=CC=4)=CC=3)S([O-])(=O)=O)=CC=2)=C1 XPRMZBUQQMPKCR-UHFFFAOYSA-L 0.000 description 3
- 229960001484 edetic acid Drugs 0.000 description 3
- 230000005670 electromagnetic radiation Effects 0.000 description 3
- 238000007046 ethoxylation reaction Methods 0.000 description 3
- VYXSBFYARXAAKO-UHFFFAOYSA-N ethyl 2-[3-(ethylamino)-6-ethylimino-2,7-dimethylxanthen-9-yl]benzoate;hydron;chloride Chemical compound [Cl-].C1=2C=C(C)C(NCC)=CC=2OC2=CC(=[NH+]CC)C(C)=CC2=C1C1=CC=CC=C1C(=O)OCC VYXSBFYARXAAKO-UHFFFAOYSA-N 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 229910010272 inorganic material Inorganic materials 0.000 description 3
- 239000011147 inorganic material Substances 0.000 description 3
- FDZZZRQASAIRJF-UHFFFAOYSA-M malachite green Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 FDZZZRQASAIRJF-UHFFFAOYSA-M 0.000 description 3
- KVWWIYGFBYDJQC-UHFFFAOYSA-N methyl dihydrojasmonate Chemical compound CCCCCC1C(CC(=O)OC)CCC1=O KVWWIYGFBYDJQC-UHFFFAOYSA-N 0.000 description 3
- 239000011859 microparticle Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 238000002428 photodynamic therapy Methods 0.000 description 3
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 description 3
- 229920000058 polyacrylate Polymers 0.000 description 3
- 229920002647 polyamide Polymers 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- ODGAOXROABLFNM-UHFFFAOYSA-N polynoxylin Chemical compound O=C.NC(N)=O ODGAOXROABLFNM-UHFFFAOYSA-N 0.000 description 3
- 239000004800 polyvinyl chloride Substances 0.000 description 3
- 229920000915 polyvinyl chloride Polymers 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 150000003254 radicals Chemical group 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 229940100486 rice starch Drugs 0.000 description 3
- 102220202129 rs1057521108 Human genes 0.000 description 3
- 102220315634 rs1196125127 Human genes 0.000 description 3
- 102220050277 rs147509697 Human genes 0.000 description 3
- 102220258027 rs1553641257 Human genes 0.000 description 3
- 102220330036 rs1555864368 Human genes 0.000 description 3
- 102200118206 rs33936967 Human genes 0.000 description 3
- 102200082933 rs33968721 Human genes 0.000 description 3
- 102200082939 rs33972975 Human genes 0.000 description 3
- 102220040531 rs587778361 Human genes 0.000 description 3
- 102220065718 rs747893076 Human genes 0.000 description 3
- 102220286163 rs781670952 Human genes 0.000 description 3
- 102220083084 rs863224616 Human genes 0.000 description 3
- 102200091604 rs863225072 Human genes 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- AXMCIYLNKNGNOT-UHFFFAOYSA-N sodium;3-[[4-[(4-dimethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)-[4-[ethyl-[(3-sulfophenyl)methyl]amino]phenyl]methyl]-n-ethylanilino]methyl]benzenesulfonate Chemical compound [Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](C)C)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S(O)(=O)=O)=C1 AXMCIYLNKNGNOT-UHFFFAOYSA-N 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- FRPJTGXMTIIFIT-UHFFFAOYSA-N tetraacetylethylenediamine Chemical compound CC(=O)C(N)(C(C)=O)C(N)(C(C)=O)C(C)=O FRPJTGXMTIIFIT-UHFFFAOYSA-N 0.000 description 3
- 150000003573 thiols Chemical group 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- ROVRRJSRRSGUOL-UHFFFAOYSA-N victoria blue bo Chemical compound [Cl-].C12=CC=CC=C2C(NCC)=CC=C1C(C=1C=CC(=CC=1)N(CC)CC)=C1C=CC(=[N+](CC)CC)C=C1 ROVRRJSRRSGUOL-UHFFFAOYSA-N 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- 229930007850 β-damascenone Natural products 0.000 description 3
- MBDOYVRWFFCFHM-SNAWJCMRSA-N (2E)-hexenal Chemical compound CCC\C=C\C=O MBDOYVRWFFCFHM-SNAWJCMRSA-N 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 2
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 2
- CIOXZGOUEYHNBF-UHFFFAOYSA-N (carboxymethoxy)succinic acid Chemical compound OC(=O)COC(C(O)=O)CC(O)=O CIOXZGOUEYHNBF-UHFFFAOYSA-N 0.000 description 2
- JRJBVWJSTHECJK-LUAWRHEFSA-N (z)-3-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one Chemical compound CC(=O)C(\C)=C/C1C(C)=CCCC1(C)C JRJBVWJSTHECJK-LUAWRHEFSA-N 0.000 description 2
- YGFGZTXGYTUXBA-UHFFFAOYSA-N (±)-2,6-dimethyl-5-heptenal Chemical compound O=CC(C)CCC=C(C)C YGFGZTXGYTUXBA-UHFFFAOYSA-N 0.000 description 2
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 2
- VHJLVAABSRFDPM-UHFFFAOYSA-N 1,4-dithiothreitol Chemical compound SCC(O)C(O)CS VHJLVAABSRFDPM-UHFFFAOYSA-N 0.000 description 2
- FRASJONUBLZVQX-UHFFFAOYSA-N 1,4-naphthoquinone Chemical compound C1=CC=C2C(=O)C=CC(=O)C2=C1 FRASJONUBLZVQX-UHFFFAOYSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- ZNQIAQXHADXXQI-UHFFFAOYSA-N 1-anilino-4-hydroxyanthracene-9,10-dione Chemical compound C1=2C(=O)C3=CC=CC=C3C(=O)C=2C(O)=CC=C1NC1=CC=CC=C1 ZNQIAQXHADXXQI-UHFFFAOYSA-N 0.000 description 2
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 2
- JSRUDOBCTLPTFO-UHFFFAOYSA-N 2-[5-acetamido-n-(2-acetyloxyethyl)-4-[(2-bromo-4,6-dinitrophenyl)diazenyl]-2-methoxyanilino]ethyl acetate Chemical compound C1=C(N(CCOC(C)=O)CCOC(C)=O)C(OC)=CC(N=NC=2C(=CC(=CC=2Br)[N+]([O-])=O)[N+]([O-])=O)=C1NC(C)=O JSRUDOBCTLPTFO-UHFFFAOYSA-N 0.000 description 2
- UIHYHADQHHUIOF-UHFFFAOYSA-N 2-[n-ethyl-3-methyl-4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]anilino]ethanol Chemical compound CC1=CC(N(CCO)CC)=CC=C1N=NC1=NC=C([N+]([O-])=O)S1 UIHYHADQHHUIOF-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- CULIYQPRUGMRRT-UHFFFAOYSA-N 2-chloro-n-[2-[(2-cyano-4-nitrophenyl)diazenyl]-5-(diethylamino)phenyl]acetamide Chemical compound ClCC(=O)NC1=CC(N(CC)CC)=CC=C1N=NC1=CC=C([N+]([O-])=O)C=C1C#N CULIYQPRUGMRRT-UHFFFAOYSA-N 0.000 description 2
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 2
- DLHQZZUEERVIGQ-UHFFFAOYSA-N 3,7-dimethyl-3-octanol Chemical compound CCC(C)(O)CCCC(C)C DLHQZZUEERVIGQ-UHFFFAOYSA-N 0.000 description 2
- OHRBQTOZYGEWCJ-UHFFFAOYSA-N 3-(3-propan-2-ylphenyl)butanal Chemical compound CC(C)C1=CC=CC(C(C)CC=O)=C1 OHRBQTOZYGEWCJ-UHFFFAOYSA-N 0.000 description 2
- KWYJDIUEHHCHCZ-UHFFFAOYSA-N 3-[2-[bis(2-carboxyethyl)amino]ethyl-(2-carboxyethyl)amino]propanoic acid Chemical compound OC(=O)CCN(CCC(O)=O)CCN(CCC(O)=O)CCC(O)=O KWYJDIUEHHCHCZ-UHFFFAOYSA-N 0.000 description 2
- BGTBFNDXYDYBEY-FNORWQNLSA-N 4-(2,6,6-Trimethylcyclohex-1-enyl)but-2-en-4-one Chemical compound C\C=C\C(=O)C1=C(C)CCCC1(C)C BGTBFNDXYDYBEY-FNORWQNLSA-N 0.000 description 2
- CFNMUZCFSDMZPQ-GHXNOFRVSA-N 7-[(z)-3-methyl-4-(4-methyl-5-oxo-2h-furan-2-yl)but-2-enoxy]chromen-2-one Chemical compound C=1C=C2C=CC(=O)OC2=CC=1OC/C=C(/C)CC1OC(=O)C(C)=C1 CFNMUZCFSDMZPQ-GHXNOFRVSA-N 0.000 description 2
- AOMZHDJXSYHPKS-DROYEMJCSA-L Amido Black 10B Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC2=CC(S([O-])(=O)=O)=C(\N=N\C=3C=CC=CC=3)C(O)=C2C(N)=C1\N=N\C1=CC=C(N(=O)=O)C=C1 AOMZHDJXSYHPKS-DROYEMJCSA-L 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 102220487800 Estrogen receptor beta_S87D_mutation Human genes 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010053070 Glutathione Disulfide Proteins 0.000 description 2
- 102100021174 Lipoyl synthase, mitochondrial Human genes 0.000 description 2
- 239000006137 Luria-Bertani broth Substances 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 240000003183 Manihot esculenta Species 0.000 description 2
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 2
- 102000029749 Microtubule Human genes 0.000 description 2
- 108091022875 Microtubule Proteins 0.000 description 2
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- JYXGIOKAKDAARW-UHFFFAOYSA-N N-(2-hydroxyethyl)iminodiacetic acid Chemical compound OCCN(CC(O)=O)CC(O)=O JYXGIOKAKDAARW-UHFFFAOYSA-N 0.000 description 2
- MKWKNSIESPFAQN-UHFFFAOYSA-N N-cyclohexyl-2-aminoethanesulfonic acid Chemical compound OS(=O)(=O)CCNC1CCCCC1 MKWKNSIESPFAQN-UHFFFAOYSA-N 0.000 description 2
- SJEYSFABYSGQBG-UHFFFAOYSA-M Patent blue Chemical compound [Na+].C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=CC=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1 SJEYSFABYSGQBG-UHFFFAOYSA-M 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 229920002396 Polyurea Polymers 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 239000002262 Schiff base Substances 0.000 description 2
- 150000004753 Schiff bases Chemical class 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 229920001800 Shellac Polymers 0.000 description 2
- 108020004682 Single-Stranded DNA Proteins 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical class [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 239000004280 Sodium formate Substances 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 101710135785 Subtilisin-like protease Proteins 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- PZBFGYYEXUXCOF-UHFFFAOYSA-N TCEP Chemical compound OC(=O)CCP(CCC(O)=O)CCC(O)=O PZBFGYYEXUXCOF-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- MBHRHUJRKGNOKX-UHFFFAOYSA-N [(4,6-diamino-1,3,5-triazin-2-yl)amino]methanol Chemical compound NC1=NC(N)=NC(NCO)=N1 MBHRHUJRKGNOKX-UHFFFAOYSA-N 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- LIKZXCROQGHXTI-UHFFFAOYSA-M acid blue 25 Chemical compound [Na+].C1=2C(=O)C3=CC=CC=C3C(=O)C=2C(N)=C(S([O-])(=O)=O)C=C1NC1=CC=CC=C1 LIKZXCROQGHXTI-UHFFFAOYSA-M 0.000 description 2
- 239000000980 acid dye Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000002386 air freshener Substances 0.000 description 2
- 150000001294 alanine derivatives Chemical group 0.000 description 2
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 2
- 229910052910 alkali metal silicate Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- HPTYUNKZVDYXLP-UHFFFAOYSA-N aluminum;trihydroxy(trihydroxysilyloxy)silane;hydrate Chemical compound O.[Al].[Al].O[Si](O)(O)O[Si](O)(O)O HPTYUNKZVDYXLP-UHFFFAOYSA-N 0.000 description 2
- 229920003180 amino resin Polymers 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical class NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000000149 argon plasma sintering Methods 0.000 description 2
- 125000004104 aryloxy group Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- QMKYBPDZANOJGF-UHFFFAOYSA-N benzene-1,3,5-tricarboxylic acid Chemical compound OC(=O)C1=CC(C(O)=O)=CC(C(O)=O)=C1 QMKYBPDZANOJGF-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- POIARNZEYGURDG-UHFFFAOYSA-N beta-damascenone Natural products CC=CC(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 150000007942 carboxylates Chemical group 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- BPHHNXJPFPEJOF-UHFFFAOYSA-J chembl296966 Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]S(=O)(=O)C1=CC(S([O-])(=O)=O)=C(N)C2=C(O)C(N=NC3=CC=C(C=C3OC)C=3C=C(C(=CC=3)N=NC=3C(=C4C(N)=C(C=C(C4=CC=3)S([O-])(=O)=O)S([O-])(=O)=O)O)OC)=CC=C21 BPHHNXJPFPEJOF-UHFFFAOYSA-J 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- KSMVZQYAVGTKIV-UHFFFAOYSA-N decanal Chemical compound CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 239000000412 dendrimer Substances 0.000 description 2
- 229920000736 dendritic polymer Polymers 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- XSNQECSCDATQEL-UHFFFAOYSA-N dihydromyrcenol Chemical compound C=CC(C)CCCC(C)(C)O XSNQECSCDATQEL-UHFFFAOYSA-N 0.000 description 2
- 229930008394 dihydromyrcenol Natural products 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- YDGHROMBRLEXLZ-UHFFFAOYSA-L disodium 3-hydroxy-4-[(4-phenyldiazenylphenyl)diazenyl]naphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].Oc1c(cc2cc(ccc2c1N=Nc1ccc(cc1)N=Nc1ccccc1)S([O-])(=O)=O)S([O-])(=O)=O YDGHROMBRLEXLZ-UHFFFAOYSA-L 0.000 description 2
- LARMRMCFZNGNNX-UHFFFAOYSA-L disodium 7-anilino-3-[[4-[(2,4-dimethyl-6-sulfonatophenyl)diazenyl]-2-methoxy-5-methylphenyl]diazenyl]-4-hydroxynaphthalene-2-sulfonate Chemical compound [Na+].[Na+].COc1cc(N=Nc2c(C)cc(C)cc2S([O-])(=O)=O)c(C)cc1N=Nc1c(O)c2ccc(Nc3ccccc3)cc2cc1S([O-])(=O)=O LARMRMCFZNGNNX-UHFFFAOYSA-L 0.000 description 2
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- SLGWESQGEUXWJQ-UHFFFAOYSA-N formaldehyde;phenol Chemical compound O=C.OC1=CC=CC=C1 SLGWESQGEUXWJQ-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000002308 glutamine derivatives Chemical class 0.000 description 2
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 150000002332 glycine derivatives Chemical group 0.000 description 2
- 229920000578 graft copolymer Polymers 0.000 description 2
- 229910052621 halloysite Inorganic materials 0.000 description 2
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 125000001165 hydrophobic group Chemical group 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- UHOKSCJSTAHBSO-UHFFFAOYSA-N indanthrone blue Chemical compound C1=CC=C2C(=O)C3=CC=C4NC5=C6C(=O)C7=CC=CC=C7C(=O)C6=CC=C5NC4=C3C(=O)C2=C1 UHOKSCJSTAHBSO-UHFFFAOYSA-N 0.000 description 2
- 229930002839 ionone Natural products 0.000 description 2
- 150000002499 ionone derivatives Chemical class 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- SDQFDHOLCGWZPU-UHFFFAOYSA-N lilial Chemical compound O=CC(C)CC1=CC=C(C(C)(C)C)C=C1 SDQFDHOLCGWZPU-UHFFFAOYSA-N 0.000 description 2
- 229930007744 linalool Natural products 0.000 description 2
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- YDSWCNNOKPMOTP-UHFFFAOYSA-N mellitic acid Chemical compound OC(=O)C1=C(C(O)=O)C(C(O)=O)=C(C(O)=O)C(C(O)=O)=C1C(O)=O YDSWCNNOKPMOTP-UHFFFAOYSA-N 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- VHLFTCNAACYPDY-UHFFFAOYSA-N methyl 3-[n-ethyl-4-[(5-nitro-2,1-benzothiazol-3-yl)diazenyl]anilino]propanoate Chemical compound C1=CC(N(CCC(=O)OC)CC)=CC=C1N=NC1=C2C=C([N+]([O-])=O)C=CC2=NS1 VHLFTCNAACYPDY-UHFFFAOYSA-N 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- 108010020132 microbial serine proteinases Proteins 0.000 description 2
- 210000004688 microtubule Anatomy 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- WFFKSTRPZWRBEW-UHFFFAOYSA-N n-[2-[(2-bromo-4,6-dinitrophenyl)diazenyl]-5-(diethylamino)phenyl]acetamide Chemical compound CC(=O)NC1=CC(N(CC)CC)=CC=C1N=NC1=C(Br)C=C([N+]([O-])=O)C=C1[N+]([O-])=O WFFKSTRPZWRBEW-UHFFFAOYSA-N 0.000 description 2
- DMMDCPMHDXAIRV-UHFFFAOYSA-N n-[5-[bis(2-methoxyethyl)amino]-2-[(2-cyano-4-nitrophenyl)diazenyl]phenyl]acetamide Chemical compound CC(=O)NC1=CC(N(CCOC)CCOC)=CC=C1N=NC1=CC=C([N+]([O-])=O)C=C1C#N DMMDCPMHDXAIRV-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- QUBQYFYWUJJAAK-UHFFFAOYSA-N oxymethurea Chemical compound OCNC(=O)NCO QUBQYFYWUJJAAK-UHFFFAOYSA-N 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 2
- 229920001568 phenolic resin Polymers 0.000 description 2
- GVKCHTBDSMQENH-UHFFFAOYSA-L phloxine B Chemical compound [Na+].[Na+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 GVKCHTBDSMQENH-UHFFFAOYSA-L 0.000 description 2
- 150000003003 phosphines Chemical class 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920001084 poly(chloroprene) Polymers 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- 229920001707 polybutylene terephthalate Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 229920005646 polycarboxylate Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920001195 polyisoprene Polymers 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- KUIXZSYWBHSYCN-UHFFFAOYSA-L remazol brilliant blue r Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(N)=C2C(=O)C3=CC=CC=C3C(=O)C2=C1NC1=CC=CC(S(=O)(=O)CCOS([O-])(=O)=O)=C1 KUIXZSYWBHSYCN-UHFFFAOYSA-L 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 102220282554 rs1555593622 Human genes 0.000 description 2
- 102220028739 rs398123203 Human genes 0.000 description 2
- 102220132370 rs61762539 Human genes 0.000 description 2
- 102220272575 rs767681165 Human genes 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 150000003958 selenols Chemical class 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 239000004208 shellac Substances 0.000 description 2
- 229940113147 shellac Drugs 0.000 description 2
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 2
- 235000013874 shellac Nutrition 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- LGZQSRCLLIPAEE-UHFFFAOYSA-M sodium 1-[(4-sulfonaphthalen-1-yl)diazenyl]naphthalen-2-olate Chemical compound [Na+].C1=CC=C2C(N=NC3=C4C=CC=CC4=CC=C3O)=CC=C(S([O-])(=O)=O)C2=C1 LGZQSRCLLIPAEE-UHFFFAOYSA-M 0.000 description 2
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 2
- 235000019254 sodium formate Nutrition 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- GTKIEPUIFBBXJQ-UHFFFAOYSA-M sodium;2-[(4-hydroxy-9,10-dioxoanthracen-1-yl)amino]-5-methylbenzenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC1=CC=C(O)C2=C1C(=O)C1=CC=CC=C1C2=O GTKIEPUIFBBXJQ-UHFFFAOYSA-M 0.000 description 2
- FJBHGWADYLMEJG-UHFFFAOYSA-M sodium;3-[[4-[[4-(diethylamino)phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]-n-ethylanilino]methyl]benzenesulfonate Chemical compound [Na+].C1=CC(N(CC)CC)=CC=C1C(C=1C=CC(=CC=1)N(CC)CC=1C=C(C=CC=1)S([O-])(=O)=O)=C(C=C1)C=CC1=[N+](CC)CC1=CC=CC(S([O-])(=O)=O)=C1 FJBHGWADYLMEJG-UHFFFAOYSA-M 0.000 description 2
- MWNQXXOSWHCCOZ-UHFFFAOYSA-L sodium;oxido carbonate Chemical compound [Na+].[O-]OC([O-])=O MWNQXXOSWHCCOZ-UHFFFAOYSA-L 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 150000003871 sulfonates Chemical group 0.000 description 2
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 108010075550 termamyl Proteins 0.000 description 2
- QTTDXDAWQMDLOF-UHFFFAOYSA-J tetrasodium 3-[[4-[[4-[(6-amino-1-hydroxy-3-sulfonatonaphthalen-2-yl)diazenyl]-6-sulfonatonaphthalen-1-yl]diazenyl]naphthalen-1-yl]diazenyl]naphthalene-1,5-disulfonate Chemical compound [Na+].[Na+].[Na+].[Na+].Nc1ccc2c(O)c(N=Nc3ccc(N=Nc4ccc(N=Nc5cc(c6cccc(c6c5)S([O-])(=O)=O)S([O-])(=O)=O)c5ccccc45)c4ccc(cc34)S([O-])(=O)=O)c(cc2c1)S([O-])(=O)=O QTTDXDAWQMDLOF-UHFFFAOYSA-J 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 238000011179 visual inspection Methods 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- PEAGNRWWSMMRPZ-UHFFFAOYSA-L woodstain scarlet Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C2=C1N=NC(C=C1)=CC=C1N=NC1=CC=CC=C1 PEAGNRWWSMMRPZ-UHFFFAOYSA-L 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- SCMDRBZEIUMBBQ-UHFFFAOYSA-N (1e)-1-[(8-amino-3,7-dimethyl-10-phenylphenazin-10-ium-2-yl)hydrazinylidene]naphthalen-2-one;chloride Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N\N=C\3C4=CC=CC=C4C=CC/3=O)C=C2[N+]=1C1=CC=CC=C1 SCMDRBZEIUMBBQ-UHFFFAOYSA-N 0.000 description 1
- HZYHMHHBBBSGHB-UHFFFAOYSA-N (2E,6E)-2,6-Nonadienal Natural products CCC=CCCC=CC=O HZYHMHHBBBSGHB-UHFFFAOYSA-N 0.000 description 1
- HZYHMHHBBBSGHB-DYWGDJMRSA-N (2e,6e)-nona-2,6-dienal Chemical compound CC\C=C\CC\C=C\C=O HZYHMHHBBBSGHB-DYWGDJMRSA-N 0.000 description 1
- KRLBLPBPZSSIGH-CSKARUKUSA-N (6e)-3,7-dimethylnona-1,6-dien-3-ol Chemical compound CC\C(C)=C\CCC(C)(O)C=C KRLBLPBPZSSIGH-CSKARUKUSA-N 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- 239000001674 (E)-1-(2,6,6-trimethyl-1-cyclohexenyl)but-2-en-1-one Substances 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- QTKIQLNGOKOPOE-UHFFFAOYSA-N 1,1'-biphenyl;propane Chemical group CCC.C1=CC=CC=C1C1=CC=CC=C1 QTKIQLNGOKOPOE-UHFFFAOYSA-N 0.000 description 1
- QBJLBHNCDQHZLN-UHFFFAOYSA-N 1,2-bis(trimethylsilyl)hydrazine Chemical compound C[Si](C)(C)NN[Si](C)(C)C QBJLBHNCDQHZLN-UHFFFAOYSA-N 0.000 description 1
- KXTWDIPAGFPHCA-UHFFFAOYSA-N 1,2-dipropylnaphthalene Chemical compound C1=CC=CC2=C(CCC)C(CCC)=CC=C21 KXTWDIPAGFPHCA-UHFFFAOYSA-N 0.000 description 1
- ULYAQFDBACQQGC-UHFFFAOYSA-N 1,4-bis(2-ethylhexylamino)anthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(NCC(CC)CCCC)=CC=C2NCC(CC)CCCC ULYAQFDBACQQGC-UHFFFAOYSA-N 0.000 description 1
- OCQDPIXQTSYZJL-UHFFFAOYSA-N 1,4-bis(butylamino)anthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(NCCCC)=CC=C2NCCCC OCQDPIXQTSYZJL-UHFFFAOYSA-N 0.000 description 1
- JUUJTYPMICHIEM-UHFFFAOYSA-N 1,4-bis(ethylamino)anthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(NCC)=CC=C2NCC JUUJTYPMICHIEM-UHFFFAOYSA-N 0.000 description 1
- RHGBRYSELHPAFL-UHFFFAOYSA-N 1,4-bis(pentylamino)anthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(NCCCCC)=CC=C2NCCCCC RHGBRYSELHPAFL-UHFFFAOYSA-N 0.000 description 1
- KZYAYVSWIPZDKL-UHFFFAOYSA-N 1,4-diamino-2,3-dichloroanthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(N)=C(Cl)C(Cl)=C2N KZYAYVSWIPZDKL-UHFFFAOYSA-N 0.000 description 1
- FBMQNRKSAWNXBT-UHFFFAOYSA-N 1,4-diaminoanthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(N)=CC=C2N FBMQNRKSAWNXBT-UHFFFAOYSA-N 0.000 description 1
- FVUGZKDGWGKCFE-UHFFFAOYSA-N 1-(2,3,8,8-tetramethyl-1,3,4,5,6,7-hexahydronaphthalen-2-yl)ethanone Chemical compound CC1(C)CCCC2=C1CC(C(C)=O)(C)C(C)C2 FVUGZKDGWGKCFE-UHFFFAOYSA-N 0.000 description 1
- CWXZAJNUTOBAOI-UHFFFAOYSA-N 1-(2,3-dimethoxyphenyl)-2-hydroxy-2-phenylethanone Chemical class COC1=CC=CC(C(=O)C(O)C=2C=CC=CC=2)=C1OC CWXZAJNUTOBAOI-UHFFFAOYSA-N 0.000 description 1
- BGTBFNDXYDYBEY-UHFFFAOYSA-N 1-(2,6,6-trimethylcyclohexen-1-yl)but-2-en-1-one Chemical compound CC=CC(=O)C1=C(C)CCCC1(C)C BGTBFNDXYDYBEY-UHFFFAOYSA-N 0.000 description 1
- NLXFWUZKOOWWFD-UHFFFAOYSA-N 1-(2-hydroxyethylamino)-4-(methylamino)anthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(NCCO)=CC=C2NC NLXFWUZKOOWWFD-UHFFFAOYSA-N 0.000 description 1
- RTLULCVBFCRQKI-UHFFFAOYSA-N 1-amino-4-[3-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4-sulfoanilino]-9,10-dioxoanthracene-2-sulfonic acid Chemical compound C1=2C(=O)C3=CC=CC=C3C(=O)C=2C(N)=C(S(O)(=O)=O)C=C1NC(C=1)=CC=C(S(O)(=O)=O)C=1NC1=NC(Cl)=NC(Cl)=N1 RTLULCVBFCRQKI-UHFFFAOYSA-N 0.000 description 1
- IVFRHOQHKQWEHJ-UHFFFAOYSA-N 1-amino-4-[4-[(dimethylamino)methyl]anilino]anthracene-9,10-dione Chemical compound C1=CC(CN(C)C)=CC=C1NC1=CC=C(N)C2=C1C(=O)C1=CC=CC=C1C2=O IVFRHOQHKQWEHJ-UHFFFAOYSA-N 0.000 description 1
- AQXYVFBSOOBBQV-UHFFFAOYSA-N 1-amino-4-hydroxyanthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(O)=CC=C2N AQXYVFBSOOBBQV-UHFFFAOYSA-N 0.000 description 1
- DYALWCKAJBVSBZ-UHFFFAOYSA-N 1-anilino-4,5-dihydroxy-8-nitroanthracene-9,10-dione Chemical compound C1=2C(=O)C(C(=CC=C3O)[N+]([O-])=O)=C3C(=O)C=2C(O)=CC=C1NC1=CC=CC=C1 DYALWCKAJBVSBZ-UHFFFAOYSA-N 0.000 description 1
- OSSNTDFYBPYIEC-UHFFFAOYSA-N 1-ethenylimidazole Chemical compound C=CN1C=CN=C1 OSSNTDFYBPYIEC-UHFFFAOYSA-N 0.000 description 1
- BTYLJLLMYNHHNC-UHFFFAOYSA-N 1-hydroxy-1-phenylbutan-2-one Chemical compound CCC(=O)C(O)C1=CC=CC=C1 BTYLJLLMYNHHNC-UHFFFAOYSA-N 0.000 description 1
- OFHHDSQXFXLTKC-UHFFFAOYSA-N 10-undecenal Chemical compound C=CCCCCCCCCC=O OFHHDSQXFXLTKC-UHFFFAOYSA-N 0.000 description 1
- CTLDWNVYXLHMAS-UHFFFAOYSA-N 2,4,4,7-tetramethyloct-6-en-3-one Chemical compound CC(C)C(=O)C(C)(C)CC=C(C)C CTLDWNVYXLHMAS-UHFFFAOYSA-N 0.000 description 1
- VJSWLXWONORKLD-UHFFFAOYSA-N 2,4,6-trihydroxybenzene-1,3,5-trisulfonic acid Chemical compound OC1=C(S(O)(=O)=O)C(O)=C(S(O)(=O)=O)C(O)=C1S(O)(=O)=O VJSWLXWONORKLD-UHFFFAOYSA-N 0.000 description 1
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 1
- 229940029225 2,6-dimethyl-5-heptenal Drugs 0.000 description 1
- CFPOJWPDQWJEMO-UHFFFAOYSA-N 2-(1,2-dicarboxyethoxy)butanedioic acid Chemical compound OC(=O)CC(C(O)=O)OC(C(O)=O)CC(O)=O CFPOJWPDQWJEMO-UHFFFAOYSA-N 0.000 description 1
- OWHHXDIPKWEDQL-UHFFFAOYSA-N 2-(3,5-dimethoxyphenyl)-2-hydroxy-1-phenylethanone Chemical compound COC1=CC(OC)=CC(C(O)C(=O)C=2C=CC=CC=2)=C1 OWHHXDIPKWEDQL-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- YEVQZPWSVWZAOB-UHFFFAOYSA-N 2-(bromomethyl)-1-iodo-4-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=C(I)C(CBr)=C1 YEVQZPWSVWZAOB-UHFFFAOYSA-N 0.000 description 1
- GIKLVPMFFJZQLE-UHFFFAOYSA-N 2-[3-acetamido-n-(2-acetyloxyethyl)-4-[(2-bromo-4,6-dinitrophenyl)diazenyl]anilino]ethyl acetate Chemical compound CC(=O)NC1=CC(N(CCOC(C)=O)CCOC(C)=O)=CC=C1N=NC1=C(Br)C=C([N+]([O-])=O)C=C1[N+]([O-])=O GIKLVPMFFJZQLE-UHFFFAOYSA-N 0.000 description 1
- VQIRFOAILLIZOY-UHFFFAOYSA-N 2-[5-acetamido-n-(2-acetyloxyethyl)-4-[(2-bromo-4,6-dinitrophenyl)diazenyl]-2-ethoxyanilino]ethyl acetate Chemical compound C1=C(N(CCOC(C)=O)CCOC(C)=O)C(OCC)=CC(N=NC=2C(=CC(=CC=2Br)[N+]([O-])=O)[N+]([O-])=O)=C1NC(C)=O VQIRFOAILLIZOY-UHFFFAOYSA-N 0.000 description 1
- VRTQJBZLCYJJCI-UHFFFAOYSA-N 2-[5-acetamido-n-(2-acetyloxyethyl)-4-[(2-chloro-4,6-dinitrophenyl)diazenyl]-2-methoxyanilino]ethyl acetate Chemical compound C1=C(N(CCOC(C)=O)CCOC(C)=O)C(OC)=CC(N=NC=2C(=CC(=CC=2Cl)[N+]([O-])=O)[N+]([O-])=O)=C1NC(C)=O VRTQJBZLCYJJCI-UHFFFAOYSA-N 0.000 description 1
- DQMYXIPCBKSDCB-UHFFFAOYSA-N 2-[[4-[(2-chloro-4,6-dinitrophenyl)diazenyl]naphthalen-1-yl]amino]ethanol Chemical compound C12=CC=CC=C2C(NCCO)=CC=C1N=NC1=C(Cl)C=C([N+]([O-])=O)C=C1[N+]([O-])=O DQMYXIPCBKSDCB-UHFFFAOYSA-N 0.000 description 1
- YAOMDDRLRVOOIC-UHFFFAOYSA-N 2-[n-(2-acetyloxyethyl)-4-[(2-cyano-4-nitrophenyl)diazenyl]-3-methylanilino]ethyl acetate Chemical compound CC1=CC(N(CCOC(C)=O)CCOC(=O)C)=CC=C1N=NC1=CC=C([N+]([O-])=O)C=C1C#N YAOMDDRLRVOOIC-UHFFFAOYSA-N 0.000 description 1
- YPNBSXJSFUWYMV-UHFFFAOYSA-N 2-[n-(2-acetyloxyethyl)-4-[(3,5-dinitrothiophen-2-yl)diazenyl]anilino]ethyl acetate Chemical compound C1=CC(N(CCOC(C)=O)CCOC(=O)C)=CC=C1N=NC1=C([N+]([O-])=O)C=C([N+]([O-])=O)S1 YPNBSXJSFUWYMV-UHFFFAOYSA-N 0.000 description 1
- FOQABOMYTOFLPZ-UHFFFAOYSA-N 2-[n-ethyl-4-[(4-nitrophenyl)diazenyl]anilino]ethanol Chemical compound C1=CC(N(CCO)CC)=CC=C1N=NC1=CC=C([N+]([O-])=O)C=C1 FOQABOMYTOFLPZ-UHFFFAOYSA-N 0.000 description 1
- RQXTZKGDMNIWJF-UHFFFAOYSA-N 2-butan-2-ylcyclohexan-1-one Chemical compound CCC(C)C1CCCCC1=O RQXTZKGDMNIWJF-UHFFFAOYSA-N 0.000 description 1
- GZFRVDZZXXKIGR-UHFFFAOYSA-N 2-decanoyloxybenzoic acid Chemical compound CCCCCCCCCC(=O)OC1=CC=CC=C1C(O)=O GZFRVDZZXXKIGR-UHFFFAOYSA-N 0.000 description 1
- JRYKGPHTUZXUOJ-UHFFFAOYSA-N 2-hydroxy-1-(naphthalen-1-yldiazenyl)naphthalene-1,2-disulfonic acid Chemical compound C1=CC=C2C(N=NC3(C4=CC=CC=C4C=CC3(O)S(O)(=O)=O)S(O)(=O)=O)=CC=CC2=C1 JRYKGPHTUZXUOJ-UHFFFAOYSA-N 0.000 description 1
- HELBJVYNBIXRMJ-UHFFFAOYSA-N 2-hydroxy-1-[(4-phenyldiazenylphenyl)diazenyl]naphthalene-1,2-disulfonic acid Chemical compound OS(=O)(=O)C1(O)C=CC2=CC=CC=C2C1(S(O)(=O)=O)N=NC(C=C1)=CC=C1N=NC1=CC=CC=C1 HELBJVYNBIXRMJ-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- NFAVNWJJYQAGNB-UHFFFAOYSA-N 2-methylundecanal Chemical compound CCCCCCCCCC(C)C=O NFAVNWJJYQAGNB-UHFFFAOYSA-N 0.000 description 1
- OALHHIHQOFIMEF-UHFFFAOYSA-N 3',6'-dihydroxy-2',4',5',7'-tetraiodo-3h-spiro[2-benzofuran-1,9'-xanthene]-3-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 OALHHIHQOFIMEF-UHFFFAOYSA-N 0.000 description 1
- UWOFGIXNNCPENM-UHFFFAOYSA-N 3,3-difluoropentan-2-one Chemical compound CCC(F)(F)C(C)=O UWOFGIXNNCPENM-UHFFFAOYSA-N 0.000 description 1
- 229940019847 3-(3,4-methylenedioxyphenyl)-2-methylpropanal Drugs 0.000 description 1
- POELEEGOWIJNBI-UHFFFAOYSA-N 3-[2-[[4-(diethylamino)phenyl]diazenyl]-6-ethoxy-1,3-benzothiazol-3-ium-3-yl]propanamide;chloride Chemical compound [Cl-].S1C2=CC(OCC)=CC=C2[N+](CCC(N)=O)=C1N=NC1=CC=C(N(CC)CC)C=C1 POELEEGOWIJNBI-UHFFFAOYSA-N 0.000 description 1
- COCWIIAFGQLMGS-UHFFFAOYSA-N 3-[n-ethyl-3-methyl-4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]anilino]propane-1,2-diol Chemical compound CC1=CC(N(CC(O)CO)CC)=CC=C1N=NC1=NC=C([N+]([O-])=O)S1 COCWIIAFGQLMGS-UHFFFAOYSA-N 0.000 description 1
- ORMHZBNNECIKOH-UHFFFAOYSA-N 4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde Chemical compound CC(C)(O)CCCC1=CCC(C=O)CC1 ORMHZBNNECIKOH-UHFFFAOYSA-N 0.000 description 1
- GIGDKBCDRFBZHW-UHFFFAOYSA-N 4-[4-[(3-acetyl-5-nitrothiophen-2-yl)diazenyl]-n-ethyl-3-methylanilino]butyl acetate Chemical compound CC1=CC(N(CCCCOC(C)=O)CC)=CC=C1N=NC1=C(C(C)=O)C=C([N+]([O-])=O)S1 GIGDKBCDRFBZHW-UHFFFAOYSA-N 0.000 description 1
- AMPCGOAFZFKBGH-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]-(4-methyliminocyclohexa-2,5-dien-1-ylidene)methyl]-n,n-dimethylaniline Chemical compound C1=CC(=NC)C=CC1=C(C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 AMPCGOAFZFKBGH-UHFFFAOYSA-N 0.000 description 1
- GUOCOOQWZHQBJI-UHFFFAOYSA-N 4-oct-7-enoxy-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)OCCCCCCC=C GUOCOOQWZHQBJI-UHFFFAOYSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- YGUMVDWOQQJBGA-VAWYXSNFSA-N 5-[(4-anilino-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-2-[(e)-2-[4-[(4-anilino-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-2-sulfophenyl]ethenyl]benzenesulfonic acid Chemical compound C=1C=C(\C=C\C=2C(=CC(NC=3N=C(N=C(NC=4C=CC=CC=4)N=3)N3CCOCC3)=CC=2)S(O)(=O)=O)C(S(=O)(=O)O)=CC=1NC(N=C(N=1)N2CCOCC2)=NC=1NC1=CC=CC=C1 YGUMVDWOQQJBGA-VAWYXSNFSA-N 0.000 description 1
- CNGYZEMWVAWWOB-VAWYXSNFSA-N 5-[[4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-2-[(e)-2-[4-[[4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]benzenesulfonic acid Chemical compound N=1C(NC=2C=C(C(\C=C\C=3C(=CC(NC=4N=C(N=C(NC=5C=CC=CC=5)N=4)N(CCO)CCO)=CC=3)S(O)(=O)=O)=CC=2)S(O)(=O)=O)=NC(N(CCO)CCO)=NC=1NC1=CC=CC=C1 CNGYZEMWVAWWOB-VAWYXSNFSA-N 0.000 description 1
- JHRDMNILWGIFBI-UHFFFAOYSA-N 6-diazenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(N=N)=N1 JHRDMNILWGIFBI-UHFFFAOYSA-N 0.000 description 1
- VPAQKBFPDJQAMH-UHFFFAOYSA-N 6-hydroxy-5-[(4-methoxyphenyl)diazenyl]naphthalene-2-sulfonic acid Chemical compound C1=CC(OC)=CC=C1N=NC1=C(O)C=CC2=CC(S(O)(=O)=O)=CC=C12 VPAQKBFPDJQAMH-UHFFFAOYSA-N 0.000 description 1
- VRFMFQHSDWKYDM-UHFFFAOYSA-N 6-o-benzyl 1-o-butyl hexanedioate Chemical compound CCCCOC(=O)CCCCC(=O)OCC1=CC=CC=C1 VRFMFQHSDWKYDM-UHFFFAOYSA-N 0.000 description 1
- DECACTMEFWAFRE-UHFFFAOYSA-N 6-o-benzyl 1-o-octyl hexanedioate Chemical compound CCCCCCCCOC(=O)CCCCC(=O)OCC1=CC=CC=C1 DECACTMEFWAFRE-UHFFFAOYSA-N 0.000 description 1
- GZVHEAJQGPRDLQ-UHFFFAOYSA-N 6-phenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(C=2C=CC=CC=2)=N1 GZVHEAJQGPRDLQ-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- JHJCHCSUEGPIGE-UHFFFAOYSA-N 7,8-Dihydro-alpha-ionone Chemical compound CC(=O)CCC1C(C)=CCCC1(C)C JHJCHCSUEGPIGE-UHFFFAOYSA-N 0.000 description 1
- PONZBUKBFVIXOD-UHFFFAOYSA-N 9,10-dicarbamoylperylene-3,4-dicarboxylic acid Chemical compound C=12C3=CC=C(C(O)=O)C2=C(C(O)=O)C=CC=1C1=CC=C(C(O)=N)C2=C1C3=CC=C2C(=N)O PONZBUKBFVIXOD-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- CQPFMGBJSMSXLP-ZAGWXBKKSA-M Acid orange 7 Chemical compound OC1=C(C2=CC=CC=C2C=C1)/N=N/C1=CC=C(C=C1)S(=O)(=O)[O-].[Na+] CQPFMGBJSMSXLP-ZAGWXBKKSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000198134 Agave sisalana Species 0.000 description 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 description 1
- 241000193752 Bacillus circulans Species 0.000 description 1
- 241001328122 Bacillus clausii Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- 241000193381 Bacillus sp. 707 Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 108700038091 Beta-glucanases Proteins 0.000 description 1
- 240000008564 Boehmeria nivea Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000149420 Bothrometopus brevis Species 0.000 description 1
- PLOBFIRAJCYMPR-UHFFFAOYSA-N BrC1=C2C(C(Br)=C(Cl)C(C3=O)Cl)=C3C=C(C=C3)C2=C2C3=CC3=C(C=CC=C4)C4=CC4=CC=C1C2=C34 Chemical compound BrC1=C2C(C(Br)=C(Cl)C(C3=O)Cl)=C3C=C(C=C3)C2=C2C3=CC3=C(C=CC=C4)C4=CC4=CC=C1C2=C34 PLOBFIRAJCYMPR-UHFFFAOYSA-N 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 241000208199 Buxus sempervirens Species 0.000 description 1
- RTMBGDBBDQKNNZ-UHFFFAOYSA-L C.I. Acid Blue 3 Chemical compound [Ca+2].C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=C(O)C=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1.C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=C(O)C=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1 RTMBGDBBDQKNNZ-UHFFFAOYSA-L 0.000 description 1
- YCRNIVQIJVDGSM-UHFFFAOYSA-N C1=C2C(C(Br)=C(Cl)C(C3=O)Cl)=C3C=C(C=C3)C2=C2C3=CC3=C(C=CC=C4)C4=CC4=CC=C1C2=C34 Chemical compound C1=C2C(C(Br)=C(Cl)C(C3=O)Cl)=C3C=C(C=C3)C2=C2C3=CC3=C(C=CC=C4)C4=CC4=CC=C1C2=C34 YCRNIVQIJVDGSM-UHFFFAOYSA-N 0.000 description 1
- SIIUCZGVLNNCPO-UHFFFAOYSA-N C1=C2C(C=C(Cl)C(C3=O)Cl)=C3C=C(C=C3)C2=C2C3=CC3=C(C=CC=C4)C4=CC4=CC=C1C2=C34 Chemical compound C1=C2C(C=C(Cl)C(C3=O)Cl)=C3C=C(C=C3)C2=C2C3=CC3=C(C=CC=C4)C4=CC4=CC=C1C2=C34 SIIUCZGVLNNCPO-UHFFFAOYSA-N 0.000 description 1
- 239000008000 CHES buffer Substances 0.000 description 1
- CBOCVOKPQGJKKJ-UHFFFAOYSA-L Calcium formate Chemical compound [Ca+2].[O-]C=O.[O-]C=O CBOCVOKPQGJKKJ-UHFFFAOYSA-L 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102220591061 Cellular tumor antigen p53_S183A_mutation Human genes 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 108090000227 Chymases Proteins 0.000 description 1
- 102000003858 Chymases Human genes 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 240000000491 Corchorus aestuans Species 0.000 description 1
- 235000011777 Corchorus aestuans Nutrition 0.000 description 1
- 235000010862 Corchorus capsularis Nutrition 0.000 description 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 1
- PJWWRFATQTVXHA-UHFFFAOYSA-N Cyclohexylaminopropanesulfonic acid Chemical compound OS(=O)(=O)CCCNC1CCCCC1 PJWWRFATQTVXHA-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 102000016559 DNA Primase Human genes 0.000 description 1
- 108010092681 DNA Primase Proteins 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- XTJFFFGAUHQWII-UHFFFAOYSA-N Dibutyl adipate Chemical compound CCCCOC(=O)CCCCC(=O)OCCCC XTJFFFGAUHQWII-UHFFFAOYSA-N 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- HMAJVAFLGGPIPN-UHFFFAOYSA-N Disperse Blue 124 Chemical compound CC1=CC(N(CCOC(C)=O)CC)=CC=C1N=NC1=NC=C([N+]([O-])=O)S1 HMAJVAFLGGPIPN-UHFFFAOYSA-N 0.000 description 1
- FOQABOMYTOFLPZ-ISLYRVAYSA-N Disperse Red 1 Chemical compound C1=CC(N(CCO)CC)=CC=C1\N=N\C1=CC=C([N+]([O-])=O)C=C1 FOQABOMYTOFLPZ-ISLYRVAYSA-N 0.000 description 1
- 108010083608 Durazym Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- HMEKVHWROSNWPD-UHFFFAOYSA-N Erioglaucine A Chemical compound [NH4+].[NH4+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 HMEKVHWROSNWPD-UHFFFAOYSA-N 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 239000004831 Hot glue Substances 0.000 description 1
- 238000012695 Interfacial polymerization Methods 0.000 description 1
- 102100027612 Kallikrein-11 Human genes 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 241000234269 Liliales Species 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 1
- 241001625930 Luria Species 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 description 1
- 239000006001 Methyl nonyl ketone Substances 0.000 description 1
- 239000012901 Milli-Q water Substances 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 239000007977 PBT buffer Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000194109 Paenibacillus lautus Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 229930182556 Polyacetal Natural products 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000004697 Polyetherimide Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229920000265 Polyparaphenylene Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004734 Polyphenylene sulfide Substances 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 239000004954 Polyphthalamide Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102220643724 Prolactin-inducible protein_A90Y_mutation Human genes 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 102220484935 Protein CIP2A_Q185A_mutation Human genes 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- 241000220010 Rhode Species 0.000 description 1
- 102220528606 Ribonuclease P/MRP protein subunit POP5_S99D_mutation Human genes 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 239000002174 Styrene-butadiene Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- YCUVUDODLRLVIC-UHFFFAOYSA-N Sudan black B Chemical compound C1=CC(=C23)NC(C)(C)NC2=CC=CC3=C1N=NC(C1=CC=CC=C11)=CC=C1N=NC1=CC=CC=C1 YCUVUDODLRLVIC-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 1
- YSMRWXYRXBRSND-UHFFFAOYSA-N TOTP Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C YSMRWXYRXBRSND-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 102220466433 Testis-specific H1 histone_G157S_mutation Human genes 0.000 description 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 1
- 241000589500 Thermus aquaticus Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 239000007997 Tricine buffer Substances 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 101710152431 Trypsin-like protease Proteins 0.000 description 1
- 208000034953 Twin anemia-polycythemia sequence Diseases 0.000 description 1
- KMPQYAYAQWNLME-UHFFFAOYSA-N Undecanal Natural products CCCCCCCCCCC=O KMPQYAYAQWNLME-UHFFFAOYSA-N 0.000 description 1
- ZVNYJIZDIRKMBF-UHFFFAOYSA-N Vesnarinone Chemical compound C1=C(OC)C(OC)=CC=C1C(=O)N1CCN(C=2C=C3CCC(=O)NC3=CC=2)CC1 ZVNYJIZDIRKMBF-UHFFFAOYSA-N 0.000 description 1
- 229920002522 Wood fibre Polymers 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- GRPFBMKYXAYEJM-UHFFFAOYSA-M [4-[(2-chlorophenyl)-[4-(dimethylamino)phenyl]methylidene]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium;chloride Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C(=CC=CC=1)Cl)=C1C=CC(=[N+](C)C)C=C1 GRPFBMKYXAYEJM-UHFFFAOYSA-M 0.000 description 1
- CNYGFPPAGUCRIC-UHFFFAOYSA-L [4-[[4-(dimethylamino)phenyl]-phenylmethylidene]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium;2-hydroxy-2-oxoacetate;oxalic acid Chemical compound OC(=O)C(O)=O.OC(=O)C([O-])=O.OC(=O)C([O-])=O.C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1.C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 CNYGFPPAGUCRIC-UHFFFAOYSA-L 0.000 description 1
- IURGIPVDZKDLIX-UHFFFAOYSA-M [7-(diethylamino)phenoxazin-3-ylidene]-diethylazanium;chloride Chemical compound [Cl-].C1=CC(=[N+](CC)CC)C=C2OC3=CC(N(CC)CC)=CC=C3N=C21 IURGIPVDZKDLIX-UHFFFAOYSA-M 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical class [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- ZXGIHDNEIWPDFW-UHFFFAOYSA-M acid red 4 Chemical compound [Na+].COC1=CC=CC=C1N=NC1=CC(S([O-])(=O)=O)=C(C=CC=C2)C2=C1O ZXGIHDNEIWPDFW-UHFFFAOYSA-M 0.000 description 1
- 229940099540 acid violet 43 Drugs 0.000 description 1
- GTZCVFVGUGFEME-UHFFFAOYSA-N aconitic acid Chemical compound OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 description 1
- 229920006397 acrylic thermoplastic Polymers 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 229920002214 alkoxylated polymer Polymers 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- HMKKIXGYKWDQSV-KAMYIIQDSA-N alpha-Amylcinnamaldehyde Chemical compound CCCCC\C(C=O)=C\C1=CC=CC=C1 HMKKIXGYKWDQSV-KAMYIIQDSA-N 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- GUUHFMWKWLOQMM-UHFFFAOYSA-N alpha-n-hexylcinnamic aldehyde Natural products CCCCCCC(C=O)=CC1=CC=CC=C1 GUUHFMWKWLOQMM-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910000091 aluminium hydride Inorganic materials 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229940093740 amino acid and derivative Drugs 0.000 description 1
- 125000005001 aminoaryl group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 239000003849 aromatic solvent Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- CREXVNNSNOKDHW-UHFFFAOYSA-N azaniumylideneazanide Chemical group N[N] CREXVNNSNOKDHW-UHFFFAOYSA-N 0.000 description 1
- 239000000987 azo dye Substances 0.000 description 1
- QZKHGYGBYOUFGK-UHFFFAOYSA-L azocarmine B Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(S(=O)(=O)[O-])=CC=C1NC(C1=CC(=CC=C1C1=NC2=CC=CC=C22)S([O-])(=O)=O)=CC1=[N+]2C1=CC=CC=C1 QZKHGYGBYOUFGK-UHFFFAOYSA-L 0.000 description 1
- 235000012733 azorubine Nutrition 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- BDFZFGDTHFGWRQ-UHFFFAOYSA-N basic brown 1 Chemical compound NC1=CC(N)=CC=C1N=NC1=CC=CC(N=NC=2C(=CC(N)=CC=2)N)=C1 BDFZFGDTHFGWRQ-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- XJHABGPPCLHLLV-UHFFFAOYSA-N benzo[de]isoquinoline-1,3-dione Chemical compound C1=CC(C(=O)NC2=O)=C3C2=CC=CC3=C1 XJHABGPPCLHLLV-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 108010064866 biozym Proteins 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 150000001639 boron compounds Chemical class 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- FZJUFJKVIYFBSY-UHFFFAOYSA-N bourgeonal Chemical compound CC(C)(C)C1=CC=C(CCC=O)C=C1 FZJUFJKVIYFBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 239000004161 brilliant blue FCF Substances 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
- NTXGQCSETZTARF-UHFFFAOYSA-N buta-1,3-diene;prop-2-enenitrile Chemical compound C=CC=C.C=CC#N NTXGQCSETZTARF-UHFFFAOYSA-N 0.000 description 1
- MTAZNLWOLGHBHU-UHFFFAOYSA-N butadiene-styrene rubber Chemical compound C=CC=C.C=CC1=CC=CC=C1 MTAZNLWOLGHBHU-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 102220346725 c.134A>G Human genes 0.000 description 1
- 102220352322 c.232A>C Human genes 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000019255 calcium formate Nutrition 0.000 description 1
- 239000004281 calcium formate Substances 0.000 description 1
- 229940044172 calcium formate Drugs 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000002729 catgut Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- IWWWBRIIGAXLCJ-BGABXYSRSA-N chembl1185241 Chemical compound C1=2C=C(C)C(NCC)=CC=2OC2=C\C(=N/CC)C(C)=CC2=C1C1=CC=CC=C1C(=O)OCC IWWWBRIIGAXLCJ-BGABXYSRSA-N 0.000 description 1
- HFIYIRIMGZMCPC-UHFFFAOYSA-J chembl1326377 Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]S(=O)(=O)C1=CC2=CC(S([O-])(=O)=O)=C(N=NC=3C=CC(=CC=3)S(=O)(=O)CCOS([O-])(=O)=O)C(O)=C2C(N)=C1N=NC1=CC=C(S(=O)(=O)CCOS([O-])(=O)=O)C=C1 HFIYIRIMGZMCPC-UHFFFAOYSA-J 0.000 description 1
- SMQYMAVYZRHNIE-UHFFFAOYSA-N chembl1554854 Chemical compound C1=CC(C)=CC=C1N=NC1=C(O)C=CC2=CC(S(O)(=O)=O)=CC=C12 SMQYMAVYZRHNIE-UHFFFAOYSA-N 0.000 description 1
- YOCIQNIEQYCORH-UHFFFAOYSA-M chembl2028361 Chemical compound [Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=CC=C1 YOCIQNIEQYCORH-UHFFFAOYSA-M 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 238000005354 coacervation Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 239000011258 core-shell material Substances 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- 229940100539 dibutyl adipate Drugs 0.000 description 1
- FTGXCLZZPPMCHU-UHFFFAOYSA-F dicopper;tetrasodium;3-oxido-4-[[2-oxido-4-[3-oxido-4-[(2-oxido-3,6-disulfonatonaphthalen-1-yl)diazenyl]phenyl]phenyl]diazenyl]naphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].[Na+].[Na+].[Cu+2].[Cu+2].[O-]S(=O)(=O)C1=CC=C2C(N=NC3=CC=C(C=C3[O-])C=3C=C(C(=CC=3)N=NC=3C4=CC=C(C=C4C=C(C=3[O-])S([O-])(=O)=O)S([O-])(=O)=O)[O-])=C([O-])C(S([O-])(=O)=O)=CC2=C1 FTGXCLZZPPMCHU-UHFFFAOYSA-F 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- PPSZHCXTGRHULJ-UHFFFAOYSA-N dioxazine Chemical compound O1ON=CC=C1 PPSZHCXTGRHULJ-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- LHRXTFDXJQAGAV-UHFFFAOYSA-L disodium 3-hydroxy-4-(naphthalen-1-yldiazenyl)naphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].Oc1c(cc2cc(ccc2c1N=Nc1cccc2ccccc12)S([O-])(=O)=O)S([O-])(=O)=O LHRXTFDXJQAGAV-UHFFFAOYSA-L 0.000 description 1
- JCEBMROGCIEFRX-UHFFFAOYSA-L disodium 5-[(2-hydroxynaphthalen-1-yl)diazenyl]-2-[4-[(2-hydroxynaphthalen-1-yl)diazenyl]-2-sulfonatophenyl]benzenesulfonate Chemical compound OC1=C(C2=CC=CC=C2C=C1)N=NC=1C=C(C(=CC=1)C1=CC=C(C=C1S(=O)(=O)[O-])N=NC1=C(C=CC2=CC=CC=C12)O)S(=O)(=O)[O-].[Na+].[Na+] JCEBMROGCIEFRX-UHFFFAOYSA-L 0.000 description 1
- NJPXFJXCALXJCX-UHFFFAOYSA-L disodium 7-anilino-3-[[4-[(2,4-dimethyl-6-sulfonatophenyl)diazenyl]-2,5-dimethylphenyl]diazenyl]-4-hydroxynaphthalene-2-sulfonate Chemical compound [Na+].[Na+].Cc1cc(C)c(N=Nc2cc(C)c(cc2C)N=Nc2c(O)c3ccc(Nc4ccccc4)cc3cc2S([O-])(=O)=O)c(c1)S([O-])(=O)=O NJPXFJXCALXJCX-UHFFFAOYSA-L 0.000 description 1
- PMPJQLCPEQFEJW-HPKCLRQXSA-L disodium;2-[(e)-2-[4-[4-[(e)-2-(2-sulfonatophenyl)ethenyl]phenyl]phenyl]ethenyl]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC=CC=C1\C=C\C1=CC=C(C=2C=CC(\C=C\C=3C(=CC=CC=3)S([O-])(=O)=O)=CC=2)C=C1 PMPJQLCPEQFEJW-HPKCLRQXSA-L 0.000 description 1
- UHXQPQCJDDSMCB-UHFFFAOYSA-L disodium;3-[[9,10-dioxo-4-(2,4,6-trimethyl-3-sulfonatoanilino)anthracen-1-yl]amino]-2,4,6-trimethylbenzenesulfonate Chemical compound [Na+].[Na+].CC1=CC(C)=C(S([O-])(=O)=O)C(C)=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=C(C)C=C(C)C(S([O-])(=O)=O)=C1C UHXQPQCJDDSMCB-UHFFFAOYSA-L 0.000 description 1
- WSALIDVQXCHFEG-UHFFFAOYSA-L disodium;4,8-diamino-1,5-dihydroxy-9,10-dioxoanthracene-2,6-disulfonate Chemical compound [Na+].[Na+].O=C1C2=C(N)C=C(S([O-])(=O)=O)C(O)=C2C(=O)C2=C1C(O)=C(S([O-])(=O)=O)C=C2N WSALIDVQXCHFEG-UHFFFAOYSA-L 0.000 description 1
- YSVBPNGJESBVRM-UHFFFAOYSA-L disodium;4-[(1-oxido-4-sulfonaphthalen-2-yl)diazenyl]naphthalene-1-sulfonate Chemical compound [Na+].[Na+].C1=CC=C2C(N=NC3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)O)=CC=C(S([O-])(=O)=O)C2=C1 YSVBPNGJESBVRM-UHFFFAOYSA-L 0.000 description 1
- BOXAUJCFZBSNKZ-UHFFFAOYSA-L disodium;5-butyl-2-[[4-(4-butyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(CCCC)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(CCCC)C=C1S([O-])(=O)=O BOXAUJCFZBSNKZ-UHFFFAOYSA-L 0.000 description 1
- 229940117964 disperse blue 106 Drugs 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 1
- 238000004453 electron probe microanalysis Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- QGAYMQGSQUXCQO-UHFFFAOYSA-L eosin b Chemical compound [Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC([N+]([O-])=O)=C([O-])C(Br)=C1OC1=C2C=C([N+]([O-])=O)C([O-])=C1Br QGAYMQGSQUXCQO-UHFFFAOYSA-L 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
- HDERJYVLTPVNRI-UHFFFAOYSA-N ethene;ethenyl acetate Chemical group C=C.CC(=O)OC=C HDERJYVLTPVNRI-UHFFFAOYSA-N 0.000 description 1
- UZABCLFSICXBCM-UHFFFAOYSA-N ethoxy hydrogen sulfate Chemical compound CCOOS(O)(=O)=O UZABCLFSICXBCM-UHFFFAOYSA-N 0.000 description 1
- TVQGDYNRXLTQAP-UHFFFAOYSA-N ethyl heptanoate Chemical compound CCCCCCC(=O)OCC TVQGDYNRXLTQAP-UHFFFAOYSA-N 0.000 description 1
- JVICFMRAVNKDOE-UHFFFAOYSA-M ethyl violet Chemical compound [Cl-].C1=CC(N(CC)CC)=CC=C1C(C=1C=CC(=CC=1)N(CC)CC)=C1C=CC(=[N+](CC)CC)C=C1 JVICFMRAVNKDOE-UHFFFAOYSA-M 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 229940044170 formate Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- VPVSTMAPERLKKM-UHFFFAOYSA-N glycoluril Chemical compound N1C(=O)NC2NC(=O)NC21 VPVSTMAPERLKKM-UHFFFAOYSA-N 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- RBTKNAXYKSUFRK-UHFFFAOYSA-N heliogen blue Chemical compound [Cu].[N-]1C2=C(C=CC=C3)C3=C1N=C([N-]1)C3=CC=CC=C3C1=NC([N-]1)=C(C=CC=C3)C3=C1N=C([N-]1)C3=CC=CC=C3C1=N2 RBTKNAXYKSUFRK-UHFFFAOYSA-N 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 1
- HNMCSUXJLGGQFO-UHFFFAOYSA-N hexaaluminum;hexasodium;tetrathietane;hexasilicate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].S1SSS1.S1SSS1.[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] HNMCSUXJLGGQFO-UHFFFAOYSA-N 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 239000012943 hotmelt Substances 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- SYGRIMFNUFCHJC-UHFFFAOYSA-N hydron;4-methyl-6-phenyldiazenylbenzene-1,3-diamine;chloride Chemical compound Cl.C1=C(N)C(C)=CC(N=NC=2C=CC=CC=2)=C1N SYGRIMFNUFCHJC-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 150000002443 hydroxylamines Chemical class 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 125000005462 imide group Chemical group 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 235000019239 indanthrene blue RS Nutrition 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 238000002743 insertional mutagenesis Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- YJSUCBQWLKRPDL-UHFFFAOYSA-N isocyclocitral Chemical compound CC1CC(C)=CC(C)C1C=O YJSUCBQWLKRPDL-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- BSIHWSXXPBAGTC-UHFFFAOYSA-N isoviolanthrone Chemical compound C12=CC=CC=C2C(=O)C2=CC=C3C(C4=C56)=CC=C5C5=CC=CC=C5C(=O)C6=CC=C4C4=C3C2=C1C=C4 BSIHWSXXPBAGTC-UHFFFAOYSA-N 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000003350 kerosene Substances 0.000 description 1
- 239000002655 kraft paper Substances 0.000 description 1
- 238000004900 laundering Methods 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 150000002697 manganese compounds Chemical class 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 1
- 150000007974 melamines Chemical class 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 108010003855 mesentericopeptidase Proteins 0.000 description 1
- TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 108010009355 microbial metalloproteinases Proteins 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 238000002887 multiple sequence alignment Methods 0.000 description 1
- CFCALFPBVJLIHA-UHFFFAOYSA-N n-[2-[(2-bromo-4,6-dinitrophenyl)diazenyl]-5-[2-cyanoethyl(ethyl)amino]-4-methoxyphenyl]acetamide Chemical compound C1=C(OC)C(N(CCC#N)CC)=CC(NC(C)=O)=C1N=NC1=C(Br)C=C([N+]([O-])=O)C=C1[N+]([O-])=O CFCALFPBVJLIHA-UHFFFAOYSA-N 0.000 description 1
- QBCBEQSWSOZGPB-UHFFFAOYSA-N n-[5-[bis(2-methoxyethyl)amino]-2-[(5-nitro-2,1-benzothiazol-3-yl)diazenyl]phenyl]acetamide Chemical compound CC(=O)NC1=CC(N(CCOC)CCOC)=CC=C1N=NC1=C2C=C([N+]([O-])=O)C=CC2=NS1 QBCBEQSWSOZGPB-UHFFFAOYSA-N 0.000 description 1
- WXDXQSMFRITTEJ-UHFFFAOYSA-N n-[5-[bis(prop-2-enyl)amino]-2-[(2-bromo-4,6-dinitrophenyl)diazenyl]-4-methoxyphenyl]acetamide Chemical compound C1=C(N(CC=C)CC=C)C(OC)=CC(N=NC=2C(=CC(=CC=2Br)[N+]([O-])=O)[N+]([O-])=O)=C1NC(C)=O WXDXQSMFRITTEJ-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- KJPHTXTWFHVJIG-UHFFFAOYSA-N n-ethyl-2-[(6-methoxypyridin-3-yl)-(2-methylphenyl)sulfonylamino]-n-(pyridin-3-ylmethyl)acetamide Chemical compound C=1C=C(OC)N=CC=1N(S(=O)(=O)C=1C(=CC=CC=1)C)CC(=O)N(CC)CC1=CC=CN=C1 KJPHTXTWFHVJIG-UHFFFAOYSA-N 0.000 description 1
- ONLRKTIYOMZEJM-UHFFFAOYSA-N n-methylmethanamine oxide Chemical compound C[NH+](C)[O-] ONLRKTIYOMZEJM-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- CXOMTHVASMLVLX-UHFFFAOYSA-N naphtho[2,3-f]quinazoline-1-carboxamide Chemical class C1=CC=CC2=CC3=C4C(C(=O)N)=NC=NC4=CC=C3C=C21 CXOMTHVASMLVLX-UHFFFAOYSA-N 0.000 description 1
- IPSIPYMEZZPCPY-UHFFFAOYSA-N new fuchsin Chemical compound [Cl-].C1=CC(=[NH2+])C(C)=CC1=C(C=1C=C(C)C(N)=CC=1)C1=CC=C(N)C(C)=C1 IPSIPYMEZZPCPY-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- BOPPSUHPZARXTH-UHFFFAOYSA-N ocean propanal Chemical compound O=CC(C)CC1=CC=C2OCOC2=C1 BOPPSUHPZARXTH-UHFFFAOYSA-N 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000001282 organosilanes Chemical class 0.000 description 1
- 125000005375 organosiloxane group Chemical group 0.000 description 1
- 150000002905 orthoesters Chemical class 0.000 description 1
- 150000002917 oxazolidines Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1
- 229950005308 oxymethurea Drugs 0.000 description 1
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000012736 patent blue V Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000012437 perfumed product Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 150000004968 peroxymonosulfuric acids Chemical class 0.000 description 1
- 125000005342 perphosphate group Chemical group 0.000 description 1
- JRKICGRDRMAZLK-UHFFFAOYSA-L persulfate group Chemical group S(=O)(=O)([O-])OOS(=O)(=O)[O-] JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- KROGEBGRISJYMV-UHFFFAOYSA-N phenyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CC(=O)OC1=CC=CC=C1 KROGEBGRISJYMV-UHFFFAOYSA-N 0.000 description 1
- SIENSFABYFDZCL-UHFFFAOYSA-N phenyl decanoate Chemical compound CCCCCCCCCC(=O)OC1=CC=CC=C1 SIENSFABYFDZCL-UHFFFAOYSA-N 0.000 description 1
- ZPORCTAUIXXZAI-UHFFFAOYSA-N phenyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC1=CC=CC=C1 ZPORCTAUIXXZAI-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 125000005498 phthalate group Chemical class 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920002006 poly(N-vinylimidazole) polymer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000162 poly(ureaurethane) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920006260 polyaryletherketone Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920001748 polybutylene Polymers 0.000 description 1
- 229920001123 polycyclohexylenedimethylene terephthalate Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920001601 polyetherimide Polymers 0.000 description 1
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920001470 polyketone Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920001444 polymaleic acid Polymers 0.000 description 1
- 229920005594 polymer fiber Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000306 polymethylpentene Polymers 0.000 description 1
- 239000011116 polymethylpentene Substances 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920006380 polyphenylene oxide Polymers 0.000 description 1
- 229920000069 polyphenylene sulfide Polymers 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229920006375 polyphtalamide Polymers 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 230000036316 preload Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- XWZDJOJCYUSIEY-YOYNBWDYSA-L procion red MX-5B Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC2=CC(S([O-])(=O)=O)=CC(NC=3N=C(Cl)N=C(Cl)N=3)=C2C(O)=C1\N=N\C1=CC=CC=C1 XWZDJOJCYUSIEY-YOYNBWDYSA-L 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000003614 protease activity assay Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- LLBIOIRWAYBCKK-UHFFFAOYSA-N pyranthrene-8,16-dione Chemical compound C12=CC=CC=C2C(=O)C2=CC=C3C=C4C5=CC=CC=C5C(=O)C5=C4C4=C3C2=C1C=C4C=C5 LLBIOIRWAYBCKK-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 239000000985 reactive dye Substances 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- AZJPTIGZZTZIDR-UHFFFAOYSA-L rose bengal Chemical compound [K+].[K+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 AZJPTIGZZTZIDR-UHFFFAOYSA-L 0.000 description 1
- 229960003138 rose bengal sodium Drugs 0.000 description 1
- 102200016466 rs104894277 Human genes 0.000 description 1
- 102200006013 rs104894296 Human genes 0.000 description 1
- 102220004033 rs104894945 Human genes 0.000 description 1
- 102220206585 rs1057524640 Human genes 0.000 description 1
- 102200143063 rs121908290 Human genes 0.000 description 1
- 102220061994 rs144792613 Human genes 0.000 description 1
- 102220276530 rs1553127798 Human genes 0.000 description 1
- 102220024793 rs199472842 Human genes 0.000 description 1
- 102200002990 rs28937320 Human genes 0.000 description 1
- 102200027522 rs34136999 Human genes 0.000 description 1
- 102220317777 rs371353189 Human genes 0.000 description 1
- 102220044692 rs373655067 Human genes 0.000 description 1
- 102220248108 rs377129682 Human genes 0.000 description 1
- 102200152683 rs45479896 Human genes 0.000 description 1
- 102220041180 rs527934999 Human genes 0.000 description 1
- 102220039705 rs550407834 Human genes 0.000 description 1
- 102200002453 rs55758736 Human genes 0.000 description 1
- 102200051055 rs746617574 Human genes 0.000 description 1
- 102220099526 rs763184168 Human genes 0.000 description 1
- 102200006385 rs769382085 Human genes 0.000 description 1
- 102220020949 rs80357446 Human genes 0.000 description 1
- 102220020950 rs80357446 Human genes 0.000 description 1
- 102220106767 rs879255494 Human genes 0.000 description 1
- 102200083228 rs964335184 Human genes 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- RCTGMCJBQGBLKT-PAMTUDGESA-N scarlet red Chemical compound CC1=CC=CC=C1\N=N\C(C=C1C)=CC=C1\N=N\C1=C(O)C=CC2=CC=CC=C12 RCTGMCJBQGBLKT-PAMTUDGESA-N 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 1
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- HRFWHAJCOJYTHM-UHFFFAOYSA-M sodium 1-[(4-propan-2-ylphenyl)diazenyl]-6-sulfonaphthalen-2-olate Chemical compound [Na+].C1=CC(C(C)C)=CC=C1N=NC1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 HRFWHAJCOJYTHM-UHFFFAOYSA-M 0.000 description 1
- QERXHBDEEFLTOL-UHFFFAOYSA-M sodium 1-[[4-[(4-sulfophenyl)diazenyl]phenyl]diazenyl]naphthalen-2-olate Chemical compound [Na+].Oc1ccc2ccccc2c1N=Nc1ccc(cc1)N=Nc1ccc(cc1)S([O-])(=O)=O QERXHBDEEFLTOL-UHFFFAOYSA-M 0.000 description 1
- AMVMQSNQPDEWHJ-UHFFFAOYSA-N sodium 3-[[4-[[4-[(4-aminophenyl)diazenyl]-6-sulfonaphthalen-1-yl]diazenyl]-6-sulfonaphthalen-1-yl]diazenyl]-4-hydroxynaphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(=C1)C(=CC(=C2O)N=NC3=C4C=CC(=CC4=C(C=C3)N=NC5=C6C=CC(=CC6=C(C=C5)N=NC7=CC=C(C=C7)N)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O.[Na+] AMVMQSNQPDEWHJ-UHFFFAOYSA-N 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- DJDYMAHXZBQZKH-UHFFFAOYSA-M sodium;1-amino-4-(cyclohexylamino)-9,10-dioxoanthracene-2-sulfonate Chemical compound [Na+].C1=2C(=O)C3=CC=CC=C3C(=O)C=2C(N)=C(S([O-])(=O)=O)C=C1NC1CCCCC1 DJDYMAHXZBQZKH-UHFFFAOYSA-M 0.000 description 1
- GIPRGFRQMWSHAK-UHFFFAOYSA-M sodium;2-propan-2-ylbenzenesulfonate Chemical compound [Na+].CC(C)C1=CC=CC=C1S([O-])(=O)=O GIPRGFRQMWSHAK-UHFFFAOYSA-M 0.000 description 1
- AXMCIYLNKNGNOT-UHFFFAOYSA-M sodium;3-[[4-[(4-dimethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)-[4-[ethyl-[(3-sulfonatophenyl)methyl]amino]phenyl]methyl]-n-ethylanilino]methyl]benzenesulfonate Chemical compound [Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](C)C)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 AXMCIYLNKNGNOT-UHFFFAOYSA-M 0.000 description 1
- RWVGQQGBQSJDQV-UHFFFAOYSA-M sodium;3-[[4-[(e)-[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]-2-methylcyclohexa-2,5-dien-1-ylidene]methyl]-n-ethyl-3-methylanilino]methyl]benzenesulfonate Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C)C=C1 RWVGQQGBQSJDQV-UHFFFAOYSA-M 0.000 description 1
- IXNUVCLIRYUKFB-UHFFFAOYSA-M sodium;3-[[4-[[4-(diethylamino)-2-methylphenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]-n-ethylanilino]methyl]benzenesulfonate Chemical compound [Na+].CC1=CC(N(CC)CC)=CC=C1C(C=1C=CC(=CC=1)N(CC)CC=1C=C(C=CC=1)S([O-])(=O)=O)=C(C=C1)C=CC1=[N+](CC)CC1=CC=CC(S([O-])(=O)=O)=C1 IXNUVCLIRYUKFB-UHFFFAOYSA-M 0.000 description 1
- NTOOJLUHUFUGQI-UHFFFAOYSA-M sodium;4-(4-acetamidoanilino)-1-amino-9,10-dioxoanthracene-2-sulfonate Chemical compound [Na+].C1=CC(NC(=O)C)=CC=C1NC1=CC(S([O-])(=O)=O)=C(N)C2=C1C(=O)C1=CC=CC=C1C2=O NTOOJLUHUFUGQI-UHFFFAOYSA-M 0.000 description 1
- FTUYQIPAPWPHNC-UHFFFAOYSA-M sodium;4-[[4-[benzyl(ethyl)amino]phenyl]-[4-[benzyl(ethyl)azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]benzene-1,3-disulfonate Chemical compound [Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=CC=CC=2)C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC=C1 FTUYQIPAPWPHNC-UHFFFAOYSA-M 0.000 description 1
- WQZNLMYQHGWSHK-UHFFFAOYSA-M sodium;5-[[4-(dimethylamino)phenyl]-(4-dimethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)methyl]-4-ethoxy-2-(4-methyl-2-sulfonatoanilino)benzenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C=1C=C(C(=C2C=CC(C=C2)=[N+](C)C)C=2C=CC(=CC=2)N(C)C)C(OCC)=CC=1NC1=CC=C(C)C=C1S([O-])(=O)=O WQZNLMYQHGWSHK-UHFFFAOYSA-M 0.000 description 1
- FHIODWDKXMVJGO-UHFFFAOYSA-N sodium;8-anilino-5-[[4-[(5-sulfonaphthalen-1-yl)diazenyl]naphthalen-1-yl]diazenyl]naphthalene-1-sulfonic acid Chemical compound [Na+].C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1N=NC(C1=CC=CC=C11)=CC=C1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 FHIODWDKXMVJGO-UHFFFAOYSA-N 0.000 description 1
- LJFWQNJLLOFIJK-UHFFFAOYSA-N solvent violet 13 Chemical compound C1=CC(C)=CC=C1NC1=CC=C(O)C2=C1C(=O)C1=CC=CC=C1C2=O LJFWQNJLLOFIJK-UHFFFAOYSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000011115 styrene butadiene Substances 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical compound NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000001911 terphenyls Chemical class 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 150000003509 tertiary alcohols Chemical class 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- 150000004685 tetrahydrates Chemical class 0.000 description 1
- CTIIFDITHFRQBX-UHFFFAOYSA-J tetrasodium 7-anilino-4-hydroxy-3-[[6-sulfonato-4-[[6-sulfonato-4-[(3-sulfonatophenyl)diazenyl]naphthalen-1-yl]diazenyl]naphthalen-1-yl]diazenyl]naphthalene-2-sulfonate Chemical compound [Na+].[Na+].[Na+].[Na+].Oc1c(N=Nc2ccc(N=Nc3ccc(N=Nc4cccc(c4)S([O-])(=O)=O)c4cc(ccc34)S([O-])(=O)=O)c3cc(ccc23)S([O-])(=O)=O)c(cc2cc(Nc3ccccc3)ccc12)S([O-])(=O)=O CTIIFDITHFRQBX-UHFFFAOYSA-J 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- JADVWWSKYZXRGX-UHFFFAOYSA-M thioflavine T Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C1=[N+](C)C2=CC=C(C)C=C2S1 JADVWWSKYZXRGX-UHFFFAOYSA-M 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- MBDOYVRWFFCFHM-UHFFFAOYSA-N trans-2-hexenal Natural products CCCC=CC=O MBDOYVRWFFCFHM-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- SWGJCIMEBVHMTA-UHFFFAOYSA-K trisodium;6-oxido-4-sulfo-5-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2-sulfonate Chemical compound [Na+].[Na+].[Na+].C1=CC=C2C(N=NC3=C4C(=CC(=CC4=CC=C3O)S([O-])(=O)=O)S([O-])(=O)=O)=CC=C(S([O-])(=O)=O)C2=C1 SWGJCIMEBVHMTA-UHFFFAOYSA-K 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000001810 trypsinlike Effects 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- KYWIYKKSMDLRDC-UHFFFAOYSA-N undecan-2-one Chemical compound CCCCCCCCCC(C)=O KYWIYKKSMDLRDC-UHFFFAOYSA-N 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- YKSGNOMLAIJTLT-UHFFFAOYSA-N violanthrone Chemical compound C12=C3C4=CC=C2C2=CC=CC=C2C(=O)C1=CC=C3C1=CC=C2C(=O)C3=CC=CC=C3C3=CC=C4C1=C32 YKSGNOMLAIJTLT-UHFFFAOYSA-N 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 239000002025 wood fiber Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000001018 xanthene dye Substances 0.000 description 1
- PHXATPHONSXBIL-UHFFFAOYSA-N xi-gamma-Undecalactone Chemical compound CCCCCCCC1CCC(=O)O1 PHXATPHONSXBIL-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38618—Protease or amylase in liquid compositions only
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38609—Protease or amylase in solid compositions only
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38681—Chemically modified or immobilised enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
Definitions
- This invention relates to fabric and home care products comprising cold water proteases as well as methods of making and using such fabric and home care products.
- a laundry detergent composition that comprises a hueing agent, a cleaning polymer and/or a perfume capsule, improves the whiteness, whiteness perception, and/or freshness.
- This invention relates to fabric and home care products comprising one or more cold water proteases and processes for making and using such products.
- Such compositions provide improved cleaning and freshness.
- Such cold water proteases may be derived from parent enzymes, including BPN' subtilisin and subtilisin derived from Bacillus lentus, by substitution, insertion and/or deletion of one or more of the parent enzymes' amino acids.
- Figure 1 provides a plasmid map of pHPLT-BPN'-v3.
- Figure 2 provides a plasmid map of pHPLT-BPN'-v3+S78N.
- Figure 3 provides a plasmid map of pHPLT-BPN' partial opt.
- Figure 4 provides a plasmid map of pHPLT-BPN'-v36.
- Figure 5 provides an alignment of the mature reference subtilisin proteases including: BPN' (SEQ ID NO:2) and GG36 (SEQ ID NO:755).
- BPN' SEQ ID NO:2
- GG36 SEQ ID NO:755
- Each amino acid position of each protease variant described herein, including each cold water protease variant, is numbered according to the numbering of the corresponding amino acid position in the amino acid sequence of Bacillus amyloliquejaciens subtilisin protease BPN' (SEQ ID NO:2), as shown in Figure 5, as determined by alignment of the protease variant amino acid sequence with the Bacillus amyloliquejaciens subtilisin protease BPN' amino acid sequence.
- substitution positions are given in relationship to BPN'.
- Figure 6 provides map of pHPLT-GG36.
- Figure 7 provides a map of pRA68.
- Figure 8 provides a map of pRA96.
- Figure 9 provides a map of pAC-FNAre.
- Figure 10 is a schematic representation of method or targeted ISD library construction.
- Figure 11 provides a map of pAC-FNAlO.
- Figure 12 provides a map of pHPLT- FN A
- fabric and home products means products or devices generally intended to be used or consumed in the form in which they are sold and that are for treating fabrics, hard surfaces and any other surfaces in the area of fabric and home care, including: air care including air fresheners and scent delivery systems, car care, dishwashing, fabric conditioning (including softening and/or freshening), laundry detergency, laundry and rinse additive and/or care, hard surface cleaning and/or treatment including floor and toilet bowl cleaners, and other cleaning for consumer or institutional use.
- air care including air fresheners and scent delivery systems
- car care dishwashing
- fabric conditioning including softening and/or freshening
- laundry detergency including softening and/or freshening
- laundry and rinse additive and/or care including floor and toilet bowl cleaners, and other cleaning for consumer or institutional use.
- cleaning and/or treatment composition is a subset of fabric and home care products that includes, unless otherwise indicated fabric & home care products.
- Such products include, but are not limited to, products for treating fabrics, hard surfaces and any other surfaces in the area of fabric and home care, including: air care including air fresheners and scent delivery systems, car care, dishwashing, fabric conditioning (including softening and/or freshening), laundry detergency, laundry and rinse additive and/or care, hard surface cleaning and/or treatment including floor and toilet bowl cleaners, granular or powder-form all- purpose or "heavy-duty” washing agents, especially cleaning detergents; liquid, gel or paste- form all-purpose washing agents, especially the so-called heavy-duty liquid types; liquid fine- fabric detergents; hand dishwashing agents or light duty dishwashing agents, especially those of the high-foaming type; machine dishwashing agents, including the various tablet, granular, liquid and rinse-aid types for household and institutional use: car or carpet shampoos, bathroom cleaners including toilet
- the term "fabric and/or hard surface cleaning and/or treatment composition” is a subset of cleaning and treatment compositions that includes, unless otherwise indicated, granular or powder-form all-purpose or "heavy-duty” washing agents, especially cleaning detergents; liquid, gel or paste-form all-purpose washing agents, especially the so- called heavy-duty liquid types; liquid fine-fabric detergents; hand dishwashing agents or light duty dishwashing agents, especially those of the high-foaming type; machine dishwashing agents, including the various tablet, granular, liquid and rinse-aid types for household and institutional use; liquid cleaning and disinfecting agents, car or carpet shampoos, bathroom cleaners including toilet bowl cleaners; fabric conditioning products including softening and/or freshening that may be in liquid, solid and/or dryer sheet form ; as well as cleaning auxiliaries such as bleach additives and "stain-stick" or pre-treat types, substrate-laden products such as dryer added sheets. All of such products which are applicable may be in standard, concentrated or even highly concentrated form even
- solid includes granular, powder, bar and tablet product forms.
- fluid includes liquid, gel, paste and gas product forms.
- situs includes fabrics, garments, and/or hard surfaces.
- component or composition levels are in reference to the active portion of that component or composition, and are exclusive of impurities, for example, residual solvents or by-products, which may be present in commercially available sources of such components or compositions.
- a composition comprising a protease, said protease being selected from the group consisting of:
- a cold water protease having a performance index at least 1, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2 from 1 to about 10, from 1 to about 8 or even from 1 to about 5 on BMI at pH 8 and 60°F when compared to an enzyme having SEQ ID NO:6, as defined in Test Method 2 and/or Test Method 3;
- cold water protease being selected from the group consisting of:
- a variant of a parent protease said parent protease having at least 60%, or 80%, or 85% or 90% or 95% or 96% or 97% or 98% or 99% or even 100% identity to SEQ ID NO:4, said variant comprising a group of mutations selected from the following groups of mutations: P210S, P210S-N218A, S063T-S078N-S101A-S183T-T244N, N061A- S078N-S224A, S053G-S078N-P129T-Q185T, S063T-S078N-S101A, S078N-P129T, S063T-S078N-S101A-S183T and S063T-S078N-S101A-T244I;
- a variant of a parent protease said parent protease having at least 60%, or 80%, or 85% or 90% or 95% or 96% or 97% or 98% or 99% or even 100% identity to SEQ ID NO:2, said variant comprising a group of mutations selected from the following groups of mutations:
- G097A-I111 V-M124V-Y217Q G097A-I111 V-Y167A-Y217Q
- S024G-N025G-N061P- G097A-S101N-G128S-Y217Q S024G-N025G-S053G-N061P-G097A-S101N-G128A- V203Y-Y217Q
- V068A-A092G-Y217Q N061P-G097A-S101N-G128A-P210S-Y217Q
- S024G- N025G-S053G-N061P-G097A-S101N-G128A-P210S-Y217Q S024G- N0
- variants of a parent protease said parent having at least 60%, or 80%, or 85% or 90% or 95% or 96% or 97% or 98% or 99% or even 100% identity to SEQ ID NO:2, said variant comprising three, four, five or six of the following mutations X24G/R, X53G, X78N, X101N, X128A/S andX217L/Q; said variant optionally comprising at least one group of mutations selected from the following groups of mutations:
- cold water protease being selected from the group consisting of:
- a variant of a parent protease said parent protease having at least 60%, or 80%, or 85% or 90% or 95% or 96% or 97% or 98% or 99% or even 100% identity to SEQ ID NO:4, said variant comprising a group of mutations selected from the following groups of mutations: E156S-P210S, P210S-N218S, Y104F-E156S-P210I, E156A-P210S- N218S, N218A, N061A-S078N-S087E-S224A, Q059V-S078N-G211A, Q059V-S078N- V147Q, Q059V-S078N, Q059V-S078N-I108V-N252Q, S053G-S078N-P129T, S078N- G211A, S078N-Q185T, S078N-V147Q, S078N, S078N-P129T
- a variant of a parent protease said parent protease having at least 60%, or 80%, or 85% or 90% or 95% or 96% or 97% or 98% or 99% or even 100% identity to SEQ ID NO:2, said variant comprising a group of mutations selected from the following groups of mutations: G097A-I111V-Y217Q, I111V-G128A-Y217Q, I111V-M124V-Y167A, I111V-M124V-Y217Q, L096T-G097A-Y217Q, N062Q-G097A-I111V, S053G-N061P- G097A-S101N-G128S-V203Y-Y217Q, S089Y-M124V-Y217Q, V068A-I111V-Y217Q, G097A-I111V-M124V, G097A-L126A-Y217Q, G097A
- a variant of a parent protease said parent protease, having at least 60%, or 80%, or 85% or 90% or 95% or 96% or 97% or 98% or 99% or even 100% identity to SEQ ID NO:2, said variant comprising three, four, five or six of the following mutations
- said variant optionally comprising at least one group of mutations selected from the following groups of mutations: A001G, A001Y, A013G, A013V, A015F, A015G, A015K, A015M, A015P, A015T, A015W, A015Y, A029G, A073S, A088C, A088I, A088L, A088T, A088V, A098D, A098K, A098P, A098R, A098W, A116D, A116E, A116R, A128S, A133L, A133M, A133S, A134G, A134S, A137N, A137V, A144M, A144Q, A144S, A144T, A144V, A151C, A176S, A176T, A
- protease being selected from the group consisting of
- a variant of a parent protease said parent protease having at least 60%, or 80%, or 85% or 90% or 95% or 96% or 97% or 98% or 99% or even 100% identity to SEQ ID NO:4, said variant comprising a group of mutations selected from the following groups of mutations: Q059V-S078N-I108V-V147Q-G211A-N252Q, S078N-I108V-V147Q- G211A, S078N-S087E-M124I-S224A, S078N-I108V-V147Q-N252Q, S078N-I108V- V147Q-G211A-N252Q, and Q059V-S078N-I108V-V147Q-G211A-N252Q;
- a variant of a parent protease said parent protease, having at least 60%, or 80%, or 85% or 90% or 95% or 96% or 97% or 98% or 99% or even 100% identity to SEQ ID NO:2, said variant comprising a group of mutations selected from the following groups of mutations: G097A-M124V-Y167A-Y217Q, V068A-Y167A-Y217Q, G097A-I111V- M124V-Y167A, I111V-M124V-Y167A-Y217Q, V068A-I111V-Y167A-Y217Q, G097A-I111 V-M124V-Y167A-Y217Q, P052L-V068A-I11 IV, G097A-N123A-Y217Q, N061P-N062Q-G097A-G100D-Y217Q, N061P-S101N-G102A-G1
- a variant of a parent protease said parent protease having at least 60%, or 80%, or 85% or 90% or 95% or 96% or 97% or 98% or 99% or even 100% identity to SEQ ID NO:2, said variant comprising three, four, five or six of the following mutations:
- said variant optionally comprising at least one group of mutations selected from the following groups of mutations: A001D, A001H, A001N, A015C, A048C, A048E, A085T, A133R, A137R, A142C, A144D, A144R, A152S, A153G, A187P, A187Q, A187T, A187V, A216R, A230S, A272R, A273H, A273T, A274H, D036N, D036S, D181H, D181T, D259N, D259P, D259S, E156G, E156H, E156L, E156Q, E156V, E251C, F189S, F189T, F189W, F189Y, F261E, G020C, G024D, G
- a variant of a parent protease comprising an amino acid sequence comprising from three to six amino acid substitutions selected from the group consisting of X024G/R, X053G, X078N, X101N, X128A/S, and X217L/Q, wherein the variant has proteolytic activity;
- a variant of a protease the variant having proteolytic activity and comprising an amino acid sequence which comprises from two to seven alterations at the amino acid positions corresponding to amino acid positions of SEQ ID NO:2 selected from the group consisting of positions 24, 53, 78, 97, 101, 128, and 217, wherein each alteration is independently
- the variant comprises an amino acid sequence having no more than 15 alterations relative to the parent protease, wherein the alterations are independently selected from an insertion, a deletion, or a substitution, and the alterations include a substitution of glycine at positions 24 and 53, a substitution of asparagine at positions 78 and 101, a substitution of alanine or serine at position 128, and a substitution of glutamine at position 217;
- the parent protease has at least 90% sequence identity to SEQ ID NO:2; and the variant has increased proteolytic activity relative to the parent protease
- a variant of a parent protease said parent protease at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, or 97% sequence identity to SEQ ID NO:2, said variant having an amino acid sequence having at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, or 97% identity to the sequence of SEQ IDNO:2; said variant comprising an a substitution of glycine at positions 24 and 53, a substitution of asparagine at positions 78 and 101, a substitution of alanine or serine at position 128, and a substitution of glutamine at position 217, and said variant having increased proteolytic activity relative to the parent protease;
- composition being a fabric and home care product is disclosed.
- said cold water protease has either a performance index greater than 1, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2 from at least 1 to about 10, from at least 1 to about 8 or even from at least 1 to about 5 on BMI at pH 8 and 60°F when compared to an enzyme having SEQ ID NO:4, as defined in Test Method 2 or Test Method 3 or said cold water protease has a performance index at least 1, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2 from 1.0 to about 10, from 1.0 to about 8 or even from 1.0 to about 5 on BMI at pH 8 and 60°F when compared to an enzyme having SEQ ID NO:6, as defined in Test Method 2 or Test Method 3and said cold water protease is selected from the group
- a variant of a parent protease having SEQ ID NO: 4 said variant comprising a group of mutations selected from the following groups of mutations: P210S, P210S-N218A, S063T- S078N-S101A-S183T-T244N, N061A-S078N-S224A, S053G-S078N-P129T-Q185T, S063T- S078N-S101A, S078N-P129T, S063T-S078N-S101A-S183T and S063T-S078N-S101A-T244I; b) a variant of a parent protease having SEQ ID NO: 2, said variant comprising a group of mutations selected from the following groups of mutations: G097A-I111V-M124V-Y217Q, G097A-I111V-Y167A-Y217Q, S024G-N025G-N
- said variant of a parent protease comprises the amino acid substitutions: S024G+S053G+S078N+S101N+G128A/S+Y217Q/L/D; and optionally one or more groups of subsitutions selected from the following groups of mutations:
- said protease is a variant of a parent protease having SEQ ID NO: 6, said variant comprising one or more of the following groups of amino acid substitutions: A088T+N109G+A116T+G131H+N243V+L257G, S033T+N076D,
- said parent protease is a subtilisin protease.
- said parent protease is a subtilisin protease selected from the group consisting of B. amyloliquefaciens subtilisin protease BPN' (SEQ ID NO:2), Geobacillus stearothermophilus (formerly classified as B. stearothermophilus), B. subtilis, B. licheniformis, B. lentus, B. brevis, B. alkalophilus, B. amyloliquefaciens, B. clausii, B.
- said cold water protease is a variant of a parent protease, said cold water protease comprising a total of three, four, five, six, seven, eight, nine, 10, 11, 12, 13, 14 or 15 mutations selected from groups (a) and (b) below, wherein at least one mutation is selected from group (a):
- said variant of a parent protease comprises a total of three, four, five, six, seven, eight, nine, 10, 11, 12, 13, 14 or 15 mutations selected from groups (a) and (b) below, wherein at least one mutation is selected from group (a):
- said variant of a parent protease has a total net charge of -1, 0 or +1 relative to the BPN' wild-type.
- said composition comprises an adjunct ingredient selected from the group consisting of: a surfactant, a builder, a chelating agent, a dye transfer inhibiting agent, a dispersant, one or more additional enzymes, an enzyme stabilizer, a catalytic material, a bleach activator, a hydrogen peroxide, a source of hydrogen peroxide, a preformed peracid, a polymeric dispersing agent, a clay soil removal/anti-redeposition agent, a brightener, a suds suppressor, a dye, a perfume, a perfume delivery system, a structure elasticizing agent, a fabric softener, a carrier, a hydrotrope, a processing aid, a solvent, a pigment and mixtures thereof.
- a surfactant e.g., a builder, a chelating agent, a dye transfer inhibiting agent, a dispersant, one or more additional enzymes, an enzyme stabilizer, a catalytic material, a bleach activator, a hydrogen peroxid
- said composition comprises a material selected from the group consisting of an encapsulate comprising a perfume, a hueing agent, an amphiphilic cleaning polymer, a brightener, a chelating agent and mixtures thereof.
- said composition comprises a second non- immunoequivalent protease selected from the group comprising:
- said composition comprises a second non- immunoequivalent protease that is a subtilisin (EC 3.4.21.62) protease said subtilisin (EC 3.4.21.62) protease being a cold water GG36 variant protease.
- said composition comprises an additional enzyme selected from the group consisting of hemicellulases, peroxidases, proteases, cellulases, cellobiose dehydrogenases, xyloglucanases, xylanases, lipases, phospholipases, esterases, cutinases, pectinases, mannanases, pectate lyases, keratinases, reductases, oxidases, phenoloxidases, lipoxygenases, ligninases, pullulanases, tannases, pentosanases, lichenases glucanases, arabinosidases, hyaluronidase, chondroitinase, laccase, amylases, or mixtures thereof.
- an additional enzyme selected from the group consisting of hemicellulases, peroxidases, proteases, cellulases, cellobiose dehydrogenases, xylogluc
- said composition comprises an additional enzyme is selected from the group consisting of:
- alpha-amylases that are greater than 90% identical to the wild-type alkaline alpha- amylases derived from Bacillus sp. NCIB 12289, NCIB 12512, NCIB 12513, DSM 9375 DSM 12368, DSMZ no. 12649, KSM AP1378, KSM K36 or KSM K38;
- said composition comprises a material selected from the group consisting of: a) an alcohol ethoxysulphate surfactant;
- a chelant selected from the group consisting of DTPA (Diethylene triamine pentaacetic acid), HEDP (Hydroxyethane diphosphonic acid), DTPMP (Diethylene triamine penta(methylene phosphonic acid)), ethylenediaminedisuccinic acid (EDDS), 1,2- Dihydroxybenzene-3,5-disulfonic acid disodium salt hydrate, and derivatives of such chelants; and
- said composition comprises a material selected from the group consisting of:
- an alcohol ethoxysulphate surfactant having an alkyl chain length of from 10 to 14 and a degree of ethoxylation from 1 to 4;
- a chelant selected from the group consisting of DTPA (Diethylene triamine pentaacetic acid), HEDP (Hydroxyethane diphosphonic acid), DTPMP (Diethylene triamine penta(methylene phosphonic acid)), ethylenediaminedisuccinic acid (EDDS), 1,2- Dihydroxybenzene-3,5-disulfonic acid disodium salt hydrate, and derivatives of such chelants; and
- said composition comprises, based on total composition weight, a chelant level of from about 1% to about 5%.
- said composition comprises a fabric hueing agent selected from the group consisting of
- dye-clay conjugates comprising at least one cationic-basic dye and a smectite clay; and c) mixtures thereof.
- said composition comprises a fabric hueing agent selected from the group consisting of
- dye-clay conjugates comprising at least one cationic-basic dye and a smectite clay; and c) mixtures thereof.
- said composition comprises, based on total composition weight: a) from about 0.0005 wt% to about 0.1 wt% of said cold water protease; and
- said composition has a single or multi-compartment unit dose form.
- said composition is in the form of a multicompartment unit dose, wherein at least one protease is in a different compartment to any additional enzymes and/or chelant.
- composition comprising a cold water protease and a material selected from the group consisting of: an encapsulate comprising a perfume, a GG36 variant protease, a hueing agent, an amphiphilic cleaning polymer and mixtures thereof said composition being a fabric and home care product is disclosed.
- composition comprising a cold water protease and a material selected from the group consisting of: an encapsulate comprising a perfume, a GG36 variant protease, a hueing agent, an amphiphilic cleaning polymer and mixtures thereof
- said cold water protease is a variant of the protease having SEQ ID NO:2 (subtilisin BPN') said variant comprising one or more of the following sets of mutations, insertions or deletions: S182E, N109I, N109D-Y217L-S248R, N109D-S188R-Y217L, S87D-Y217L-S248R, S87R-N109D- Y217L-S248R, S87R-N109D-S188D-Y217L-S248R, G128A-Y217Q, I111V-M124V, M124V- Y217Q, N62Q-G97A, S89Y
- composition comprising a cold water protease and a material selected from the group consisting of: an encapsulate comprising a perfume, a GG36 variant protease, a hueing agent, an amphiphilic cleaning polymer and mixtures thereof, said variant of the protease having SEQ ID NO:2 comprises three, four, five, six, seven, eight, nine, 10, 11, 12, 13, 14 or 15 mutations within the group of positions comprising positions 24, 25, 40, 52.
- composition comprising a cold water protease and a material selected from the group consisting of: an encapsulate comprising a perfume, a GG36 variant protease, a hueing agent, an amphiphilic cleaning polymer and mixtures thereof, said variant of the protease having SEQ ID NO:2 comprises a total of three, four, five, six, seven, eight, nine, 10, 11, 12, 13, 14 or 15 mutations selected from groups (a) and (b) below:
- composition comprising a cold water protease and a material selected from the group consisting of: an encapsulate comprising a perfume, a GG36 variant protease, a hueing agent, an amphiphilic cleaning polymer and mixtures thereof, said variant of the protease having SEQ ID NO:2 comprises one or more mutations, and having a total net charge of -1, 0 or +1 relative to the BPN' wild-type.
- composition comprising a cold water protease and a material selected from the group consisting of: an encapsulate comprising a perfume, a GG36 variant protease, a hueing agent, an amphiphilic cleaning polymer and mixtures thereof
- said composition comprises an adjunct ingredient selected from the group consisting of: a surfactant, a builder, a chelating agent, a dye transfer inhibiting agent, a dispersant, one or more additional enzyme, an enzyme stabilizer, a catalytic material, a bleach activators, a hydrogen peroxide, a source of hydrogen peroxide, a preformed peracid, a polymeric dispersing agent, a clay soil removal/anti-redeposition agent, a brightener, a suds suppressor, a dye, a perfume, a perfume delivery system, a structure elasticizing agent, a fabric softener, a carrier, a hydrotrope, a processing aid, a solvent, a pigment and mixtures thereof.
- composition comprising a cold water protease and a material selected from the group consisting of: an encapsulate comprising a perfume, a GG36 variant protease, a hueing agent, an amphiphilic cleaning polymer and mixtures thereof
- said composition comprises a third non-immunoequivalent protease that is a subtilisin (EC 3.4.21.62) protease said subtilisin (EC 3.4.21.62) protease being a cold water GG36 variant protease.
- composition comprising a cold water protease and a material selected from the group consisting of: an encapsulate comprising a perfume, a GG36 variant protease, a hueing agent, an amphiphilic cleaning polymer and mixtures thereof, said composition comprises an additional enzyme selected from the group consisting of
- hemicellulases peroxidases, proteases, cellulases, cellobiose dehydrogenases, xyloglucanases, xylanases, lipases, phospholipases, esterases, cutinases, pectinases, mannanases, pectate lyases, keratinases, reductases, oxidases, phenoloxidases, lipoxygenases, ligninases, pullulanases, tannases, pentosanases, lichenases glucanases, arabinosidases, hyaluronidase, chondroitinase, laccase, amylases, or mixtures thereof.
- composition comprising a cold water protease and a material selected from the group consisting of: an encapsulate comprising a perfume, a GG36 variant protease, a hueing agent, an amphiphilic cleaning polymer and mixtures thereof, said composition comprises an additional enzyme is selected from the group consisting of:
- alpha-amylases that are greater than 90% identical to the wild-type alkaline alpha- amylases derived from Bacillus sp. NCIB 12289, NCIB 12512, NCIB 12513, DSM 9375 DSM 12368, DSMZ no. 12649, KSM AP1378, KSM K36 or KSM K38;
- composition comprising a cold water protease and a material selected from the group consisting of: an encapsulate comprising a perfume, a GG36 variant protease, a hueing agent, an amphiphilic cleaning polymer and mixtures thereof, said composition comprises a material selected from the group consisting of:
- a) an alcohol ethoxysulphate surfactant b) a chelant selected from the group consisting of DTPA (Diethylene triamine pentaacetic acid), HEDP (Hydroxyethane diphosphonic acid), DTPMP (Diethylene triamine penta(methylene phosphonic acid)), ethylenediaminedisuccinic acid (EDDS), 1,2- Dihydroxybenzene-3,5-disulfonic acid disodium salt hydrate, and derivatives of such chelants; and
- composition comprising a cold water protease and a material selected from the group consisting of: an encapsulate comprising a perfume, a GG36 variant protease, a hueing agent, an amphiphilic cleaning polymer and mixtures thereof, said composition comprises a material selected from the group consisting of:
- an alcohol ethoxy sulphate surfactant having an alkyl chain length of from 10 to 14 and a degree of ethoxylation from 1 to 4;
- a chelant selected from the group consisting of DTPA (Diethylene triamine pentaacetic acid), HEDP (Hydroxyethane diphosphonic acid), DTPMP (Diethylene triamine penta(methylene phosphonic acid)), ethylenediaminedisuccinic acid (EDDS), 1,2- Dihydroxybenzene-3,5-disulfonic acid disodium salt hydrate, and derivatives of such chelants; and
- composition comprising a cold water protease and a material selected from the group consisting of: an encapsulate comprising a perfume, a GG36 variant protease, a hueing agent, an amphiphilic cleaning polymer and mixtures thereof, said composition comprises, based on total composition weight, a chelant level of from about 1% to about 5%.
- composition comprising a cold water protease and a material selected from the group consisting of: an encapsulate comprising a perfume, a GG36 variant protease, a hueing agent, an amphiphilic cleaning polymer and mixtures thereof, said composition comprises a fabric hueing agent selected from the group consisting of
- dye-clay conjugates comprising at least one cationic-basic dye and a smectite clay; and c) mixtures thereof.
- composition comprising a cold water protease and a material selected from the group consisting of: an encapsulate comprising a perfume, a GG36 variant protease, a hueing agent, an amphiphilic cleaning polymer and mixtures thereof, said composition comprises a fabric hueing agent selected from the group consisting of
- dye-clay conjugates comprising at least one cationic-basic dye and a smectite clay; and c) mixtures thereof.
- composition comprising a cold water protease and a material selected from the group consisting of: an encapsulate comprising a perfume, a GG36 variant protease, a hueing agent, an amphiphilic cleaning polymer and mixtures thereof, said composition comprises based on total composition weight:
- composition comprising a cold water protease and a material selected from the group consisting of: an encapsulate comprising a perfume, a GG36 variant protease, a hueing agent, an amphiphilic cleaning polymer and mixtures thereof, said composition has a single or multi-compartment unit dose form.
- composition comprising a cold water protease and a material selected from the group consisting of: an encapsulate comprising a perfume, a GG36 variant protease, a hueing agent, an amphiphilic cleaning polymer and mixtures thereof, said composition is in the form of a multi-compartment unit dose, wherein at least one protease is in a different compartment to any additional enzymes and/or chelant.
- a fabric and home product that may comprise one or more cold water proteases and a material selected from the group consisting of: an encapsulate comprising a perfume, a hueing agent, an amphiphilic cleaning polymer and mixtures thereof, with the balance of any aspects of the aforementioned composition is made up of one or more adjunct materials, is disclosed.
- said fabric and home care product may comprise, based on total fabric and home care product weight, from about 0.0005 wt% to about 0.1 wt%, from about 0.001 wt% to about 0.05 wt%, or even from about 0.002wt% to about 0.03wt% of said cold water protease.
- said fabric and home care product may comprise, based on total fabric and home care product weight, about
- said fabric and home care product may comprise, based on total fabric and home care product weight, from about 0.001wt% to about 5wt%, from about 0.01wt% to about 2wt%, or even from about 0.03 wt% to about 0.5wt%, perfume capsules.
- said fabric and home care product may comprise, based on total fabric and home care product weight, from about 0.1 wt% to about 5 wt%, from about 0.25 wt% to about 2.5 wt%, or even from about 0.3 wt% to about 1.5 wt% amphiphilic cleaning polymer.
- suitable cold water protease variants are enzymes that exhibit one or more of the following four criteria:
- GG36 cold water proteases may be Series 1 GG36 cold water protesaes.
- Suitable Series 1 GG36 cold water protease variants include enzymes derived from a parent protease, said parent protease 's sequence being at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO:755, said variant having one or more of the following characteristics:
- Suitable Series 1 GG36 cold water proteases can be derived from subtilisins, particularly those derived from subtilisin Bacillus Lentus of SEQ ID NO:755 and in one aspect may comprise one or more of the following mutations:
- suitable Series 1 GG36 cold water proteases include subtlisins, particularly Bacillus Lentus of SEQ ID NO:755, that may comprise one or more of the following sets of mutations, insertions or deletions:
- suitable Series 1 GG36 cold water proteases include variants of subtlisins, particularly Bacillus Lentus of SEQ ID NO:755, said variants comprising three, four, five, six, seven, eight, nine, 10, 11, 12, 13, 14 or 15 mutations within the group of positions comprising positions 1, 2, 4, 9, 10, 14, 16, 17, 18, 20, 22, 24, 25, 26, 42, 43, 46, 52, 57, 59, 62, 68, 71, 72, 74, 75, 76, 78, 82, 86, 89, 91, 94, 100, 101, 103, 104, 106, 108, 111, 112, 115, 117, 118, 121, 128, 129, 144, 148, 158, 159, 160, 166, 185, 186, 188, 197, 203, 209, 210, 212, 214, 215, 217, 224, 230, 231, 236, 238, 239, 241, 242, 243, 244, 248,
- suitable Series 1 GG36 cold water proteases include variants of subtlisins, particularly Bacillus Lentus of SEQ ID NO:755, said variants comprising a total of three, four, five, six, seven, eight, nine, 10, 11, 12, 13, 14 or 15 mutations selected from the group comprising: AIR, Q2S, V4R, V4S, S9A, R10S, P14K, A16S, H17R, N18R, G20R, T22A, T22R, S24R, S24W, G25R, G25V, V26F, L42I, N43R, N43A, G46R, P52F, P52E, P52N, T57R, Q59A, N62E, N62Q, V68A, V68C, T71G, I72C, A74C.
- said Series 1 GG36 cold water protease is variant of subtilisin GG36 having SEQ ID NO:755, said variant comprising one or more mutations, and having a total net charge of -5, -4, -3, -2, -1 or 0 relative to subtilisin GG36 wild-type, is disclosed.
- said Series 1 GG36 cold water proteases are low ionic strength cold water proteases.
- Such low ionic strength proteases are variants of subtilisin GG36 having SEQ ID NO:755, said variants comprising one or more mutations, and having a total net charge of -5, -4, - 3, -2, -1 or 0 relative to subtilisin GG36 wild-type, is disclosed. These mutations are selected from:
- the above low ionic strength Series 1 GG36 cold water proteases form part of a detergent composition that is diluted in water, typically within a washing machine, to form a wash liquor, whose conductivity is from about 0.1 mS/cm to about 3 mS/cm, from about 0.3 mS/cm to about 2.5 mS/cm, or even from about 0.5 mS/cm to about 2 mS/cm
- said Series 1 GG36 cold water proteases are high ionic strength cold water proteases.
- Such high ionic strength proteases are variants of subtilisin GG36 having SEQ ID NO:755, said variants comprising two or more mutations, and having a total net charge of +5, +4, +3, +2, +1 or 0 relative to subtilisin GG36 wild-type. These mutations are selected from:
- the above high ionic strength Series 1 GG36 cold water proteases form part of a detergent composition that is diluted in water, typically within a washing machine, to form a wash liquor, whose conductivity is from about 3 mS/cm to about 30 mS/cm, from about 3.5 mS/cm to about 20 mS/cm, or even from about 4mS/cm to about 10 mS/cm.
- the charge of the Series 1 GG36 cold water protease variants is expressed relative to subtilisin GG36 protease wild-type having the amino acid sequence of SEQ ID NO:755.
- the amino acids that impart a single negative charge are D and E and those that impart a single positive charge are R, H and K. Any amino acid change versus SEQ ID NO:755 that changes a charge is used to calculate the charge of the Series 1 GG36 cold water protease variant.
- introducing a negative charge mutation from a wild-type neutral position will add a net charge of -1 to the Series 1 GG36 cold water protease variant
- introducing a negative charge mutation (D or E) from a wild-type positive amino acid residue (R, H or K) will add a net charge of -2.
- Summing the charge changes from all the amino acid residues that are different for the Series 1 GG36 cold water protease variant versus subtilisin GG36 protease wild-type having the amino acid sequence of SEQ ID NO:755 gives the charge change of the Series 1 GG36 cold water protease variant.
- Low conductivity solutions are defined as having a conductivity of from about 0.1 mS/cm to about 3 mS/cm, from about 0.3 mS/cm to about 2.5 mS/cm, or even from about 0.5 mS/cm to about 2 mS/cm.
- High conductivity having conductivity solutions are defined as having a conductivity of from about 3 mS/cm to about 30 mS/cm, from about 3.5 mS/cm to about 20 mS/cm, or even from about 4 mS/cm to about 10 mS/cm
- the enzyme charge can also be balanced by mutations in further positions.
- amyloliquejaciens subtilisin BPN' numbering system Each amino acid position of each protease variant, including each Series 1 GG36 cold water protease variant, is numbered according to the numbering of corresponding amino acid position in the amino acid sequence of Bacillus amyloliquejaciens subtilisin BPN' as determined by alignment of the variant protease amino acid sequence with the Bacillus amyloliquejaciens subtilisin BPN' amino acid sequence.
- An alternative numbering scheme is numbering the specific amino acid sequence of the B. lentus subtilisin GG36 protease, having the amino acid sequence of SEQ ID NO:755. None of the amino acid positions of the protease variants, including the Series 1 GG36 cold water protease variants, described herein are numbered using this alternative numbering scheme.
- Mutations are named by the one letter code for the parent amino acid, followed by a three digit position number and then the one letter code for the variant amino acid.
- mutating glycine (G) at position 87 to serine (S) is represented as “G087S” or “G87S”.
- Multiple mutations are indicated by inserting a "-" between the mutations.
- Mutations at positions 87 and 90 are represented as either "G087S-A090Y” or "G87S-A90Y” or "G87S + A90Y” or "G087S + A090Y”.
- the one letter code "Z” is used.
- the one letter code "Z" is on the left side of the position number.
- the one letter code "Z" is on the right side of the position number.
- the position number is the position number before the inserted amino acid(s), plus 0.01 for each amino acid.
- an insertion of three amino acids alanine (A), serine (S) and tyrosine (Y) between position 87 and 88 is shown as "Z087.01A-Z087.02S-Z087.03Y.”
- the accepted IUPAC single letter or triple letter amino acid abbreviation is employed.
- the single letter X refers to any of the twenty amino acids.
- wild-type in reference to an amino acid sequence or nucleic acid sequence indicates that the amino acid sequence or nucleic acid sequence is native or naturally occurring sequence.
- naturally-occurring refers to anything (e.g., proteins, amino acids, or nucleic acid sequences) that are found in nature (i.e., have not been manipulated by means of recombinant methods).
- non-naturally occurring refers to anything that is not found in nature (e.g., recombinant nucleic acids produced in the laboratory).
- corresponding to or “corresponds to” or “corresponds” refers to an amino acid residue at the enumerated position in a protein or peptide, or an amino acid residue that is analogous, homologous, or equivalent to an enumerated residue in a protein or peptide.
- corresponding region generally refers to an analogous position along related proteins or a reference protein.
- the terms "derived from” and “obtained from” refer to not only a protease produced or producible by a strain of the organism in question, but also a protease encoded by a DNA sequence isolated from such strain and produced in a host organism containing such DNA sequence. Additionally, the term refers to a protease which is encoded by a DNA sequence of synthetic and/or cDNA origin and which has the identifying characteristics of the protease in question.
- proteases derived from Bacillus refers to those enzymes having proteolytic activity which are naturally-produced by Bacillus, as well as to serine proteases like those produced by Bacillus sources but which through the use of genetic engineering techniques are produced by non-Bacillus organisms transformed with a nucleic acid encoding the serine proteases.
- nucleic acids or polypeptide sequences refers to the residues in the two sequences that are the same when aligned for maximum
- homologous genes refers to a pair of genes from different, but usually related species, which correspond to each other and which are identical or very similar to each other.
- the term encompasses genes that are separated by speciation (i.e., the development of new species) (e.g., orthologous genes), as well as genes that have been separated by genetic duplication (e.g., paralogous genes).
- mature form of a protein, polypeptide, or peptide refers to the functional form of the protein, polypeptide, or peptide without the signal peptide sequence and propeptide sequence.
- homology refers to sequence similarity or identity, with identity being preferred. Homology may be determined using standard techniques known in the art (See e.g., Smith and Waterman, Adv. Appl. Math. 2:482 [1981]; Needleman and Wunsch, J. Mol. Biol. 48:443 [1970 ⁇ ; Pearson and Lipman, Proc. Natl. Acad. Sci. USA 85:2444 [1988]; software programs such as GAP, BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Software Package (Genetics Computer Group, Madison, WI); and Devereux et al., Nucl. Acid Res. 12:387-395 [1984]).
- PILEUP One example of a useful algorithm is PILEUP.
- PILEUP creates a multiple sequence alignment from a group of related sequences using progressive, pair-wise alignments. It can also plot a tree showing the clustering relationships used to create the alignment. PILEUP uses a simplification of the progressive alignment method of Feng and Doolittle (See, Feng and Doolittle, J. Mol. Evol. 35:351-360 [1987]). The method is similar to that described by Higgins and Sharp (See, Higgins and Sharp, CABIOS 5: 151-153 [1989]). Useful PILEUP parameters including a default gap weight of 3.00, a default gap length weight of 0.10, and weighted end gaps.
- BLAST BLAST algorithm
- WU-BLAST-2 WU-BLAST-2 uses several search parameters, most of which are set to the default values.
- the HSP S and HSP S2 parameters are dynamic values and are established by the program itself depending upon the composition of the particular sequence and composition of the particular database against which the sequence of interest is being searched. However, the values may be adjusted to increase sensitivity.
- the percent sequence identity between a reference sequence and a test sequence of interest may be readily determined by one skilled in the art.
- the percent identity shared by polynucleotide or polypeptide sequences is determined by direct comparison of the sequence information between the molecules by aligning the sequences and determining the identity by methods known in the art.
- An example of an algorithm that is suitable for determining sequence similarity is the BLAST algorithm, (See, Altschul, et al, J. Mol. Biol., 215:403-410 [1990]).
- Software for performing BLAST analyses is publicly available through the National Center for Biotechnology Information.
- This algorithm involves first identifying high scoring sequence pairs (HSPs) by identifying short words of length W in the query sequence that either match or satisfy some positive- valued threshold score T when aligned with a word of the same length in a database sequence.
- HSPs high scoring sequence pairs
- These initial neighborhood word hits act as starting points to find longer HSPs containing them.
- the word hits are expanded in both directions along each of the two sequences being compared for as far as the cumulative alignment score can be increased.
- Extension of the word hits is stopped when: the cumulative alignment score falls off by the quantity X from a maximum achieved value; the cumulative score goes to zero or below; or the end of either sequence is reached.
- the BLAST algorithm parameters W, T, and X determine the sensitivity and speed of the alignment.
- the BLAST program uses as defaults a wordlength (W) of 11, the BLOSUM62 scoring matrix (See, Henikoff and Henikoff, Proc. Natl. Acad. Sci. USA 89: 10915 [1992]) alignments (B) of 50, expectation (E) of 10, M'5, N'-4, and a comparison of both strands.
- the BLAST algorithm then performs a statistical analysis of the similarity between two sequences (See e.g., Karlin and Altschul, supra).
- One measure of similarity provided by the BLAST algorithm is the smallest sum probability (P(N)), which provides an indication of the probability by which a match between two nucleotide or amino acid sequences would occur by chance.
- P(N) the smallest sum probability
- a nucleic acid is considered similar to a serine protease nucleic acid of this invention if the smallest sum probability in a comparison of the test nucleic acid to a serine protease nucleic acid is less than about 0.1, more preferably less than about 0.01, and most preferably less than about 0.001.
- test nucleic acid encodes a serine protease polypeptide
- it is considered similar to a specified serine protease nucleic acid if the comparison results in a smallest sum probability of less than about 0.5, and more preferably less than about 0.2.
- Percent “identical” or “identity” in the context of two or more nucleic acid or polypeptide sequences refers to two or more sequences that are the same or have a specified percentage of nucleic acid residues or amino acid residues, respectively, that are the same, when compared and aligned for maximum similarity, as determined using a sequence comparison algorithm or by visual inspection.
- "Percent sequence identity” or “% identity” or “% sequence identity or “% amino acid sequence identity” of a subject amino acid sequence to a reference (i.e., query) amino acid sequence means that the subject amino acid sequence is identical (i.e., on an amino acid-by-amino acid basis) by a specified percentage to the query amino acid sequence over a comparison length when the sequences are optimally aligned.
- 80% amino acid sequence identity or 80% identity with respect to two amino acid sequences means that 80% of the amino acid residues in two optimally aligned amino acid sequences are identical.
- Percent sequence identity or “% identity” or “% sequence identity or “% nucleotide sequence identity” of a subject nucleic acid sequence to a reference (i.e. query) nucleic acid sequence means that the subject nucleic acid sequence is identical (i.e., on a nucleotide-by- nucleotide basis for a polynucleotide sequence) by a specified percentage to the query sequence over a comparison length when the sequences are optimally aligned.
- 80% nucleotide sequence identity or 80% identity with respect to two nucleic acid sequences means that 80% of the nucleotide residues in two optimally aligned nucleic acid sequences are identical.
- the percent sequence identity or % sequence identity" or "% identity" of a subject sequence to a query sequence can be calculated by optimally aligning the two sequences and comparing the two optimally aligned sequences over the comparison length. The number of positions in the optimal alignment at which identical residues occur in both sequences are determined, thereby providing the number of matched positions, and the number of matched positions is then divided by the total number of positions of the comparison length (which, unless otherwise specified, is the length of the query sequence). The resulting number is multiplied by 100 to yield the percent sequence identity of the subject sequence to the query sequence.
- Optimal alignment or “optimally aligned” refers to the alignment of two (or more) sequences giving the highest percent identity score.
- optimal alignment of two protein sequences can be achieved by manually aligning the sequences such that the maximum number of identical amino acid residues in each sequence are aligned together or by using software programs or procedures described herein or known in the art.
- Optimal alignment of two nucleic acid sequences can be achieved by manually aligning the sequences such that the maximum number of identical nucleotide residues in each sequence are aligned together or by using software programs or procedures described herein or known in the art.
- two polypeptide sequences are deemed "optimally aligned" when they are aligned using defined parameters, such as a defined amino acid substitution matrix, gap existence penalty (also termed gap open penalty), and gap extension penalty, so as to achieve the highest similarity score possible for that pair of sequences.
- a defined amino acid substitution matrix such as a defined amino acid substitution matrix, gap existence penalty (also termed gap open penalty), and gap extension penalty, so as to achieve the highest similarity score possible for that pair of sequences.
- gap existence penalty also termed gap open penalty
- gap extension penalty e.g., BLOSUM62 scoring matrix (See, Henikoff and Henikoff, supra) is often used as a default scoring substitution matrix in polypeptide sequence alignment algorithms (e.g., BLASTP).
- the gap existence penalty is imposed for the introduction of a single amino acid gap in one of the aligned sequences, and the gap extension penalty is imposed for each residue position in the gap.
- the alignment score is defined by the amino acid positions of each sequence at which the alignment begins and ends (e.g., the alignment window), and optionally by the insertion of a gap or multiple gaps into one or both sequences, so as to achieve the highest possible similarity score.
- Optimal alignment between two or more sequences can be determined manually by visual inspection or by using a computer, such as, but not limited to for example, the BLASTP program for amino acid sequences and the BLASTN program for nucleic acid sequences (See e.g., Altschul et al, Nucleic Acids Res. 25(17):3389-3402 (1997); See also, the National Center for Biotechnology Information (NCBI) website).
- a computer such as, but not limited to for example, the BLASTP program for amino acid sequences and the BLASTN program for nucleic acid sequences (See e.g., Altschul et al, Nucleic Acids Res. 25(17):3389-3402 (1997); See also, the National Center for Biotechnology Information (NCBI) website).
- Fluorescent optical brighteners emit at least some visible light.
- fabric hueing agents can alter the tint of a surface as they absorb at least a portion of the visible light spectrum.
- Suitable fabric hueing agents include dyes, dye-clay conjugates, and pigments that satisfy the requirements of Test Method 1 in the Test Method Section of the present specification.
- Suitable dyes include small molecule dyes and polymeric dyes.
- Suitable small molecule dyes include small molecule dyes selected from the group consisting of dyes falling into the Colour Index (C.I.) classifications of Direct Blue, Direct Red, Direct Violet, Acid Blue, Acid Red, Acid Violet, Basic Blue, Basic Violet and Basic Red, or mixtures thereof, for example:
- the C ring may be substituted at the 5 position by an NH 2 or NHPh group
- X is a benzyl or naphthyl ring substituted with up to 2 sulfonate groups and may be substituted at the 2 position with an OH group and may also be substituted with an N3 ⁇ 4 or NHPh group.
- the A ring is preferably substituted by a methyl and methoxy group at the positions indicated by arrows, the A ring may also be a naphthyl ring, the Y group is a benzyl or naphthyl ring, which is substituted by sulfate group and may be mono or disubstituted by methyl groups.
- both the aromatic groups may be a substituted benzyl or naphthyl group, which may be substituted with non water- solubilising groups such as alkyl or alkyloxy or aryloxy groups, X and Y may not be substituted with water solubilising groups such as sulfonates or carboxylates.
- X is a nitro substituted benzyl group and Y is a benzyl group
- B is a naphthyl or benzyl group that may be substituted with non water solubilising groups such as alkyl or alkyloxy or aryloxy groups, B may not be substituted with water solubilising groups such as sulfonates or carboxylates.
- X and Y independently of one another, are each hydrogen, Ci-C 4 alkyl or C1-C4- alkoxy, Ra is hydrogen or aryl, Z is C1-C4 alkyl; Ci-C4-alkoxy; halogen; hydroxyl or carboxyl, n is 1 or 2 and m is 0, 1 or 2, as well as corresponding salts thereof and mixtures thereof
- suitable small molecule dyes include small molecule dyes selected from the group consisting of Colour Index (Society of Dyers and Colourists, Bradford, UK) numbers 1 ,4-Naphthalenedione, 1 - [2- [4- [[4-(acetyloxy)butyl]ethylamino] -2- methylphenyl]diazenyl]-5-nitro-3-thienyl]-Ethanone, l-hydroxy-2-(l-naphthalenylazo)- Naphthalenedisulfonic acid, ion(2-), l-hydroxy-2-[[4-(phenylazo)phenyl]azo]- Naphthalenedisulfonic acid, ion(2-), 2-[(lE)-[4-[bis(3-methoxy-3-oxopropyl)amino]-2- methylphenyl]azo]-5-nitro-3-Thiophenecarboxylic acid, ethyl ester, 2-[
- Acid black 1 C.I. Acid Blue 10, C.I. Acid Blue 113, C.I. Acid Blue 25, C.I. Acid Blue 29, CI. Acid Blue 290 C.I. Acid Red 103, C.I. Acid red 150, C.I. Acid red 52, C.I. Acid red 73, C.I. Acid red 88, C.I. Acid red 91, C.I. Acid violet 17, C.I. Acid violet 43, C.I. Direct Blue 1, C.I. Direct Blue 120, C.I. Direct Blue 34, C.I. Direct Blue 70, C.I. Direct Blue 71, C.I. Direct Blue 72, C.I. Direct Blue 82, C.I. Direct violet 51, C.I. Disperse Blue 10, C.I.
- Disperse Blue 100 C.I. Disperse Blue 101, C.I. Disperse Blue 102, C.I. Disperse Blue 106:1, C.I. Disperse Blue 11, C.I. Disperse Blue 12, C.I. Disperse Blue 121, C.I. Disperse Blue 122, C.I. Disperse Blue 124, C.I. Disperse Blue 125, C.I. Disperse Blue 128, C.I. Disperse Blue 130, C.I. Disperse Blue 133, C.I. Disperse Blue 137, C.I. Disperse Blue 138, C.I. Disperse Blue 139, C.I. Disperse Blue 142, C.I. Disperse Blue 146, C.I.
- Disperse Blue 148 C.I. Disperse Blue 149, C.I. Disperse Blue 165, C.I. Disperse Blue 165:1, C.I. Disperse Blue 165:2, C.I. Disperse Blue 165:3, C.I. Disperse Blue 171, C.I. Disperse Blue 173, C.I. Disperse Blue 174, C.I. Disperse Blue 175, C.I. Disperse Blue 177, C.I. Disperse Blue 183, C.I. Disperse Blue 187, C.I. Disperse Blue 189, C.I. Disperse Blue 193, C.I. Disperse Blue 194, C.I. Disperse Blue 200, C.I.
- Disperse Blue 201 C.I. Disperse Blue 202, C.I. Disperse Blue 205, C.I. Disperse Blue 206, C.I. Disperse Blue 207, C.I. Disperse Blue 209, C.I. Disperse Blue 21, C.I. Disperse Blue 210, C.I. Disperse Blue 211, C.I. Disperse Blue 212, C.I. Disperse Blue 219, C.I. Disperse Blue 220, C.I. Disperse Blue 222, C.I. Disperse Blue 224, C.I. Disperse Blue 225, C.I. Disperse Blue 248, C.I. Disperse Blue 252, C.I.
- Disperse Blue 346 C.I. Disperse Blue 351, C.I. Disperse Blue 352, C.I. Disperse Blue 353, C.I. Disperse Blue 355, C.I. Disperse Blue 356, C.I. Disperse Blue 357C.I. Disperse Blue 358, C.I. Disperse Blue 36, C.I. Disperse Blue 360, C.I. Disperse Blue 366, C.I. Disperse Blue 368, C.I. Disperse Blue 369, C.I. Disperse Blue 371, C.I. Disperse Blue 373, C.I. Disperse Blue 374, C.I. Disperse Blue 375, C.I. Disperse Blue 376, C.I.
- Disperse Blue 378 C.I. Disperse Blue 38, C.I. Disperse Blue 42, C.I. Disperse Blue 43, C.I. Disperse Blue 44, C.I. Disperse Blue 47, C.I. Disperse Blue 79, C.I. Disperse Blue 79:1, C.I. Disperse Blue 79:2, C.I. Disperse Blue 79:3, C.I. Disperse Blue 82, C.I. Disperse Blue 85, C.I. Disperse Blue 88, C.I. Disperse Blue 90, C.I. Disperse Blue 94, C.I. Disperse Blue 96, C.I. Disperse Violet 10, C.I. Disperse Violet 100, C.I.
- Disperse Violet 102 C.I. Disperse Violet 103, C.I. Disperse Violet 104, C.I. Disperse Violet 106, C.I. Disperse Violet 107, C.I. Disperse Violet 12, C.I. Disperse Violet 13, C.I. Disperse Violet 16, C.I. Disperse Violet 2, C.I. Disperse Violet 24, C.I. Disperse Violet 25, C.I. Disperse Violet 3, C.I. Disperse Violet 33, C.I. Disperse Violet 39, C.I. Disperse Violet 42, C.I. Disperse Violet 43, C.I. Disperse Violet 45, C.I. Disperse Violet 48, C.I. Disperse Violet 49, C.I.
- Disperse Violet 5 C.I. Disperse Violet 50, C.I. Disperse Violet 53, C.I. Disperse Violet 54, C.I. Disperse Violet 55, C.I. Disperse Violet 58, C.I. Disperse Violet 6, C.I. Disperse Violet 60, C.I. Disperse Violet 63, C.I. Disperse Violet 66, C.I. Disperse Violet 69, C.I. Disperse Violet 7, C.I. Disperse Violet 75, C.I. Disperse Violet 76, C.I. Disperse Violet 77, C.I. Disperse Violet 82, C.I. Disperse Violet 86, C.I. Disperse Violet 88, C.I.
- Disperse Violet 9 C.I. Disperse Violet 91, C.I. Disperse Violet 92, C.I. Disperse Violet 93, C.I. Disperse Violet 93:1, C.I. Disperse Violet 94, C.I. Disperse Violet 95, C.I. Disperse Violet 96, C.I. Disperse Violet 97, C.I. Disperse Violet 98, C.I. Disperse Violet 99, C.I. Reactive Black 5, C.I. Reactive Blue 19, C.I. Reactive Blue 4, C.I. Reactive Red 2, C.I. Solvent Blue 43, C.I. Solvent Blue 43, C.I.
- Solvent Red 14 C.I.Acid black 24, C.I.Acid blue 113, C.I.Acid Blue 29, C.I.Direct violet 7, C.I.Food Red 14, Dianix Violet CC, Direct blue 1, Direct Blue 71, Direct blue 75, Direct blue 78, Direct blue 80, Direct blue 279, Direct violet 11, Direct violet 31, Direct violet 35, Direct violet 48, Direct violet 5, Direct Violet 51, Direct violet 66, Direct violet 9, Disperse Blue 106, Disperse blue 148, Disperse blue 165, Disperse Blue 3, Disperse Blue 354, Disperse Blue 364, Disperse blue 367, Disperse Blue 56, Disperse Blue 77, Disperse Blue 79, Disperse blue 79:1, Disperse Red 1, Disperse Red 15, Disperse Violet 26, Disperse Violet 27, Disperse Violet 28, Disperse violet 63, Disperse violet 77, Eosin Y, Ethanol, 2,2'-[[4-[(3,5-dinitro-2- thienyl)
- Suitable polymeric dyes include polymeric dyes selected from the group consisting of polymers containing conjugated chromogens (dye-polymer conjugates) and polymers with chromogens co-polymerized into the backbone of the polymer and mixtures thereof.
- suitable polymeric dyes include polymeric dyes selected from the group consisting of fabric-substantive colorants sold under the name of Liquitint® (Milliken, Spartanburg, South Carolina, USA), dye-polymer conjugates formed from at least one reactive dye and a polymer selected from the group consisting of polymers comprising a moiety selected from the group consisting of a hydroxyl moiety, a primary amine moiety, a secondary amine moiety, a thiol moiety and mixtures thereof.
- suitable polymeric dyes include polymeric dyes selected from the group consisting of Liquitint® (Milliken, Spartanburg, South Carolina, USA) Violet CT, carboxymethyl cellulose (CMC) conjugated with a reactive blue, reactive violet or reactive red dye such as CMC conjugated with C.I. Reactive Blue 19, sold by Megazyme, Wicklow, Ireland under the product name AZO-CM-CELLULOSE, product code S-ACMC, alkoxylated triphenyl-methane polymeric colourants, alkoxylated thiophene polymeric colourants, and mixtures thereof.
- Liquitint® Moquitint®
- CMC carboxymethyl cellulose
- a reactive blue, reactive violet or reactive red dye such as CMC conjugated with C.I. Reactive Blue 19, sold by Megazyme, Wicklow, Ireland under the product name AZO-CM-CELLULOSE
- product code S-ACMC alkoxylated triphenyl-methane polymeric colourants, alkoxylated
- Suitable dye clay conjugates include dye clay conjugates selected from the group comprising at least one cationic/basic dye and a smectite clay, and mixtures thereof.
- suitable dye clay conjugates include dye clay conjugates selected from the group consisting of one cationic/basic dye selected from the group consisting of C.I. Basic Yellow 1 through 108, C.I. Basic Orange 1 through 69, C.I. Basic Red 1 through 118, C.I. Basic Violet 1 through 51, C.I. Basic Blue 1 through 164, C.I. Basic Green 1 through 14, C.I. Basic Brown 1 through 23, CI Basic Black 1 through 11, and a clay selected from the group consisting of Montmorillonite clay, Hectorite clay, Saponite clay and mixtures thereof.
- suitable dye clay conjugates include dye clay conjugates selected from the group consisting of: Montmorillonite Basic Blue B7 C.I. 42595 conjugate, Montmorillonite Basic Blue B9 C.I. 52015 conjugate, Montmorillonite Basic Violet V3 C.I. 42555 conjugate, Montmorillonite Basic Green Gl C.I. 42040 conjugate, Montmorillonite Basic Red Rl C.I. 45160 conjugate,
- Suitable pigments include pigments selected from the group consisting of flavanthrone, indanthrone, chlorinated indanthrone containing from 1 to 4 chlorine atoms, pyranthrone, dichloropyranthrone, monobromodichloropyranthrone, dibromodichloropyranthrone, tetrabromopyranthrone, perylene-3,4,9,10-tetracarboxylic acid diimide, wherein the imide groups may be unsubstituted or substituted by C1-C3 -alkyl or a phenyl or heterocyclic radical, and wherein the phenyl and heterocyclic radicals may additionally carry substituents which do not confer solubility in water, anthrapyrimidinecarboxylic acid amides, violanthrone, isoviolanthrone, dioxazine pigments, copper phthalocyanine which may contain up to 2 chlorine atoms per molecule, polychloro
- phthalocyanine containing up to 14 bromine atoms per molecule and mixtures thereof.
- suitable pigments include pigments selected from the group consisting of Ultramarine Blue (C.I. Pigment Blue 29), Ultramarine Violet (C.I. Pigment Violet 15) and mixtures thereof.
- the aforementioned fabric hueing agents can be used in combination (any mixture of fabric hueing agents can be used).
- Suitable fabric hueing agents can be purchased from Aldrich, Milwaukee, Wisconsin, USA; Ciba Specialty Chemicals, Basel, Switzerland; BASF,
- Suitable hueing agents are described in more detail in US 7,208,459 B2.
- an encapsulate comprising a core, a shell having an inner and outer surface, said shell encapsulating said core.
- said core may comprise a material selected from the group consisting of perfumes; brighteners; dyes; insect repellants; silicones; waxes; flavors; vitamins; fabric softening agents; skin care agents in one aspect, paraffins; enzymes; antibacterial agents; bleaches; sensates; and mixtures thereof; and said shell may comprise a material selected from the group consisting of polyethylenes; polyamides; polystyrenes;
- aminoplasts in one aspect said aminoplast may comprise a polyureas, polyurethane, and/or polyureaurethane, in one aspect said polyurea may comprise polyoxymethyleneurea and/or melamine formaldehyde; poly olefins; polysaccharides, in one aspect said polysaccharide may comprise alginate and/or chitosan; gelatin; shellac; epoxy resins; vinyl polymers; water insoluble inorganics; silicone; and mixtures thereof.
- said core may comprise perfume.
- said shell may comprise melamine formaldehyde and/or cross linked melamine formaldehyde.
- suitable encapsulates may comprise a core material and a shell, said shell at least partially surrounding said core material, is disclosed. At least 75%, 85% or even 90% of said encapsulates may have a fracture strength of from about 0.2 MPa to about 10 MPa, from about 0.4 MPa to about 5MPa, from about 0.6 MPa to about 3.5 MPa, or even from about 0.7 MPa to about 3MPa; and a benefit agent leakage of from 0% to about 30%, from 0% to about 20%, or even from 0% to about 5%.
- At least 75%, 85% or even 90% of said encapsulates may have a particle size of from about 1 microns to about 80 microns, about 5 microns to 60 microns, from about 10 microns to about 50 microns, or even from about 15 microns to about 40 microns.
- At least 75%, 85% or even 90% of said encapsulates may have a particle wall thickness of from about 30 nm to about 250 nm, from about 80 nm to about 180 nm, or even from about 100 nm to about 160 nm.
- said encapsulates' core material may comprise a material selected from the group consisting of a perfume raw material and/or optionally a material selected from the group consisting of vegetable oil, including neat and/or blended vegetable oils including caster oil, coconut oil, cottonseed oil, grape oil, rapeseed, soybean oil, corn oil, palm oil, linseed oil, safflower oil, olive oil, peanut oil, coconut oil, palm kernel oil, castor oil, lemon oil and mixtures thereof; esters of vegetable oils, esters, including dibutyl adipate, dibutyl phthalate, butyl benzyl adipate, benzyl octyl adipate, tricresyl phosphate, trioctyl phosphate and mixtures thereof; straight or branched chain hydrocarbons, including those straight or branched chain hydrocarbons having a boiling point of greater than about 80 °C; partially hydrogenated terphenyls, dialkyl phthalates, alky
- said encapsulates' wall material may comprise a suitable resin including the reaction product of an aldehyde and an amine
- suitable aldehydes include, formaldehyde.
- suitable amines include melamine, urea, benzoguanamine, glycoluril, and mixtures thereof.
- Suitable melamines include, methylol melamine, methylated methylol melamine, imino melamine and mixtures thereof.
- Suitable ureas include, dimethylol urea, methylated dimethylol urea, urea-resorcinol, and mixtures thereof.
- suitable formaldehyde scavengers may be employed with the encapsulates, for example, in a capsule slurry and/or added to a fabric and home care product before, during or after the encapsulates are added to such fabric and home care product.
- Suitable capsules that can be made by following the teaching of USPA 2008/0305982 Al; and/or USPA 2009/0247449 Al.
- suitable capsules can be purchased from Appleton Papers Inc. of Appleton, Wisconsin USA.
- the materials for making the aforementioned encapsulates can be obtained from Solutia Inc. (St Louis, Missouri U.S.A.), Cytec Industries (West Paterson, New Jersey U.S.A.), sigma-Aldrich (St. Louis, Missouri U.S.A.), CP Kelco Corp. of San Diego, California, USA; BASF AG of Ludwigshafen, Germany; Rhodia Corp. of Cranbury, New Jersey, USA; Hercules Corp. of Wilmington, Delaware, USA; Agrium Inc.
- Amphiphilic alkoxylated grease cleaning polymers of the present invention refer to any alkoxylated polymers having balanced hydrophilic and hydrophobic properties such that they remove grease particles from fabrics and surfaces.
- Specific embodiments of the amphiphilic alkoxylated grease cleaning polymers of the present invention comprise a core structure and a plurality of alkoxylate groups attached to that core structure.
- the core structure may comprise a polyalkylenimine structure comprising, in condensed form, repeating units of formulae (I), (II), (III) and (IV):
- the core structure may alternatively comprise a polyalkanolamine structure of the condensation products of at least one compound selected from N- (hy droxy alky 1) amines of formulae (I.a) and/or (I.b),
- A are independently selected from Ci-C 6 -alkylene;
- R 1 , R 1 *, R 2 , R 2 *, R 3 , R 3 *, R 4 , R 4 *, R 5 and R 5 * are independently selected from hydrogen, alkyl, cycloalkyl or aryl, wherein the last three mentioned radicals may be optionally substituted;
- R 6 is selected from hydrogen, alkyl, cycloalkyl or aryl, wherein the last three mentioned radicals may be optionally substituted.
- the plurality of alkylenoxy groups attached to the core structure are independently selected from alkylenoxy units of the formula (V)
- a 2 is in each case independently selected from 1,2-propylene, 1,2- butylene and 1,2-isobutylene;
- a 3 is 1,2-propylene;
- R is in each case independently selected from hydrogen and Ci-C4-alkyl;
- m has an average value in the range of from 0 to about 2;
- n has an average value in the range of from about 20 to about 50;
- p has an average value in the range of from about 10 to about 50.
- amphiphilic alkoxylated grease cleaning polymers may be selected from alkoxylated polyalkylenimines having an inner polyethylene oxide block and an outer polypropylene oxide block, the degree of ethoxylation and the degree of propoxylation not going above or below specific limiting values.
- Specific embodiments of the alkoxylated polyalkylenimines according to the present invention have a minimum ratio of polyethylene blocks to polypropylene blocks (n/p) of about 0.6 and a maximum of about 1.5(x+2y+l) 1/2.
- Alkoxykated polyalkyenimines having an n/p ratio of from about 0.8 to about 1.2(x+2y+l) 1 2 have been found to have especially beneficial properties.
- the alkoxylated polyalkylenimines according to the present invention have a backbone which consists of primary, secondary and tertiary amine nitrogen atoms which are attached to one another by alkylene radicals A and are randomly arranged.
- Primary amino moieties which start or terminate the main chain and the side chains of the polyalkylenimine backbone and whose remaining hydrogen atoms are subsequently replaced by alkylenoxy units are referred to as repeating units of formulae (I) or (IV), respectively.
- Secondary amino moieties whose remaining hydrogen atom is subsequently replaced by alkylenoxy units are referred to as repeating units of formula (II).
- Tertiary amino moieties which branch the main chain and the side chains are referred to as repeating units of formula (III).
- cyclization can occur in the formation of the polyalkylenimine backbone, it is also possible for cyclic amino moieties to be present to a small extent in the backbone.
- Such polyalkylenimines containing cyclic amino moieties are of course alkoxylated in the same way as those consisting of the noncyclic primary and secondary amino moieties.
- the polyalkylenimine backbone consisting of the nitrogen atoms and the groups A 1 has an average molecular weight Mw of from about 60 to about 10,000 g/mole, preferably from about 100 to about 8,000 g/mole and more preferably from about 500 to about 6,000 g/mole.
- the sum (x+2y+l) corresponds to the total number of alkylenimine units present in one individual polyalkylenimine backbone and thus is directly related to the molecular weight of the polyalkylenimine backbone.
- the values given in the specification however relate to the number average of all polyalkylenimines present in the mixture.
- the sum (x+2y+2) corresponds to the total number amino groups present in one individual polyalkylenimine backbone.
- the radicals A connecting the amino nitrogen atoms may be identical or different, linear or branched C2-C6-alkylene radicals, such as 1 ,2-ethylene, 1 ,2-propylene, 1,2-butylene, 1,2- isobutylene,l,2-pentanediyl, 1 ,2-hexanediyl or hexamethylen.
- a preferred branched alkylene is 1,2-propylene.
- Preferred linear alkylene are ethylene and hexamethylene.
- a more preferred alkylene is 1,2-ethylene.
- a 2 in each case is selected from 1,2-propylene, 1,2-butylene and 1,2-isobutylene; preferably A 2 is 1,2-propylene.
- a 3 is 1,2-propylene; R in each case is selected from hydrogen and Ci-C4-alkyl, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl and tert.-butyl; preferably R is hydrogen.
- the index m in each case has a value of 0 to about 2; preferably m is 0 or approximately 1; more preferably m is 0.
- the index n has an average value in the range of from about 20 to about 50, preferably in the range of from about 22 to about 40, and more preferably in the range of from about 24 to about 30.
- the index p has an average value in the range of from about 10 to about 50, preferably in the range of from about 11 to about 40, and more preferably in the range of from about 12 to about 30.
- the alkylenoxy unit of formula (V) is a non-random sequence of alkoxylate blocks.
- non-random sequence it is meant that the [-A 2 -0-] m is added first (i.e., closest to the bond to the nitrgen atom of the repeating unit of formula (I), (II), or (III)), the [- CH 2 -CH 2 -0-] n is added second, and the [-A 3 -0-] p is added third.
- This orientation provides the alkoxylated polyalkylenimine with an inner polyethylene oxide block and an outer polypropylene oxide block.
- alkylenoxy units of formula (V) The substantial part of these alkylenoxy units of formula (V) is formed by the ethylenoxy units -[CH 2 -CH 2 -0)] n - and the propylenoxy units -[CH 2 -CH 2 (CH 3 )-0] P -.
- the alkylenoxy units may additionally also have a small proportion of propylenoxy or butylenoxy units -[A 2 -0] m -, i.e.
- the polyalkylenimine backbone saturated with hydrogen atoms may be reacted initially with small amounts of up to about 2 mol, especially from about 0.5 to about 1.5 mol, in particular from about 0.8 to about 1.2 mol, of propylene oxide or butylene oxide per mole of NH- moieties present, i.e. incipiently alkoxylated.
- the amphiphilic alkoxylated grease cleaning polymers are present in the fabric and home care products, including but not limited to detergents, of the present invention at levels ranging from about 0.05% to 10% by weight of the fabric and home care product.
- Embodiments of the fabric and home care products may comprise from about 0.1% to about 5% by weight. More specifically, the embodiments may comprise from about 0.25 to about 2.5% of the grease cleaning polymer.
- the fabric and home care products can comprise one or more enzymes which provide cleaning performance and/or fabric care benefits.
- suitable enzymes include, but are not limited to, hemicellulases, peroxidases, proteases, cellulases, xylanases, lipases,
- a typical combination is an enzyme cocktail that may comprise, for example, a protease and lipase in conjunction with amylase.
- the aforementioned additional enzymes may be present at levels from about 0.00001% to about 2%, from about 0.0001% to about 1% or even from about 0.001% to about 0.5% enzyme protein by weight of the fabric and home care product.
- Suitable proteases include metalloproteases and serine proteases, including neutral or alkaline microbial serine proteases, such as subtilisins (EC 3.4.21.62).
- Suitable proteases include those of animal, vegetable or microbial origin. In one aspect, such suitable protease may be of microbial origin.
- the suitable proteases include chemically or genetically modified mutants of the aforementioned suitable proteases.
- the suitable protease may be a serine protease, such as an alkaline microbial protease or/and a trypsin-type protease.
- suitable neutral or alkaline proteases include:
- subtilisins (EC 3.4.21.62), including those derived from Bacillus, such as Bacillus lentus, B. alkalophilus, B. subtilis, B. amyloliquefaciens, Bacillus pumilus and Bacillus gibsonii described in US 6,312,936 B l, US 5,679,630, US 4,760,025, US7,262,042 and WO09/021867.
- trypsin-type or chymotrypsin-type proteases such as trypsin (e.g. , of porcine or bovine origin), including the Fusarium protease described in WO 89/06270 and the
- chymotrypsin proteases derived from Cellumonas described in WO 05/052161 and WO 05/052146.
- metalloproteases including those derived from Bacillus amyloliquefaciens described in WO 07/044993 A2.
- Preferred proteases include those derived from Bacillus gibsonii or Bacillus Lentus.
- Suitable commercially available protease enzymes include those sold under the trade names Alcalase®, Savinase®, Primase®, Durazym®, Polarzyme®, Kannase®, Liquanase®, Liquanase Ultra®, Savinase Ultra®, Ovozyme®, Neutrase®, Everlase® and Esperase® by Novozymes A/S (Denmark), those sold under the tradename Maxatase®, Maxacal®,
- BLAP BLAP
- BLAP R BLAP with S3T + V4I + V199M + V205I + L217D
- BLAP X BLAP with S3T + V4I + V205I
- BLAP F49 BLAP with S3T + V4I + A194P + V199M + V205I + L217D
- the fabric and home care product may comprise a protease that is not immunoequivalent to the cold water protease of this invention.
- an immunoequivalent protease will have a high degree of identity (>80%) with BPN' and will cross-react with the same antibody.
- Suitable non-immunoequivalent enzymes will include those derived from Bacillus Lentus, Bacillus gibsonii and the metalloprotease derived from Bacillus amyloliquefaciens.
- Suitable alpha- amylases include those of bacterial or fungal origin. Chemically or genetically modified mutants (variants) are included.
- a preferred alkaline alpha-amylase is derived from a strain of Bacillus, such as Bacillus licheniformis, Bacillus amyloliquefaciens, Bacillus stearothermophilus, Bacillus subtilis, or other Bacillus sp., such as Bacillus sp. NCIB 12289, NCIB 12512, NCIB 12513, DSM 9375 (USP 7,153,818) DSM 12368, DSMZ no. 12649, KSM AP1378 (WO 97/00324), KSM K36 or KSM K38 (EP 1,022,334).
- Preferred amylases include:
- WOOO/60060 and WO 06/002643 especially the variants with one or more substitutions in the following positions versus the AA560 enzyme listed as SEQ ID No. 12 in WO 06/002643:
- variants exhibiting at least 90% identity with SEQ ID No. 4 in WO06/002643, the wild-type enzyme from Bacillus SP722, especially variants with deletions in the 183 and 184 positions and variants described in WO 00/60060, which is incorporated herein by reference.
- variants exhibiting at least 95% identity with the wild- type enzyme from Bacillus sp.707 (SEQ ID NO:7 in US 6,093, 562), especially those comprising one or more of the following mutations M202, M208, S255, R172, and/or M261.
- said amylase comprises one or more of M202L, M202V, M202S, M202T, M202I, M202Q, M202W, S255N and/or R172Q. Particularly preferred are those comprising the M202L or M202T mutations.
- Suitable commercially available alpha-amylases include DURAMYL®,
- suitable amylases include NATALASE®, STAINZYME® and STAINZYME PLUS® and mixtures thereof.
- such additional enzyme may be selected from the group consisting of: lipases, including "first cycle lipases” such as those described in U.S. Patent 6,939,702 Bl and US PA 2009/0217464.
- the lipase is a first-wash lipase, preferably a variant of the wild-type lipase from Thermomyces lanuginosus comprising T231R and N233R mutations.
- the wild-type sequence is the 269 amino acids (amino acids 23 - 291) of the Swissprot accession number Swiss-Prot 059952 (derived from Thermomyces lanuginosus (Humicola lanuginosa)).
- Preferred lipases would include those sold under the tradenames Lipex® and Lipolex®.
- other preferred enzymes include microbial-derived endoglucanases exhibiting endo-beta-l,4-glucanase activity (E.C. 3.2.1.4), including a bacterial polypeptide endogenous to a member of the genus Bacillus which has a sequence of at least 90%, 94%, 97% and even 99% identity to the amino acid sequence SEQ ID NO:2 in 7,141,403B2) and mixtures thereof.
- Suitable endoglucanases are sold under the tradenames Celluclean® and Whitezyme® (Novozymes A/S, Bagsvaerd, Denmark).
- Pectate lyases sold under the tradenames Pectawash®, Pectaway® and mannanases sold under the tradenames Mannaway® (all from Novozymes A/S, Bagsvaerd, Denmark), and Purabrite® (Genencor International Inc., Palo Alto, California).
- adjuncts illustrated hereinafter are suitable for use in the instant fabric and home care products and may be desirably incorporated in certain embodiments of the invention, for example to assist or enhance cleaning performance, for treatment of the substrate to be cleaned, or to modify the aesthetics of the fabric and home care product as is the case with perfumes, colorants, dyes or the like.
- the levels of any such adjuncts incorporated in any fabric and home care product are in addition to any materials previously recited for incorporation. The precise nature of these additional components, and levels of incorporation thereof, will depend on the physical form of the fabric and home care product and the nature of the cleaning operation for which it is to be used.
- Suitable adjunct materials include, but are not limited to, surfactants, builders, chelating agents, dye transfer inhibiting agents, dispersants, additional enzymes, and enzyme stabilizers, catalytic materials, bleach activators, hydrogen peroxide, sources of hydrogen peroxide, preformed peracids, polymeric dispersing agents, clay soil removal/anti-redeposition agents, brighteners, suds suppressors, dyes, perfumes, perfume delivery systems, structure elasticizing agents, fabric softeners, carriers, hydrotropes, processing aids, solvents and/or pigments.
- suitable examples of such other adjuncts and levels of use are found in U.S. Patent Nos. 5,576,282, 6,306,812 Bl and 6,326,348 Bl that are incorporated by reference.
- adjunct ingredients are not essential to Applicants' fabric and home care products.
- certain embodiments of Applicants' fabric and home care products do not contain one or more of the following adjuncts materials: surfactants, builders, chelating agents, dye transfer inhibiting agents, dispersants, additional enzymes, and enzyme stabilizers, catalytic materials, bleach activators, hydrogen peroxide, sources of hydrogen peroxide, preformed peracids, polymeric dispersing agents, clay soil removal/anti-redeposition agents, brighteners, suds suppressors, dyes, perfumes, perfume delivery systems, structure elasticizing agents, fabric softeners, carriers, hydrotropes, processing aids, solvents and/or pigments.
- one or more adjuncts may be present as detailed below:
- compositions of the present invention may comprise a neat perfume and/or perfume technology systems that can be combined to yield the desired scent experience from the store shelf stage of a product, through its total performance cycle.
- Suitable perfumes include those perfumes that are enduring perfumes and/or quadrant perfumes. Examples of such neat perfumes are disclosed USP Nos. 5,500,138; 5,500,154; 6,491,728; 5,500,137 and 5,780,404.
- Suitable perfume delivery systems, methods of making certain perfume delivery systems and the uses of such perfume delivery systems are disclosed in USPA 2007/0275866 Al.
- Such perfume delivery systems include:
- PAD Polymer Assisted Delivery
- This perfume delivery technology uses polymeric materials to deliver perfume materials.
- Classical coacervation, water soluble or partly soluble to insoluble charged or neutral polymers, liquid crystals, hot melts, hydrogels, perfumed plastics, microcapsules, nano- and micro-latexes, polymeric film formers, and polymeric absorbents, polymeric adsorbents, etc. are some examples.
- PAD includes but is not limited to:
- the fragrance is dissolved or dispersed in a polymer matrix or particle.
- Perfumes for example, may be 1) dispersed into the polymer prior to formulating into the product or 2) added separately from the polymer during or after formulation of the product. Diffusion of perfume from the polymer is a common trigger that allows or increases the rate of perfume release from a polymeric matrix system that is deposited or applied to the desired surface (situs), although many other triggers are know that may control perfume release.
- Absorption and/or adsorption into or onto polymeric particles, films, solutions, and the like are aspects of this technology. Nano- or micro-particles composed of organic materials (e.g., latexes) are examples.
- Suitable particles include a wide range of materials including, but not limited to polyacetal, polyacrylate, polyacrylic, polyacrylonitrile, polyamide, polyaryletherketone, polybutadiene, polybutylene, polybutylene terephthalate, polychloroprene, poly ethylene, polyethylene terephthalate, polycyclohexylene dimethylene terephthalate, polycarbonate, polychloroprene, polyhydroxyalkanoate, polyketone, polyester, polyethylene, polyetherimide, polyethersulfone, polyethylenechlorinates, polyimide, polyisoprene, polylactic acid, polymethylpentene, polyphenylene oxide, polyphenylene sulfide, polyphthalamide, polypropylene, polystyrene, polysulfone, polyvinyl acetate, polyvinyl chloride, as well as polymers or copolymers based on acrylonitrile-butadiene, cellulose acetate, ethylene-
- “Standard” systems refer to those that are "pre-loaded” with the intent of keeping the pre-loaded perfume associated with the polymer until the moment or moments of perfume release. Such polymers may also suppress the neat product odor and provide a bloom and/or longevity benefit depending on the rate of perfume release.
- One challenge with such systems is to achieve the ideal balance between 1) in- product stability (keeping perfume inside carrier until you need it) and 2) timely release (during use or from dry situs). Achieving such stability is particularly important during in-product storage and product aging. This challenge is particularly apparent for aqueous-based, surfactant-containing products, such as heavy duty liquid laundry detergents. Many "Standard" matrix systems available effectively become “Equilibrium” systems when formulated into aqueous-based products.
- "Equilibrium” systems are those in which the perfume and polymer may be added separately to the product, and the equilibrium interaction between perfume and polymer leads to a benefit at one or more consumer touch points (versus a free perfume control that has no polymer-assisted delivery technology).
- the polymer may also be pre-loaded with perfume; however, part or all of the perfume may diffuse during in-product storage reaching an equilibrium that includes having desired perfume raw materials (PRMs) associated with the polymer.
- PRMs perfume raw materials
- Matrix systems also include hot melt adhesives and perfume plastics.
- hydrophobically modified polysaccharides may be formulated into the perfumed product to increase perfume deposition and/or modify perfume release. All such matrix systems, including for example polysaccharides and nanolatexes may be combined with other PDTs, including other PAD systems such as PAD reservoir systems in the form of a perfume microcapsule (PMC).
- PMC perfume microcapsule
- Polymer Assisted Delivery (PAD) matrix systems may include those described in the following references: US Patent Applications 2004/0110648 Al; 2004/0092414 Al; 2004/0091445 Al and 2004/0087476 Al; and US Patents 6,531,444; 6,024,943; 6,042,792; 6,051,540; 4,540,721 and 4,973,422.
- Silicones are also examples of polymers that may be used as PDT, and can provide perfume benefits in a manner similar to the polymer-assisted delivery "matrix system". Such a PDT is referred to as silicone-assisted delivery (SAD).
- SAD silicone-assisted delivery
- Suitable silicones as well as making same may be found in WO 2005/102261; USPA 20050124530A1; USPA 20050143282A1; and WO 2003/015736.
- Functionalized silicones may also be used as described in USPA 2006/003913 Al. Examples of silicones include polydimethylsiloxane and poly alky ldimethylsiloxanes.
- Reservoir systems are also known as a core-shell type technology, or one in which the fragrance is surrounded by a perfume release controlling membrane, which may serve as a protective shell.
- the material inside the microcapsule is referred to as the core, internal phase, or fill, whereas the wall is sometimes called a shell, coating, or membrane.
- Microparticles or pressure sensitive capsules or microcapsules are examples of this technology.
- Microcapsules of the current invention are formed by a variety of procedures that include, but are not limited to, coating, extrusion, spray-drying, interfacial, in-situ and matrix polymerization.
- the possible shell materials vary widely in their stability toward water. Among the most stable are polyoxymethyleneurea (PMU)-based materials, which may hold certain PRMs for even long periods of time in aqueous solution (or product).
- PMU polyoxymethyleneurea
- Such systems include but are not limited to urea-formaldehyde and/or melamine-formaldehyde.
- Gelatin-based microcapsules may be prepared so that they dissolve quickly or slowly in water, depending for example on the degree of cross- linking.
- capsule wall materials are available and vary in the degree of perfume diffusion stability observed.
- rate of release of perfume from a capsule for example, once deposited on a surface is typically in reverse order of in-product perfume diffusion stability.
- urea- formaldehyde and melamine-formaldehyde microcapsules for example, typically require a release mechanism other than, or in addition to, diffusion for release, such as mechanical force (e.g., friction, pressure, shear stress) that serves to break the capsule and increase the rate of perfume (fragrance) release.
- Other triggers include melting, dissolution, hydrolysis or other chemical reaction, electromagnetic radiation, and the like.
- microcapsules that are based on urea-formaldehyde and/or melamine-formaldehyde are relatively stable, especially in near neutral aqueous- based solutions.
- suitable microcapsules include microcapsules having shells that comprise urethane materials, acrylics and/or vinyl alcohols. These materials may require a friction trigger which may not be applicable to all product applications.
- Other microcapsule materials e.g., gelatin
- Perfume microcapsules may include those described in the following references: US Patent Applications: 2003/0125222 Al; 2003/215417 Al; 2003/216488 Al; 2003/158344 Al; 2003/165692 Al; 2004/071742 Al; 2004/071746 Al; 2004/072719 Al; 2004/072720 Al; 2006/0039934 Al; 2003/203829 Al; 2003/195133 Al; 2004/087477 Al; 2004/0106536 Al; and US Patents 6,645,479 Bl; 6,200,949 Bl; 4,882,220; 4,917,920; 4,514,461; 6,106,875 and 4,234,627, 3,594,328 and US RE 32713.
- Non-polymer materials or molecules may also serve to improve the delivery of perfume.
- perfume may non- covalently interact with organic materials, resulting in altered deposition and/or release.
- organic materials include but are not limited to hydrophobic materials such as organic oils, waxes, mineral oils, petrolatum, fatty acids or esters, sugars, surfactants, liposomes and even other perfume raw material (perfume oils), as well as natural oils, including body and/or other soils.
- Perfume fixatives are yet another example.
- non- polymeric materials or molecules have a CLogP greater than about 2.
- Molecule-Assisted Delivery (MAD) may also include those described in USP 7,119,060 and USP 5,506,201.
- Fiber- Assisted Delivery The choice or use of a situs itself may serve to improve the delivery of perfume.
- the situs itself may be a perfume delivery technology.
- different fabric types such as cotton or polyester will have different properties with respect to ability to attract and/or retain and/or release perfume.
- the amount of perfume deposited on or in fibers may be altered by the choice of fiber, and also by the history or treatment of the fiber, as well as by any fiber coatings or treatments. Fibers may be woven and non-woven as well as natural or synthetic.
- Natural fibers include those produced by plants, animals, and geological processes, and include but are not limited to cellulose materials such as cotton, linen, hemp jute, flax, ramie, and sisal, and fibers used to manufacture paper and cloth.
- Fiber-Assisted Delivery may consist of the use of wood fiber, such as thermomechanical pulp and bleached or unbleached kraft or sulfite pulps.
- Animal fibers consist largely of particular proteins, such as silk, sinew, catgut and hair (including wool).
- Polymer fibers based on synthetic chemicals include but are not limited to polyamide nylon, PET or PBT polyester, phenol-formaldehyde (PF), polyvinyl alcohol fiber (PVOH), polyvinyl chloride fiber (PVC), polyolefins (PP and PE), and acrylic polymers. All such fibers may be pre-loaded with a perfume, and then added to a product that may or may not contain free perfume and/or one or more perfume delivery technologies. In one aspect, the fibers may be added to a product prior to being loaded with a perfume, and then loaded with a perfume by adding a perfume that may diffuse into the fiber, to the product. Without wishing to be bound by theory, the perfume may absorb onto or be adsorbed into the fiber, for example, during product storage, and then be released at one or more moments of truth or consumer touch points.
- Amine Assisted Delivery The amine-assisted delivery technology approach utilizes materials that contain an amine group to increase perfume deposition or modify perfume release during product use. There is no requirement in this approach to pre-complex or pre-react the perfume raw material(s) and amine prior to addition to the product.
- amine- containing AAD materials suitable for use herein may be non-aromatic; for example, polyalkylimine, such as polyethyleneimine (PEI), or polyvinylamine (PVAm), or aromatic, for example, anthranilates. Such materials may also be polymeric or non-polymeric. In one aspect, such materials contain at least one primary amine.
- This technology will allow increased longevity and controlled release also of low ODT perfume notes (e.g., aldehydes, ketones, enones) via amine functionality, and delivery of other PRMs, without being bound by theory, via polymer-assisted delivery for polymeric amines. Without technology, volatile top notes can be lost too quickly, leaving a higher ratio of middle and base notes to top notes.
- the use of a polymeric amine allows higher levels of top notes and other PRMS to be used to obtain freshness longevity without causing neat product odor to be more intense than desired, or allows top notes and other PRMs to be used more efficiently.
- AAD systems are effective at delivering PRMs at pH greater than about neutral.
- conditions in which more of the amines of the AAD system are deprotonated may result in an increased affinity of the deprotonated amines for PRMs such as aldehydes and ketones, including unsaturated ketones and enones such as damascone.
- PRMs such as aldehydes and ketones
- polymeric amines are effective at delivering PRMs at pH less than about neutral.
- conditions in which more of the amines of the AAD system are protonated may result in a decreased affinity of the protonated amines for PRMs such as aldehydes and ketones, and a strong affinity of the polymer framework for a broad range of PRMs.
- polymer-assisted delivery may be delivering more of the perfume benefit; such systems are a subspecies of AAD and may be referred to as Amine- Polymer-Assisted Delivery or APAD.
- APAD Amine- Polymer-Assisted Delivery
- PAD Polymer-Assisted Delivery
- AAD and PAD systems may interact with other materials, such as anionic surfactants or polymers to form coacervate and/or coacervates-like systems.
- a material that contains a heteroatom other than nitrogen for example sulfur, phosphorus or selenium, may be used as an alternative to amine compounds.
- the aforementioned alternative compounds can be used in combination with amine compounds.
- a single molecule may comprise an amine moiety and one or more of the alternative heteroatom moieties, for example, thiols, phosphines and selenols.
- Suitable AAD systems as well as methods of making same may be found in US Patent Applications 2005/0003980 Al; 2003/0199422 Al; 2003/0036489 Al; 2004/0220074 Al and USP 6,103,678.
- Cyclodextrin Delivery System This technology approach uses a cyclic oligosaccharide or cyclodextrin to improve the delivery of perfume.
- a perfume and cyclodextrin (CD) complex is formed.
- Such complexes may be preformed, formed in-situ, or formed on or in the situs.
- loss of water may serve to shift the equilibrium toward the CD-Perfume complex, especially if other adjunct ingredients (e.g., surfactant) are not present at high concentration to compete with the perfume for the cyclodextrin cavity.
- a bloom benefit may be achieved if water exposure or an increase in moisture content occurs at a later time point.
- cyclodextrin allows the perfume formulator increased flexibility in selection of PRMs. Cyclodextrin may be pre-loaded with perfume or added separately from perfume to obtain the desired perfume stability, deposition or release benefit. Suitable CDs as well as methods of making same may be found in USPA 2005/0003980 Al and 2006/0263313 Al and US Patents 5,552,378; 3,812,011; 4,317,881; 4,418,144 and 4,378,923.
- Starch Encapsulated Accord The use of a starch encapsulated accord (SEA) technology allows one to modify the properties of the perfume, for example, by converting a liquid perfume into a solid by adding ingredients such as starch.
- the benefit includes increased perfume retention during product storage, especially under non-aqueous conditions. Upon exposure to moisture, a perfume bloom may be triggered. Benefits at other moments of truth may also be achieved because the starch allows the product formulator to select PRMs or PRM concentrations that normally cannot be used without the presence of SEA.
- Another technology example includes the use of other organic and inorganic materials, such as silica to convert perfume from liquid to solid. Suitable SEAs as well as methods of making same may be found in USPA 2005/0003980 Al and USP 6,458,754 B l.
- SEA's may be made by preparing a mixture comprising starch, water, acid and a perfume, the acid being incorporated in the mixture in an amount sufficient to lower the pH of the starch- water mixture by at least 0.25 units; and atomising and drying the mixture thereby forming encapsulated perfume.
- an aqueous mixture is prepared comprising starch, water, perfume and acid. These ingredients may be added in any order, but usually the starch-water mixture is prepared first and
- the acid and perfume are added.
- the acid may be added prior to the ingredient for encapsulation.
- the acid is added after the ingredient for encapsulation.
- concentration of starch in the aqueous mixture may be from as low as 5 or 10 wt% to as high as 60 or even 75 wt%. Generally the concentration of starch in the mixture is from 20 to 50 wt%, more usually around 25 to 40 wt% in the aqueous mixture.
- Suitable starches can be made from raw starch, pregelatinized starch, modified starch derived from tubers, legumes, cereal and grains for example corn starch , wheat starch, rice starch, waxy corn starch, oat starch, cassava starch, waxy barley starch, waxy rice starch, sweet rice starch, amioca, potato starch, tapioca starch and mixtures thereof.
- Modified starches may be particularly suitable for use in the present invention, and these include hydrolyzed starch, acid thinned starch, starch having hydrophobic groups, such as starch esters of long chain hydrocarbons (C 5 or greater), starch acetates, starch octenyl succinate and mixtures thereof.
- starch esters such as starch octenyl succinates are employed .
- hydrolyzed starch refers to oligosaccharide-type materials that are typically obtained by acid and/or enzymatic hydrolysis of starches, preferably corn starch. It may be preferred to include in the starch water-mixture, a starch ester. Particularly preferred are the modified starches comprising a starch derivative containing a hydrophobic group or both a hydrophobic and a hydrophilic group which has been degraded by at least one enzyme capable of cleaving the 1,4 linkages of the starch molecule from the non-reducing ends to produce short chained saccharides to provide high oxidation resistance while maintaining substantially high molecular weight portions of the starch base.
- the aqueous starch mixture may also include a plasticizer for the starch.
- Suitable examples include monosaccharides, disaccharides, oligosaccharides and maltodextrins, such as glucose, sucrose, sorbitol, gum arabic, guar gums and maltodextrin.
- the acid used in the process of the invention may be any acid. Examples include sulphuric acid, nitric acid, hydrochloric acid, sulphamic acid and phosphonic acid.
- carboxylic organic acids are employed.
- organic acids comprising more than one carboxylic acid groups are employed.
- suitable organic acids include citric acid, tartaric acid, maleic acid, malic acid, succinic acid, sebacic acid, adipic acid, itaconic acid, acetic acid and ascorbic acid, etc.
- saturated acids such as citric acid, are employed.
- Suitable perfumes for encapsulation include the HIA perfumes including those having a boiling point determined at the normal standard pressure of about 760 mmHg of 275 °C or lower, an octanol/water partition coefficient P of about 2000 or higher and an odour detection thresholdof less than or equal 50 parts per billion (ppb).
- the perfume may have logP of 2 or higher.
- Suitable perfumes may be selected from the group consisting of 3-(4-t-butylphenyl)-2- methyl propanal, 3-(4-t-butylphenyl)-propanal, 3-(4-isopropylphenyl)-2-methylpropanal, 3-(3,4- methylenedioxyphenyl)-2-methylpropanal, and 2,6-dimethyl-5-heptenal, Alpha -damascone, Delta -damascone, Iso-damascone, Beta-damascenone, 6,7-dihydro-l, 1,2,3, 3-pentamethyl- 4(5H)-indanone, methyl-7,3-dihydro-2H-l,5-benzodioxepine-3-one, 2-[2-(4-methyl-3- cyclohexenyl-l-yl)propyl]cyclopentan-2-one, 2-sec-butylcyclohexanone, and Alpha
- the mixture is mixed under high shear to form an emulsion or dispersion of ingredient for encapsulation in the aqueous starch solution.
- Suitable technique may then be used for the final stage of processing where the aqueous mixture including acid and perfumes is atomised and dried.
- Suitable techniques include, but are not limited to those known in the art including spray drying, extrusion, spray chilling/crystallisation methods, fluid bed coating and the use of phase transfer catalysts to promote interfacial polymerization. Spray efficiencies may be increased by methods known in the art, such as by using high drying towers, lightly oiling the chamber walls, or using preconditioned air in which the moisture has been substantially removed.
- ZIC Inorganic Carrier Delivery System
- PZ perfume-loaded zeolite
- Suitable zeolite and inorganic carriers as well as methods of making same may be found in USPA 2005/0003980 Al and US Patents 5,858,959; 6,245,732 Bl; 6,048,830 and 4,539,135.
- Silica is another form of ZIC.
- a suitable inorganic carrier includes inorganic tubules, where the perfume or other active material is contained within the lumen of the nano- or micro-tubules.
- the perfume-loaded inorganic tubule (or Perfume- Loaded Tubule or PLT) is a mineral nano- or micro-tubule, such as halloysite or mixtures of halloysite with other inorganic materials, including other clays.
- the PLT technology may also comprise additional ingredients on the inside and/or outside of the tubule for the purpose of improving in-product diffusion stability, deposition on the desired situs or for controlling the release rate of the loaded perfume.
- Monomeric and/or polymeric materials may be used to coat, plug, cap, or otherwise encapsulate the PLT. Suitable PLT systems as well as methods of making same may be found in USP 5,651,976.
- Pro-Perfume (PP) This technology refers to perfume technologies that result from the reaction of perfume materials with other substrates or chemicals to form materials that have a covalent bond between one or more PRMs and one or more carriers. The PRM is converted into a new material called a pro-PRM (i.e., pro-perfume), which then may release the original PRM upon exposure to a trigger such as water or light.
- a pro-PRM i.e., pro-perfume
- Pro-perfumes may provide enhanced perfume delivery properties such as increased perfume deposition, longevity, stability, retention, and the like.
- Pro-perfumes include those that are monomeric (non-polymeric) or polymeric, and may be pre-formed or may be formed in-situ under equilibrium conditions, such as those that may be present during in-product storage or on the wet or dry situs.
- Nonlimiting examples of pro- perfumes include Michael adducts (e.g., beta-amino ketones), aromatic or non-aromatic imines (Schiffs Bases), oxazolidines, beta-keto esters, and orthoesters.
- Another aspect includes compounds comprising one or more beta-oxy or beta-thio carbonyl moieties capable of releasing a PRM, for example, an alpha, beta-unsaturated ketone, aldehyde or carboxylic ester.
- the typical trigger for perfume release is exposure to water; although other triggers may include enzymes, heat, light, pH change, autoxidation, a shift of equilibrium, change in concentration or ionic strength and others.
- light-triggered pro-perfumes are particularly suited.
- Such photo-pro-perfumes (PPPs) include but are not limited to those that release coumarin derivatives and perfumes and/or pro-perfumes upon being triggered.
- the released pro-perfume may release one or more PRMs by means of any of the above mentioned triggers.
- the photo-pro-perfume releases a nitrogen-based pro-perfume when exposed to a light and/or moisture trigger.
- the nitrogen-based pro-perfume, released from the photo-pro-perfume releases one or more PRMs selected, for example, from aldehydes, ketones (including enones) and alcohols.
- the PPP releases a dihydroxy coumarin derivative.
- the light-triggered pro-perfume may also be an ester that releases a coumarin derivative and a perfume alcohol.
- the pro-perfume is a dimethoxybenzoin derivative as described in USPA 2006/0020459 Al.
- the pro-perfume is a 3', 5 '-dimethoxybenzoin (DMB) derivative that releases an alcohol upon exposure to electromagnetic radiation.
- the pro-perfume releases one or more low ODT PRMs, including tertiary alcohols such as linalool, tetrahydrolinalool, or dihydromyrcenol.
- ARP Amine Reaction Product
- ARP is a subclass or species of PP.
- the reactive amines are primary and/or secondary amines, and may be part of a polymer or a monomer (non-polymer).
- Such ARPs may also be mixed with additional PRMs to provide benefits of polymer-assisted delivery and/or amine-assisted delivery.
- Nonlimiting examples of polymeric amines include polymers based on poly alky limines, such as polyethyleneimine (PEI), or polyvinylamine (PVAm).
- Nonlimiting examples of monomeric (non-polymeric) amines include hydroxyl amines, such as 2-aminoethanol and its alkyl substituted derivatives, and aromatic amines such as anthranilates.
- the ARPs may be premixed with perfume or added separately in leave-on or rinse-off applications.
- a material that contains a heteroatom other than nitrogen, for example oxygen, sulfur, phosphorus or selenium may be used as an alternative to amine compounds.
- the aforementioned alternative compounds can be used in combination with amine compounds.
- a single molecule may comprise an amine moiety and one or more of the alternative heteroatom moieties, for example, thiols, phosphines and selenols.
- the benefit may include improved delivery of perfume as well as controlled perfume release. Suitable ARPs as well as methods of making same can be found in USPA 2005/0003980 Al and USP 6,413,920 Bl.
- the amine reaction product's perfume component which is reacted with the amine to form the amine reaction product, is selected from a perfume comprising a ketone moiety and/or an aldehyde moiety.
- such perfumes comprise a chain containing at least 5 carbon atoms.
- suitable perfumes comprising a ketone moiety may be selected from Alpha Damascone, Delta Damascone, Iso Damascone, Carvone, Gamma-Methyl-Ionone, Iso-E-Super, 2,4,4,7-Tetramethyl-oct-6-en-3-one, Benzyl Acetone, Beta Damascone, Damascenone, methyl dihydrojasmonate, methyl cedrylone, and mixtures thereof.
- suitable perfumes comprising an aldehyde moiety may be selected from 1 -decanal, benzaldehyde, florhydral, 2,4-dimethyl-3-cyclohexen-l-carboxaldehyde; cis/trans-3,7-dimethyl- 2,6-octadien- 1-al; heliotropin; 2,4,6-trimethyl-3-cyclohexene- 1-carboxaldehyde; 2,6-nonadienal; alpha-n-amyl cinnamic aldehyde, alpha-n-hexyl cinnamic aldehyde, P.T.
- the suitable perfume be selected from undecylenic aldehyde, undecalactone gamma, heliotropin, dodecalactone gamma, p-anisic aldehyde, para hydroxy-phenyl-butanone, cymal, benzyl acetone, ionone alpha, p.t.bucinal, damascenone, ionone beta and methyl-nonyl ketone, and/or mixtures thereof.
- suitable amine reaction products are those resulting from the reaction of polethyleneimine polymer like Lupasol polymers, with one or more of the following Alpha Damascone, Delta Damascone, Carvone, Hedione, Florhydral, Lilial, Heliotropine, Gamma-Methyl-Ionone and 2,4-dimethyl-3- cyclohexen- 1-carboxaldehyde; amine reaction products are those resulting from the reaction of Astramol Dendrimers with Carvone and amine reaction products resulting from the reaction of ethyl-4-amino benzoate with 2,4-dimethyl-3-cyclohexen- 1-carboxaldehyde.
- suitable amine reaction products are those resulting from the reaction of Lupasol HF with Delta Damascone; LupasolG35 with Alpha Damascone; LupasolGlOO with 2,4-dimethyl-3- cyclohexen- 1-carboxaldehyde, ethyl-4-amino benzoate with 2,4-dimethyl-3-cyclohexen-l- carboxaldehyde.
- suitable primary and/or secondary amine containing compounds are characterized by an Odor Intensity Index of less than that of a 1% solution of methylanthranilate in dipropylene glycol.
- a general structure for a suitable primary amine compound is as follows:
- B is a carrier material
- n is an index of value of at least 1.
- Suitable compounds comprising a secondary amine group may have a structure similar to the above excepted that the compound comprises one or more -NH- moieties in addition to any - NH2 moieties.
- an amine compound may have the formula:
- B is a carrier material, and each n is independently an index of value of at least 1.
- B carriers may be inorganic having non-or substantially non carbon based backbones, or organic carriers having essentially carbon bond backbones.
- Suitable inorganic carriers include mono or polymers or organic-organosilicon copolymers of amino derivatised organo silane, siloxane, silazane, alumane, aluminum siloxane, or aluminum silicate compounds.
- Typical examples of such carriers are: organosiloxanes with at least one primary amine moiety like the diaminoalkylsiloxane [ ⁇ 2 ⁇ 3 ⁇ 4( ⁇ 3 ⁇ 4) 2 8 ⁇ ]0, or the organoaminosilane (C 6 H 5 ) 3SiN3 ⁇ 4 (described in: Chemistry and Technology of Silicone, W. Noll, Academic Press Inc. 1998, London, pp 209, 106).
- Mono or polymer or organic- organosilicon copolymers containing one or more organosilylhydrasine moiety are also suitable.
- a typical example of such a carrier material is N,N'-bis(trimethylsilyl)hydrazine (Me 3 Si) 2 NNH 2 .
- Typical suitable amines comprising an organic carrier include aminoaryl derivatives, polyamines, aminoacids and derivatives, substituted amines and amides, glucamines, dendrimers and amino-substitued mono-, di-, oligo-, poly-saccharides.
- the amine compound may be interrupted or substituted by linkers or cellulose substantive group.
- a general formula for this amine compound is as follows:
- each m is an index of value 0 or at least 1
- n is an index of value of at least 1 as defined herein before.
- the amine group is linked to a carrier molecule as defined by classes hereinafter described.
- the primary and/or secondary amine group is either directly linked to the carrier group or via a linker group L.
- the carrier can also be substituted by a R* substituent, and R* can be linked to the carrier either directly or via a linker group L.
- R* can also contain branching groups like e.g. tertiary amine and amide groups.
- the amine compound comprises at least one primary and/or secondary amine group to react with the perfume aldehyde and/or ketone to form the reaction products.
- Such reaction is typically known as a Schiff base reaction as a Schiff base is formed.
- the amine compound is not limited to having only one amine function. Indeed, more preferably, the amine compound comprises more than one amine function, thereby enabling the amine compound to react with several aldehydes and/or ketones. Accordingly, reaction products carrying mixed aldehyde(s) and/or ketone(s) can be achieved, thereby resulting in a mixed release of such fragrances.
- the fabric and home care products of the present invention may comprise one or more bleaching agents.
- Suitable bleaching agents other than bleaching catalysts include photobleaches, bleach activators, hydrogen peroxide, sources of hydrogen peroxide, preformed peracids and mixtures thereof.
- the fabric and home care products of the present invention may comprise from about 0.1% to about 50% or even from about 0.1% to about 25% bleaching agent by weight of the subject fabric and home care product.
- suitable bleaching agents include:
- photobleaches for example sulfonated zinc phthalocyanine sulfonated aluminium phthalocyanines, xanthene dyes and mixtures thereof;
- Suitable preformed peracids include, but are not limited to, compounds selected from the group consisting of percarboxylic acids and salts, percarbonic acids and salts, perimidic acids and salts, peroxymonosulfuric acids and salts, for example, Oxone ®, and mixtures thereof.
- inorganic perhydrate salts including alkali metal salts such as sodium salts of perborate (usually mono- or tetra-hydrate), percarbonate, persulphate, perphosphate, persilicate salts and mixtures thereof.
- the inorganic perhydrate salts are selected from the group consisting of sodium salts of perborate, percarbonate and mixtures thereof.
- inorganic perhydrate salts are typically present in amounts of from 0.05 to 40 wt%, or 1 to 30 wt% of the overall fabric and home care product and are typically incorporated into such fabric and home care products as a crystalline solid that may be coated. Suitable coatings include, inorganic salts such as alkali metal silicate, carbonate or borate salts or mixtures thereof, or organic materials such as water-soluble or dispersible polymers, waxes, oils or fatty soaps; and
- suitable leaving groups are benzoic acid and derivatives thereof - especially benzene sulphonate.
- Suitable bleach activators include dodecanoyl oxybenzene sulphonate, decanoyl oxybenzene sulphonate, decanoyl oxybenzoic acid or salts thereof, 3,5,5-trimethyl hexanoyloxybenzene sulphonate, tetraacetyl ethylene diamine (TAED) and nonanoyloxybenzene sulphonate (NOBS).
- TAED tetraacetyl ethylene diamine
- NOBS nonanoyloxybenzene sulphonate
- Suitable bleach activators are also disclosed in WO 98/17767. While any suitable bleach activator may be employed, in one aspect of the invention the subject fabric and home care product may comprise NOBS, TAED or mixtures thereof.
- the peracid and/or bleach activator is generally present in the fabric and home care product in an amount of from about 0.1 to about 60 wt%, from about 0.5 to about 40 wt % or even from about 0.6 to about 10 wt% based on the fabric and home care product.
- One or more hydrophobic peracids or precursors thereof may be used in combination with one or more hydrophilic peracid or precursor thereof.
- the amounts of hydrogen peroxide source and peracid or bleach activator may be selected such that the molar ratio of available oxygen (from the peroxide source) to peracid is from 1:1 to 35:1, or even 2:1 to 10:1.
- the fabric and home care products according to the present invention may comprise a surfactant or surfactant system wherein the surfactant can be selected from nonionic surfactants, anionic surfactants, cationic surfactants, ampholytic surfactants, zwitterionic surfactants, semi-polar nonionic surfactants and mixtures thereof.
- surfactant is typically present at a level of from about 0.1% to about 60%, from about 1% to about 50% or even from about 5% to about 40% by weight of the subject fabric and home care product.
- the fabric and home care products of the present invention may comprise one or more detergent builders or builder systems.
- the subject fabric and home care product will typically comprise at least about 1%, from about 5% to about 60% or even from about 10% to about 40% builder by weight of the subject fabric and home care product.
- Builders include, but are not limited to, the alkali metal, ammonium and
- hydroxypolycarboxylates copolymers of maleic anhydride with ethylene or vinyl methyl ether, 1, 3, 5-trihydroxy benzene-2, 4, 6-trisulphonic acid, and carboxymethyloxysuccinic acid, the various alkali metal, ammonium and substituted ammonium salts of polyacetic acids such as ethylenediamine tetraacetic acid and nitrilotriacetic acid, as well as polycarboxylates such as mellitic acid, succinic acid, citric acid, oxydisuccinic acid, polymaleic acid, benzene 1,3,5- tricarboxylic acid, carboxymethyloxysuccinic acid, and soluble salts thereof.
- polyacetic acids such as ethylenediamine tetraacetic acid and nitrilotriacetic acid
- polycarboxylates such as mellitic acid, succinic acid, citric acid, oxydisuccinic acid, polymaleic acid, benzen
- the fabric and home care products herein may contain a chelating agent.
- Suitable chelating agents include copper, iron and/or manganese chelating agents and mixtures thereof.
- the subject fabric and home care product may comprise from about 0.005% to about 15% or even from about 3.0% to about 10% chelating agent by weight of the subject fabric and home care product.
- Suitable chelants include DTPA (Diethylene triamine pentaacetic acid), HEDP (Hydroxyethane diphosphonic acid), DTPMP (Diethylene triamine penta(methylene phosphonic acid)), l,2-Dihydroxybenzene-3,5-disulfonic acid disodium salt hydrate, ethylenediamine, diethylene triamine, ethylenediaminedisuccinic acid (EDDS), N-hydroxyethylethylenediaminetri-acetic acid (HEDTA),
- TTHA triethylenetetraaminehexaacetic acid
- HEIDA N-hydroxyethyliminodiacetic acid
- DHEG dihydroxyethylglycine
- EDTP ethylenediaminetetrapropionic acid
- the fabric and home care products of the present invention may also include one or more dye transfer inhibiting agents.
- Suitable polymeric dye transfer inhibiting agents include, but are not limited to, polyvinylpyrrolidone polymers, polyamine N-oxide polymers, copolymers of N-vinylpyrrolidone and N-vinylimidazole, polyvinyloxazolidones and polyvinylimidazoles or mixtures thereof.
- the dye transfer inhibiting agents may be present at levels from about 0.0001% to about 10%, from about 0.01% to about 5% or even from about 0.1% to about 3% by weight of the fabric and home care product.
- Brighteners - The fabric and home care products of the present invention can also contain additional components that may tint articles being cleaned, such as fluorescent brighteners.
- Suitable fluorescent brightener levels include lower levels of from about 0.01, from about 0.05, from about 0.1 or even from about 0.2 wt % to upper levels of 0.5 or even 0.75 wt %.
- Dispersants - The fabric and home care products of the present invention can also contain dispersants.
- Suitable water-soluble organic materials include the homo- or co-polymeric acids or their salts, in which the polycarboxylic acid comprises at least two carboxyl radicals separated from each other by not more than two carbon atoms.
- Enzyme Stabilizers - Enzymes for use in detergents can be stabilized by various techniques.
- the enzymes employed herein can be stabilized by the presence of water-soluble sources of calcium and/or magnesium ions in the finished fabric and home care products that provide such ions to the enzymes.
- a reversible protease inhibitor such as a boron compound, or compounds such as calcium formate, sodium formate and 1,2-propane diol can be added to further improve stability.
- Catalytic Metal Complexes - Applicants' compositions may include catalytic metal complexes.
- One type of metal-containing bleach catalyst is a catalyst system comprising a transition metal cation of defined bleach catalytic activity, such as copper, iron, titanium, ruthenium, tungsten, molybdenum, or manganese cations, an auxiliary metal cation having little or no bleach catalytic activity, such as zinc or aluminum cations, and a sequestrate having defined stability constants for the catalytic and auxiliary metal cations, particularly
- compositions herein can be catalyzed by means of a manganese compound.
- a manganese compound Such compounds and levels of use are well known in the art and include, for example, the manganese- based catalysts disclosed in U.S. 5,576,282.
- Cobalt bleach catalysts useful herein are known, and are described, for example, in U.S.
- compositions herein may also suitably include a transition metal complex of ligands such as bispidones (WO 05/042532 Al) and/or macropolycyclic rigid ligands - abbreviated as "MRLs".
- ligands such as bispidones (WO 05/042532 Al) and/or macropolycyclic rigid ligands - abbreviated as "MRLs”.
- MRLs macropolycyclic rigid ligands
- Suitable transition-metals in the instant transition-metal bleach catalyst include, for example, manganese, iron and chromium.
- Suitable MRLs include 5,12-diethyl-l,5,8,12- tetraazabicyclo[6.6.2]hexadecane.
- Suitable transition metal MRLs are readily prepared by known procedures, such as taught for example in WO 00/32601, and U.S. 6,225,464.
- Solvents - Suitable solvents include water and other solvents such as lipophilic fluids.
- suitable lipophilic fluids include siloxanes, other silicones, hydrocarbons, glycol ethers, glycerine derivatives such as glycerine ethers, perfluorinated amines, perfluorinated and hydrofluoroether solvents, low-volatility nonfluorinated organic solvents, diol solvents, other environmentally-friendly solvents and mixtures thereof.
- the fabric and home care products of the present invention can be formulated into any suitable form and prepared by any process chosen by the formulator, non-limiting examples of which are described in Applicants' examples and in U.S. 4,990,280; U.S. 20030087791A1; U.S. 20030087790A1; U.S. 20050003983 Al; U.S. 20040048764A1; U.S. 4,762,636; U.S. 6,291,412; U.S. 20050227891 Al; EP 1070115A2; U.S. 5,879,584; U.S. 5,691,297; U.S. 5,574,005; U.S. 5,569,645; U.S. 5,565,422; U.S. 5,516,448; U.S. 5,489,392; U.S. 5,486,303 all of which are incorporated herein by reference.
- the present invention includes a method for cleaning and/or treating a situs inter alia a surface or fabric.
- such method comprises the steps of optionally washing and/or rinsing said surface or fabric, contacting said surface or fabric with any fabric and home care product disclosed in this specification then optionally washing and/or rinsing said surface or fabric is disclosed.
- washing includes but is not limited to, scrubbing, and mechanical agitation. Drying of such surfaces or fabrics may be accomplished by any one of the common means employed either in domestic or industrial settings. Such means include but are not limited to forced air or still air drying at ambient or elevated temperatures at pressures between 5 and 0.01 atmospheres in the presence or absence of electromagnetic radiation, including sunlight, infrared, ultraviolet and microwave irradiation.
- said drying may be accomplished at temperatures above ambient by employing an iron wherein, for example, said fabric may be in direct contact with said iron for relatively short or even extended periods of time and wherein pressure may be exerted beyond that otherwise normally present due to gravitational force.
- said drying may be accomplished at temperatures above ambient by employing a dryer.
- Apparatus for drying fabric is well known and it is frequently referred to as a clothes dryer.
- clothes In addition to clothes such appliances are used to dry many other items including towels, sheets, pillowcases, diapers and so forth and such equipment has been accepted as a standard convenience in many countries of the world substantially replacing the use of clothes lines for drying of fabric.
- Most dryers in use today use heated air which is passed over and or through the fabric as it is tumbled within the dryer.
- the air may be heated, for example, either electronically, via gas flame, or even with microwave radiation.
- the cleaning compositions of the present invention are ideally suited for use in laundry applications. Accordingly, the present invention includes a method for laundering a fabric. The method comprises the steps of contacting a fabric to be laundered with a said cleaning laundry solution comprising at least one embodiment of Applicants' cleaning composition, cleaning additive or mixture thereof.
- the fabric may comprise most any fabric capable of being laundered in normal consumer or institutional use conditions.
- the solution preferably has a pH of from about 8 to about 10.5.
- the compositions may be employed at concentrations of from about 500 ppm to about 15,000 ppm in solution.
- the water temperatures typically range from about 5 °C to about 90 °C.
- the water to fabric ratio is typically from about 1:1 to about 30:1.
- IEC-B detergent IEC 60456 Washing Machine Reference Base Detergent Type B, supplied by wfk, Briiggen-Bracht, Germany, to each pot.
- TEST METHOD 2- For Test Method 2 the BMI microswatch assay is run using the detergent compositions 1, 2 or 4 from Table 1-3.
- the detergent is dissolved in water that has a hardness of 6gpg and adjusted to a temperature of 16°C.
- Performance of the variant enzymes is then determined as per the BMI microswatch assay described.
- the performance index is determined by comparing the performance of the variant with that of the enzyme of SEQ ID NO:2, SEQ ID NO:4 or SEQ ID NO:6, with in all cases the enzyme dosage being 1 ppm. This Method is described in further detail in Example 31.
- TEST METHOD 3- For Test Method 3 the BMI microswatch assay is run using the detergent compositions 1, 2 or 4 from Table 1-3.
- the detergent is dissolved in water that has a hardness of 6gpg and adjusted to a temperature of 16°C.
- Performance of the variant enzymes is then determined as per the BMI microswatch assay described.
- the performance index is determined by comparing the performance of the variant with that of the enzyme of SEQ ID NO:2, SEQ ID NO:4 or SEQ ID NO:6, with in all cases the enzyme dosage being 0.4 ppm. This Method is described in further detail in Example 1.
- TEST METHOD 4- For Test Method 4 the BMI microswatch assay is run using the detergent composition 10 from Table 19-4. The detergent is dissolved in water that has a hardness of 12gpg and adjusted to a temperature of 16°C. Performance of the variant enzymes is then determined as per the BMI microswatch assay described. The performance index is determined by comparing the performance of the variant with that of the enzyme of SEQ ID NO:755, with in all cases the enzyme dosage being 1.6 ppm. Enzymes having a performance index of 1.1 or greater are viewed to be Series 1 GG36 cold water proteases. This Method is described in further detail in Example 19.
- TEST METHOD 5 - For Test Method 5 the BMI microswatch assay is run using the detergent composition 7 from Table 19-4. The detergent is dissolved in water that has a hardness of 6gpg and adjusted to a temperature of 16°C. Performance of the variant enzymes is then determined as per the BMI microswatch assay described. The performance index is determined by comparing the performance of the variant with that of the enzyme of SEQ ID NO:755, with in all cases the enzyme dosage being 4 ppm. Enzymes having a performance index of 1.1 or greater are viewed to be Series 1 GG36 cold water proteases. This Method is described in further detail in Example 19.
- TEST METHOD 6 - For Test Method 6 the BMI microswatch assay is run using the detergent composition 7 from Table 19-4.
- the detergent is dissolved in water that has a hardness of 6gpg and adjusted to a temperature of 16°C.
- Performance of the variant enzymes is then determined as per the BMI microswatch assay described.
- the performance index is determined by comparing the performance of the variant with that of a reference enzyme, said reference enzyme being the enzyme of SEQ ID NO:755 consisting the A158E mutation, with in all cases the enzyme dosage being 4 ppm.
- Enzymes having a performance index of 1.0 or greater are viewed to be Series 1 GG36 cold water proteases. This Method is described in further detail in Example 19.
- TEST METHOD 7 Electrical conductivity of an aqueous solution is assayed according to the standard method ASTM Dl 125 and reported in units of milliSiemens/cm, abbreviated to mS/cm in this patent.
- RNA ribonucleic acid
- MgCl 2 magnesium chloride
- NaCl sodium chloride
- w/v weight to volume
- v/v volume to volume
- w/w weight to weight
- Tricine N- [tris-(hydroxymethyl)-methyl] - glycine
- CHES (2-(N-cyclo-hexylamino) ethane- sulfonic acid)
- TAPS (3- ⁇ [frisky droxymethyl) -methyl] -amino ⁇ -propanesulfonic acid);
- CAPS (3-(cyclo-hexylamino)-propane- sulfonic acid;
- DMSO dimethyl sulfoxide
- DTT 1,4-dithio-DL-threitol
- SA sinapinic acid (s,5-dimethoxy-4-hydroxy cinnamic acid
- TCA trichloroacetic acid
- Glut and GSH reduced glutathione
- GSSG oxidized glutathione
- TCEP Tris[2-carboxyethyl] phosphine
- Ts tosyl
- Bn benzyl
- Ph phenyl
- Ms mesyl
- Et ethyl
- Me Me
- Taq Thermus aquaticus DNA polymerase
- Klenow DNA polymerase I large (Klenow) fragment
- EGTA ethylene glycol-bis(6-aminoethyl ether) N, N, N', N'-tetraacetic acid
- EDTA ethylene glycol-bis(6-aminoethyl ether) N, N, N', N'-tetraacetic acid
- EDTA ethylene glycol-bis(6-aminoethyl ether
- NA and WE North American (NA) and Western European (WE) heavy duty liquid laundry (HDL) detergents
- heat inactivation of the enzymes present in commercially-available detergents is performed by placing pre- weighed liquid detergent (in a glass bottle) in a water bath at 95 °C for 2 hours.
- the incubation time for heat inactivation of NA and WE auto dish washing (ADW) detergents is 8 hours. Both un-heated and heated detergents are assayed within 5 minutes of dissolving the detergent to accurately determine percentage deactivated. Enzyme activity is tested by the AAPF assay.
- compositions of the detergents used in the assays in BPN' Variant (or Part I) Examples are shown in Table 1-3.
- BPN' variant protein samples were added to the detergent compositions as described in Part I Example 1 to assay for the various properties tested.
- liquid laundry detergent compositions suitable for top-loading automatic washing machines (1, 2 & 4) and front loading washing machines (3).
- Ci6_i7 Branched alkyl sulfate 1.7 1.29 3.09
- Random graft co-polymer 1 1.46 0.5
- Amphiphilic alkoxylated grease cleaning polymer 3 1.28 1 0.4 1.93
- Random graft copolymer is a polyvinyl acetate grafted polyethylene oxide copolymer having a polyethylene oxide backbone and multiple polyvinyl acetate side chains.
- the molecular weight of the polyethylene oxide backbone is about 6000 and the weight ratio of the polyethylene oxide to polyvinyl acetate is about 40 to 60 and no more than 1 grafting point per 50 ethylene oxide units.
- modified polynucleotides of the invention that encode protease variants of the invention (such as cold water proteases of the invention), including, but not limited to, e.g., site-saturation mutagenesis, scanning mutagenesis, insertional mutagenesis, deletion mutagenesis, random mutagenesis, site- directed mutagenesis, and directed-evolution, as well as various other recombinatorial approaches.
- Methods for making modified polynucleotides and proteins include DNA shuffling methodologies (see, e.g., Stemmer WP, Proc. Natl. Acad. Sci.
- oligonucleotides to insert random and targeted mutations, deletions and/or insertions (Ness et al., Nat. Biotechnol.20:1251-5 [2002]; Coco et al., Nat. Biotechnol. 20:1246-50 [2002]; Zha et al., Chembiochem.4:34-9 [2003]; Glaser et al., J. Immunol.149:3903- 13 [1992]); see also Arkin and Youvan, Biotechnology 10:297-300 (1992); Reidhaar- Olson et al., Methods Enzymol. 208:564- 86 (1991).
- a full-length parent polynucleotide is ligated into an appropriate expression plasmid, and the following mutagenesis method is used to facilitate the construction of the modified protease of the present invention, although other methods may be used.
- the method is based on that described by Pisarchik et al. (Pisarchik et al., Prot. Eng. Des. Select. 20:257-265 [2007]).
- an added advantage is provided in that the restriction enzyme cuts outside its recognition sequence, which allows digestion of practically any nucleotide sequence and precludes formation of a restriction site scar.
- a naturally-occurring gene encoding a full-length protease is obtained and sequenced and scanned for one or more points at which it is desired to make a mutation (e.g., deletion, insertion, substitution) at one or more amino acids.
- Mutation of the gene in order to change its sequence to conform to the desired sequence is accomplished by primer extension in accord with generally known methods.
- Fragments to the left and to the right of the desired point(s) of mutation are amplified by PCR and to include the Eaml 1041 restriction site.
- the left and right fragments are digested with Earn 11041 to generate a plurality of fragments having complementary three base overhangs, which are then pooled and ligated to generate a library of modified sequences containing one or more mutations.
- This method avoids the occurrence of frame-shift mutations. This method also simplifies the mutagenesis process because all of the oligonucleotides can be synthesized so as to have the same restriction site, and no synthetic linkers are necessary to create the restriction sites as is required by some other methods.
- this assay was started using filtered B. subtilis bacterial culture supernatant from microtiter plates grown 3-4 days at 33-37°C with shaking at 230-250 rpm and humidified aeration. A fresh 96-well flat bottom microtiter plate (MTP) was used for the assay. First, 100 ⁇ /well of 0.25 N HC1 was placed in each well. Then, 25 ⁇ of filtered culture broth was added. The light scattering/absorbance at 405 nm (use 5 sec mixing mode in the plate reader) was then determined in order to provide the "blank" reading.
- TCA trichloroacetic acid
- a standard curve can be created by calibrating the TCA readings with AAPF assays of clones with known conversion factors.
- the TCA results are linear with respect to protein concentration from 250 to 2500 micrograms protein per ml (ppm) and can thus be plotted directly against enzyme performance for the purpose of choosing good-performing variants.
- Tris/HCl, pH 8.6, containing 0.005% TWEENO-80 Tris dilution buffer
- 100 mM Tris buffer, pH 8.6, containing 10 mM CaCl 2 and 0.005% TWEENO-80 Tris/Ca buffer
- 160 mM suc- AAPF-pNA in DMSO suc- AAPF-pNA stock solution
- suc- AAPF-pNA working solution 1 ml suc-AAPF-pNA stock solution was added to 100 ml Tris/Ca buffer and mixed well for at least 10 seconds.
- Blood milk and ink (BMI) stained microswatches of 5.5 millimeter circular diameter were obtained from CFT. Before cutting the swatches, the fabric (EMPA 116) was washed with water. One microswatch was placed in each well of a 96- well non-binding microtiter plate (Corning 3641).
- the detergents used for the assays included Detergent Composition 1, Detergent Composition 2, and Detergent Composition 4.
- the detergents were diluted in Milli-Q (deionized) water to a working strength concentration of 0.788 g/L. These detergents were buffered with 5 mM HEPES pH 8.2 or pH 7.2, which upon addition to detergent, buffers at pH 8 or pH 7, respectively.
- the master dilution was prepared from the culture supematants at 8 ⁇ g/mL, where the approximate enzyme concentration of the culture supematants and BPN'-v3 or BPN'-v36 parent controls was determined using the AAPF protease activity assay, basing the concentration on a purified BPN'-v3 or BPN'-v36 standard of known concentration.
- the MTP was sealed with tape and placed in the iEMS incubator/shaker (Thermo/Labsystems) pre-set at 16°C in a refrigerated dairy case or at 32°C on the benchtop for 20 minutes, with agitation at 1400 rpm.
- the stability of protease variants was determined in the presence of 40% concentrated Detergent Composition 3 diluted in water.
- the reagents used were Detergent Composition 3 diluted to 50% in Milli-Q water, 10 mM MES 0.01 % TWEENO-80 pH 5.8 master dilution buffer, AAPF reagents: see protocol AAPF assay.
- F-bottom MTP Coming 9017
- Biomek FX Beckman Coulter
- Spectramax Plus 384 MTP Reader Molecular Devices
- iEMS Incubator/Shaker (1 mm amplitude) (Thermo Electron Corporation)
- sealing tape Nunc (236366)
- circulating reservoir Biller Fx
- Detergent Composition 3 was initially diluted to 50% in water. This detergent was kept at room temperature and cycled through the circulating reservoir. The iEMS incubators/shakers (Thermo/Labsystems) were pre-set at 43°C. Culture supernatants were diluted into plates containing master dilution buffer to a concentration of ⁇ 20 ppm (master dilution plate). Then, 40 ⁇ of sample from the master dilution plate was added to plates containing 160 ⁇ 50% Detergent Composition 3 to give a final incubation concentration of 4 ppm. The contents were mixed and kept at room temperature and triplicate AAPF assays were performed immediately on these plates and recorded as unstressed reads.
- the reagents used were dodecyllbenzene sulfonate, sodium salt (DOBS, Sigma No. D-2525), TWEENO-80 (Sigma No. P-8074), di- sodium EDTA (Siegfried Handel No. 164599-02), HEPES (Sigma No.
- V- or U-bottom MTPs as dilution plates (Greiner 651101 and 650161, respectively), F- bottom MTPs (Corning 9017) for unstressed and LAS/EDTA buffer as well as for suc-AAPF- pNA plates, Biomek FX (Beckman Coulter), Spectramax Plus 384 MTP Reader (Molecular Devices), iEMS Incubator/Shaker (1 mm amplitude) (Thermo Electron Corporation), and Nunc sealing tape (236366).
- the iEMS incubator/shaker (Thermo/Labsystems) was set at 29°C. Culture supernatants were diluted into plates containing unstressed buffer to a concentration of ⁇ 25 ppm (master dilution plate). Then, 20 ⁇ of sample from the master dilution plate was added to plates containing 180 ⁇ unstressed buffer to give a final incubation concentration of 2.5 ppm. The contents were mixed and kept at room temperature and an AAPF assay was performed on this plate.
- the performance index provides a comparison of the performance of a variant (actual value) and a standard or reference protease enzyme (theoretical value) at the same protein concentration.
- the theoretical values can be calculated using the parameters of a performance dose response curve (i.e. using a Langmuir equation to generate the performance curve) of the standard/reference protease.
- the PI identifies winners (e.g., variants having enhanced proteolytic activity compared to that of the standard/reference protease) as well as variants that may be less desirable for use under certain circumstances (e.g., variants having proteolytic activity lower than the proteolytic activity of the standard/reference protease).
- protease variants of the invention having performance index values lower than that of a reference or standard protease are nevertheless useful in the applications and methods described herein.
- protease variants of the invention having performance index values lower than that of a reference or standard protease have proteolytic activity and thus are useful in the compositions of the invention, such as, but not limited to, e.g., cleaning compositions (including, but not limited, to, e.g., detergent cleaning compositions) for cleaning a variety of surfaces and items, including, but not limited to, e.g., laundry, fabrics, and dishware, and in personal care applications and compositions as described elsewhere herein; such protease variants are also useful in fabric and home care products and compositions and in non-fabric and home care products and compositions described elsewhere herein and in methods of the invention, including, but not limited, to, e.g., cleaning methods, methods for personal care, etc., described elsewhere herein.
- non-deleterious variants have a PI >0.05
- deleterious variants have a PI less than or equal to 0.05
- combinable variants are those for which the variant has performance index values greater than or equal to 0.2 for at least one property, and >0.05 for all properties.
- Combinable variants are those that can be combined to deliver proteins with appropriate performance indices for one or more desired properties.
- subtilase or protease to be engineered has an amino acid different from that of subtilisin BPN' at one or more particular positions, these data find use in identifying amino acid substitutions that alter the desired properties by identifying the best choices for substitutions, including substitutions of the BPN' wild type amino acid.
- the BPN'-v3 (BPN' protease containing G097A-G128A-Y217Q substitutions) expression cassette used for combinatorial library construction was generated using the BPN' expression cassette, which comprises the aprE-BPN' hybrid leader sequence (i.e., signal sequence), BPN' pro and BPN' mature sequence from B. amyloliquejaciens.
- the DNA sequence is shown below as SEQ ID NO: l and encodes the BPN' precursor protein shown below as SEQ ID NO: 168.
- nucleotide sequence of SEQ ID NO:l the DNA sequence encoding the mature protease is shown in bold, the nucleotide sequence encoding leader sequence (aprE-BPN' hybrid leader sequence) is shown in standard (non-underlined) text, and the nucleotide sequence encoding the pro sequence ( ⁇ ') is underlined.
- amino acid sequence (aprE-BPN' hybrid leader sequence, BPN' pro sequence, and BPN' mature protein sequence) of the BPN' precursor protein set forth in SEQ ID NO: 168 the bolded portion indicates the mature BPN' subtilisin protease.
- amino acid sequence of the mature BPN' subtilisin protease is shown as SEQ ID NO: 1
- the nucleotide sequence of the mature BPN'-v3 gene is that of SEQ ID NO:3 (the signal sequence and propeptide sequence used in the BPN'-v3 expression cassette is the same as that for BPN' shown in SEQ ID NO: 1).
- the protein sequence of the mature BPN'-v3 protease variant is that of SEQ ID NO:4 (the signal sequence and propeptide sequence used in the BPN'- v3 expression cassette is the same as that for BPN' shown in SEQ ID NO: 168).
- pHPLT-BPN'-v3 plasmid (see Figure 1) containing the BPN'-v3 expression cassette described above served as template DNA for cloning to provide variants derived from BPN'-v3.
- the vector pHPLT ( Figure 4 in US Patent No. 6,566,112) contains the B. licheniformis LAT promoter ("Plat”); a sequence encoding the LAT signal peptide ("preLAT”). Additional plasmid elements from plasmid pUBHO disclosed in McKenzie et al., Plasmid 15(2): 93-103 (1986):
- ori-pUB is the origin of replication from pUB HO;
- neo is the neomycin/kanamycin resistance gene from pUB HO;
- Terminator is the transcriptional terminator from B.
- a combinatorial DNA library was synthesized at DNA 2.0 and delivered as individual ligation reactions.
- the DNA from the ligation reaction mixtures was amplified by rolling circle amplification (RCA) using the Illustra
- Templiphi kit (GE Healthcare). The reaction was performed according to the manufacturer's protocol. One microliter of ten-fold diluted amplified DNA was used to transform 50 ⁇ L of competent B. subtilis cells (AaprE, AnprE, amyE::xylRPxylAcomK-phleo). The transformation mixture was shaken at 37°C for 1 hour. Ten micro-liter aliquots of the transformation mixture were plated on skim milk (1.6%) Luria agar plates supplemented with 10 ⁇ g/ml of neomycin
- the transformants that formed halos on the skim milk plates were picked into microtiter plates containing 150 ⁇ 1 Luria broth (LB) medium supplemented with 10 ⁇ g/ml neomycin. Plates were grown overnight at 37°C with 250-300 rpm shaking and 70-80% humidity using
- Enzyscreen lids for microtiter plates (Enzyscreen). Using a 96 pin replicating tool, (Enzyscreen) the overnight culture plate was used to inoculate a new microtiter plate containing 180 ⁇ of MBD medium (a MOPS based defined medium) with 2.5 ⁇ g/ml neomycin. MBD medium was prepared essentially as known in the art (see Neidhardt et al., J. Bacterid.
- micronutrients were made up as a 100X stock solution containing in one liter, 400 mg FeS0 4 -7H 2 0, 100 mg MnS0 4 -H 2 0, 100 mg ZnSCv 7H 2 0, 50 mg CuCl 2 -2H 2 0, 100 mg CoCl 2 -6H 2 0, 100 mg NaMo0 4 -2H 2 0, 100 mg
- protease variants were tested for cleaning performance using a BMI microswatch assay in Detergent Composition 1 at 16°C and pH 8 and BMI microswatch assay in Detergent Composition 2 at 16°C and pH 8. Protein content was determined using the TCA assay. Assays were performed as described in Example 1 and Performance Indices were calculated relative to BPN'-v3 (with a PI value of 1) as per Test Method 3.
- BPN' subtilisin protease variant was determined to have a PI value greater than 1.0, at least 1.1, or from greater than 1.0 to about 5 relative to BPN'-v3 in a BMI microswatch cleaning assay in Detergent Composition 1 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising the set of amino acid substitutions G097A-G128A-P210S- Y217Q, wherein amino acid positions of the variant are numbered by correspondence with the sequence of SEQ ID NO:2.
- Such variant has a PI value of 1.1 relative to BPN'-v3 in this BMI microswatch cleaning assay, and enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) in this assay, the variant having an amino acid sequence comprising amino acid substitutions G097A-G128A-P210S- Y217Q, wherein amino acid positions of the variant are numbered by correspondence with the sequence of SEQ ID NO:2.
- protease variant having enhanced proteolytic activity compared to SEQ ID NO:2 in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% identity to the sequence of SEQ ID NO:2 and comprising amino acid substitutions G097A- G128A-P210S-Y217Q, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- subtilisin protease variant having enhanced proteolytic activity compared to BPN' and/or a PI value greater than that of BPN' (SEQ ID NO:2) and/or BPN'-v3 in a BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% identity to SEQ ID NO:2, wherein the variant comprises substitutions X097A-X128A-X210S-X217Q, wherein positions of the variant are numbered by correspondence with the sequence of SEQ ID NO: 2, and optionally wherein the variant comprises at least one substitution selected from the group of G097A, G128A, P210S, and Y217Q.
- protease variant may be an isolated, recombinant, substantially pure, or non- naturally occurring protease variant.
- compositions including, but not limited to, e.g., cleaning compositions, comprising such protease variant and methods for cleaning utilizing such variant as described in greater detail elsewhere herein.
- BPN' variants were determined to have a PI value equal to about 1.0 relative to BPN'-v3 (i.e., having a PI value approximately equivalent to that of BPN'-v3) in a BMI microswatch cleaning assay in Detergent Composition 1 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of G097A-G128A-Y217Q, G097A-G128A-E156S-P210S-Y217Q, G097A-G128A-P210S-Y217Q-N218A, G097A-G128A-P210S-Y217Q-N218S, and G097A- Y104F-G128A-E156S-P210I-Y217Q, wherein amino acid positions of the variant are numbered by correspondence with the sequence of SEQ ID NO:2.
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) or a PI value of 1.0 relative to BPN'-v3 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% identity to the sequence of SEQ ID NO:2 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO: 2 sequence.
- subtilisin protease variant having enhanced proteolytic activity compared to BPN' and/or a PI value of 1.0 compared to BPN'-v3 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% identity to SEQ ID NO:2, wherein the variant comprises at least one substitution selected from the group of X097A, X104F, X128A, X156A/S, X210I/S, X217Q, X218A/S, and optionally at least one substitution selected from the group of G097A, Y104F, G128A, E156A/S, P210I/S, Y217Q, and N218A/S, wherein positions of the variant are numbered by correspondence with the sequence of SEQ ID NO:2.
- compositions including, but not limited to, e.g., cleaning composition
- BPN' variants were determined to have a PI value of about 0.9 relative to BPN'-v3 in a BMI microswatch cleaning assay in Detergent Composition 1 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of G097A-G128A-E156A-P210S-Y217Q- N218S and G097A-G128A-Y217Q-N218A, wherein positions of the variant are numbered by correspondence with the sequence of SEQ ID NO: 2.
- Such variants have proteolytic activity.
- the invention includes a protease variant having proteolytic activity, a PI value of 0.9 relative to BPN'-v3, and/or enhanced proteolytic activity compared to BPN' in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% identity to the sequence of SEQ ID NO:2 and at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' variants were determined to have a PI value of greater than 1.0 to about 5 relative to BPN'-v3 in a BMI microswatch cleaning assay in Detergent Composition 2 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of G097A-G128A-P210S-Y217Q-N218A and G097A-G128A-P210S-Y217Q, wherein amino acid positions of the variant are numbered by correspondence with the sequence of SEQ ID NO:2.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of greater than 1.0 to about 5 relative to BPN'-v3 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% identity to the sequence of SEQ ID NO:2 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- subtilisin protease variant having enhanced proteolytic activity compared to BPN' and/or a PI value of greater than 1 compared to BPN'-v3 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% identity to SEQ ID NO:2, wherein the variant comprises at least one substitution selected from the group of X097A, X104F, X128A, X156A/S, X210I/S, X217Q, X218A/S, and optionally at least one substitution selected from the group of G097A, Y104F, G128A, E156A/S, P210I/S, Y217Q, and N218A/
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' variants were determined to have a PI value equal to about 1.0 relative to BPN'-v3 in a BMI microswatch cleaning assay in Detergent Composition 2 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of G097A-G128A-Y217Q (i.e., BPN'-v3), G097A-G128A-E156S-P210S-Y217Q, and G097A-G128A-P210S-Y217Q-N218S, wherein positions of the variant are numbered by correspondence with the sequence of SEQ ID NO:2.
- Such variants have proteolytic activity and enhanced proteolytic activity compared to BPN' in this assay.
- the invention includes a protease variant having proteolytic activity, PI value of 1.0 relative to BPN'-v3, and/or enhanced proteolytic activity compared to BPN' in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% identity to the sequence of SEQ ID NO:2 and at least one set of amino acid substitutions selected from said group above, wherein positions of the variant are numbered by correspondence with positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' variants were determined to have a PI value of about 0.9 relative to BPN'-v3 in a BMI microswatch cleaning assay in Detergent Composition 2 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of G097A-G128A-E156A-P210S-Y217Q- N218S, G097A-G128A-Y217Q-N218A, and G097A-Y104F-G128A-E156S-P210I-Y217Q, wherein positions of the variant are numbered by correspondence with the sequence of SEQ ID NO:2.
- Such variants have proteolytic activity.
- the invention includes a protease variant having proteolytic activity, a PI value of 0.9 relative to BPN'-v3, and/or enhanced proteolytic activity compared to BPN' in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% identity to the sequence of SEQ ID NO:2 and at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- GcMlOO SEQ ID NO:23 SEQ ID NO:24 b) Construction of combinatorial libraries CG1-CG5 and CG8 using the synthetic genes GcM90-94 and GcMlOO
- the parent plasmids (template DNA) containing the synthetic genes GcM90-94, and GcMlOO were methylated were methylated using two micrograms of DNA and methylase (NEB), according to the NEB protocol. Methylated DNA was then purified using DNA Clean and Concentrator kit (Zymo Research). Combinatorial libraries CGI -5 and CG8 were made using a QUIKCHANGE® Multi Site-Directed Mutagenesis kit ("QCMS kit”; Stratagene) following the manufacturer's protocol (see Table 3-1 for respective template and primer combinations), with the exception of libraries CG3 and CG4, which used 86.5ng of each primer in place of the 50ng suggested in the protocol.
- QCMS kit QUIKCHANGE® Multi Site-Directed Mutagenesis kit
- BPN'-v3+S78N Additional variants of BPN'-v3+S78N were produced by DNA2.0. The following substitutions were introduced individually into the BPN'-v3+S78N parent molecule: Q59G, N62Q, V68A, S89Y, A92G, I108V, II 15V, M124T, P129L, A138T, V147L, S161P, Y167A, P172V, G211T, L267V, and A273S.
- BPN' variants were determined to have a PI value greater than 1.0, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2, from greater than 1.0 to about 10, from greater than 1.0 to about 8, or from greater than 1.0 to about 5 relative to the enzyme of SEQ ID NO:4 in a BMI microswatch cleaning assay in Detergent Composition 1 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of S063T-S078N-G097A-S101A-G128A-S183T-Y217Q-T244N, N061A-S078N-G097A-G128A- Y217Q-S224A, S053G-S078N-G097A-G128A-P129T-Q185
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' and BPN'-v3 in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of greater than 1 to about 5 relative to BPN'-v3 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% identity to SEQ ID NO:2 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- subtilisin protease variant having enhanced proteolytic activity compared to BPN' and/or a PI value of greater than 1.0 to about 5 relative to BPN'-v3 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% identity to SEQ ID NO:2, wherein the variant comprises at least one substitution selected from the group of X040E, X053G, X059V, X061A, X062H/Q, X068A, X078N, X087E, X101A, X102A, X108V, X124I, X125A, X126V, X129T, X147Q, X159D, X183T, X185T, X211A, X224A, X244I/N, X252Q, and X27
- BPN' variants were determined to have a PI value equal to about 1.0 relative to the enzyme of SEQ ID NO:4 (alternatively referred to as BPN'-v3) in a BMI microswatch cleaning assay in Detergent Composition 1 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of G097A-G128A-Y217Q, N061A-S078N-S087E-G097A-G128A-Y217Q- S224A, Q059V-S078N-G097A-G128A-G211A-Y217Q, Q059V-S078N-G097A-G128A- V147Q-Y217Q, Q059V-S078N-G097A-G128A-Y217Q, Q059V-S078N-G097A-I108V-
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of 1.0 relative to BPN'-v3 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% identity to the sequence of SEQ ID NO:2 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' variant was determined to have a PI value of about 0.9 relative to BPN'-v3 in a BMI microswatch cleaning assay in Detergent Composition 1 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising the set of amino acid substitutions S078N-G097A-I108V-G128A-V147Q-Y217Q, wherein positions of the variant are numbered by correspondence with the sequence of SEQ ID NO:2.
- Such variants have proteolytic activity.
- the invention includes a protease variant having proteolytic activity, a PI value of 0.9 relative to BPN'-v3, and/or enhanced proteolytic activity compared to BPN' in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and comprising said set of amino acid substitutions above, wherein amino acid positions of the variant are numbered by correspondence with positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of Q059V-S078N- G097A-I108V-G128A-V147Q-G211A-Y217Q-N252Q, S078N-G097A-I108V-G128A-V147Q- G211A-Y217Q, S078N-G097A-I108V-G128A-V147Q- G211A-Y217Q, S078N-G097A-I108V-G128A-V147Q-G211A-Y217Q-N252Q, S078N- G097A-I108V-G128A-V147Q-Y217Q-N252Q, S078N- G097A-I108V-G128A-V147Q-Y217Q-N252Q, and S078N-S087E-G097
- the invention includes a protease variant having proteolytic activity, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and at least one set of amino acid substitutions selected from said group above, wherein positions of the variant are numbered by correspondence with positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' variants were determined to have a PI value greater than 1.0, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2, from greater than 1.0 to about 10, from greater than 1.0 to about 8, or from greater than 1.0 to about 5 relative to BPN'-v3 in a BMI microswatch cleaning assay in Detergent Composition 2 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of S063T-S078N-G097A- S101A-G128A-S183T-Y217Q, S063T-S078N-G097A-S101A-G128A-S183T-Y217Q-T244N, S063T-S078N-G097A-S101A-G128A-Y2
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of greater than 1.0 to about 5 relative to BPN'-v3 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO: 6 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as
- BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of G097A-G128A-Y217Q, N061A-S078N- G097A-G128A-Y217Q-S224A, N061A-S078N-S087E-G097A-G128A-Y217Q-S224A, Q059V-S078N-G097A-G128A-G211A-Y217Q, Q059V-S078N-G097A-G128A-V147Q- Y217Q, Q059V-S078N-G097A-G128A-Y217Q, Q059V-S078N-G097A-G128A-Y217Q, Q059V-S078N-G097A-G128A-Y217Q, Q059V-S078N-G
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of about 1 relative to BPN'-v3 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' variants were determined to have a PI value of about 0.9 relative to BPN'-v3 in a BMI microswatch cleaning assay in Detergent Composition 2 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of S078N-G097A-G128A-V147Q-Y217Q and S078N-G097A-I108V-G128A-V147Q-Y217Q, wherein positions of the variant are numbered by correspondence with the sequence of SEQ ID NO:2.
- Such variants have proteolytic activity.
- the invention includes a protease variant having proteolytic activity, a PI value of 0.9 relative to BPN'-v3, and/or an enhanced proteolytic activity compared to BPN' in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with positions of the SEQ ID NO:2 sequence.
- compositions including cleaning compositions, comprising at least one such variant and methods for cleaning an item or surface in need of cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' variants were determined to a PI value equal to or greater than 0.5 and less than 0.9 relative to BPN'-v3 in a BMI microswatch cleaning assay in Detergent Composition 2 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of Q059V-S078N- G097A-I108V-G128A-V147Q-G211A-Y217Q-N252Q, S078N-G097A-I108V-G128A-V147Q- G211A-Y217Q, S078N-G097A-I108V-G128A-V147Q-G211A-Y217Q, S078N-G097A-I108V-
- the invention includes a protease variant having proteolytic activity, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and at least one set of amino acid substitutions selected from said group above, wherein positions of the variant are numbered by correspondence with positions of the SEQ ID NO:2 sequence.
- compositions including cleaning compositions, comprising at least one such variant and methods for cleaning an item or surface in need of cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' variants were constructed from different parental plasmids using
- the parental plasmids (Table 4-1) were methylated using a NEB Dam Methylase Kit in a reaction containing 77.5 ⁇ H20 + 10 ⁇ Buffer 10X + 0.25 ⁇ SAM + 2 uL DAM methylase + 10 uL miniprep DNA (-150 ng/ ⁇ ) at 37 °C overnight.
- the methylated plasmid DNA was purified using a QIAGEN® PCR
- QUIKCHANGE® Multi Site-Directed Mutagenesis reactions were set up for each of the DNA templates in a reaction mix containing 2.5 ⁇ Buffer 5X + 0.5 ⁇ primer 1 (25 ⁇ ) + 0.5 ⁇ primer 2 (25 ⁇ ) + 1 ⁇ dNTP's + 1 ⁇ enzyme blend + 18 ⁇ H 2 0 + 1.5 ⁇ DNA.
- the PCR program used was: 95°C for 1 min; (95°C for 1 min, 53°C for 1 min, 65°C for 9:39 min) x 29 cycles; 65°C for 10 min, 4°C hold. Primer sequences are shown in Table 4-2. In all reactions, PCR was performed using a MJ Research PTC-200 Peltier thermal cycler.
- BPN' variant proteins were produced by growing B. subtilis transformants in 96 well microtiter plates at 37°C for 68 hours in a MOPS based medium containing urea as described in Example 2.
- LC5 through LC37 BPN' variants are as follows, respectively: BPN'-P52L-V68A-G97A-I111V, BPN-I111V-M124V-Y167A-Y217Q, BPN'- Y104N-G128A-Y217Q, BPN'-M124V-Y167A-Y217Q, BPN'-I111V-M124V-Y217Q, BPN'- P52L-V68A-G97A, BPN'-G97A-I111V-M124V, BPN'-V68A-A92G-G97A, BPN'-G97A- II 11 V-M124V-Y167A-Y217Q, BPN'-P52L-V68A-
- Transformants were picked into microtiter plates and grown as described in Example 2. The variants were assayed for cleaning performance using a BMI microswatch assay in
- Detergent Composition 2 at 16°C and pH 8. Protein content was determined using the TCA assay. The assays were performed as described in Example 1 and the Performance Indices were calculated relative to BPN'-v3 (with a PI value of 1.0).
- BPN' variants were determined to have a PI value greater than 1.0, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2, from greater than 1.0 to about 10, from greater than 1.0 to about 8, or from greater than 1.0 to about 5 relative to BPN'-v3 in a BMI microswatch cleaning assay in Detergent Composition 2 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of G097A-I111V- M124V-Y217Q, G097A-I111V-Y167A-Y217Q, S024G-N025G-N061P-G097A-S101N-G128S- Y217Q, S024G-N025G-S053G-N061P-G097A-S
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of greater than 1.0 to about 5 relative to BPN'-v3 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- subtilisin protease variant having enhanced proteolytic activity compared to BPN' and/or a PI value of greater than 1.0 compared to BPN'-v3 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% identity to SEQ ID NO:2, wherein the variant comprises at least one substitution selected from the group of X024G, X025G, X052L, X053G, X055P, X061P, X062Q, X068A, X089Y, X092G, X096T, X097A, X101N, X104N, X111V, X124V, X126A, X128A/S, X167A, X203Y, and X217Q, and optionally at least one substitution selected from the group of S
- BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of G097A-G128A-Y217Q, G097A-G128S- Y217Q, G097A-I111V-Y217Q, I111V-G128A-Y217Q, I111V-M124V-Y167A, I111V-M124V- Y217Q, L096T-G097A-Y217Q, N062Q-G097A-I111V, S053G-N061P-G097A-S101N-G128S- V203Y-Y217Q, S089Y-M124V-Y217Q, and V068A-I111V, S053G-N061P-G097A-S101N-G128S- V203Y-Y217Q, S089Y-M124V-Y217Q, and V068A
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of 1.0 relative to BPN'-v3 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% identity to the sequence of SEQ ID NO:2 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of G097A-I111V-M124V, G097A-L126A- Y217Q, G097A-M124V-Y217Q, I111V-Y167A-Y217Q, M124V-Y167A-Y217Q, P052L- V068A-G097A, S089Y-I111V-M124V, V068A-A092G-G097A, V068A-A092G-I111V, V068A-G097A-I111V, V068A-S089Y-I111V, and Y104N-G128A-Y217Q, where
- the invention includes a protease variant having proteolytic activity, a PI value of 0.9 relative to BPN'-v3, and/or an enhanced proteolytic activity compared to BPN' in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of G097A-M124V- Y167A-Y217Q, V068A-Y167A-Y217Q, G097A-I111V-M124V-Y167A, I111V-M124V- Y167A-Y217Q, V068A-I111 V-Y167A-Y217Q, G097A-I111 V-M124V-Y167A-Y217Q, P052L-V068A-I111V, wherein positions of the variant are numbered by correspondence with the sequence of SEQ ID NO: 2.
- the invention includes a protease variant having proteolytic activity, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and at least one set of amino acid substitutions selected from said group above, wherein positions of the variant are numbered by correspondence with positions of the SEQ ID NO:2 sequence.
- Such variants have proteolytic activity.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- Variants based on parent BPN' were made by DNA 2.0.
- the variants were grown as described in Example 2 and tested for cleaning performance on BMI microswatch assay in Detergent Composition 1 at 16°C and pH 8, BMI microswatch assay in Detergent Composition 4 at 16°C and pH 8, and egg microswatch assay in Detergent Composition 4 at 16°C and pH 8.
- the protein content was determined using the TCA assay.
- the assays were performed as described in Example 1 and the Performance Indices were calculated relative to BPN'-v3 (with a PI value of 1.0).
- BPN' variants were determined to have a PI value greater than 1.0, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2, from greater than 1.0 to about 10, from greater than 1.0 to about 8, or from greater than 1.0 to about 5 relative to BPN'-v3 in a BMI microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of N061P-G097A-S101N- G128A-P210S-Y217Q, S024G-N025G-S053G-N061P-G097A-S101N-G128A-P210S-Y217Q, S024G-N025G-S053G-N061P-G097A-S
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of greater than 1.0 to about 5 relative to BPN'-v3 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein
- BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of G097A-G128A-Y217Q, G097A-G128A- P210S-Y217Q, G097A-G128S-P210S-Y217Q, G097A-I111V-M124I-Y217Q, G097A-I111V- M124V-P210S-Y217Q, G097A-N123Q-P210S-Y217Q, G097A-N123Q-Y217Q, N061P- G097A-G128A-P210S-Y217Q, N061P-G097A-G128S-Y217Q, N061P-G097A-G128S-Y217Q,
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of 1.0 relative to BPN'-v3 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of N061P-G097A-M124I-Y217Q, N061P- G097A-M124V-Y217Q, N061P-N062Q-G097A-G100D-Y217Q, N061P-N062Q-G097A- G100Q-S101N-Y217Q, N061P-N062Q-G097A-G100Q-Y217Q, N061P-N062Q-G100N- G102A-Y217Q, N061P-N062Q-S078N-G097A-G100N-I111V-Y217Q,
- the invention includes a protease variant having proteolytic activity, a PI value of 0.9 relative to BPN'-v3, and/or an enhanced proteolytic activity compared to BPN' in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- subtilisin protease variant having enhanced proteolytic activity compared to BPN' and/or a PI value of greater than 1.0 compared to BPN'-v3 in a BMI microswatch cleaning assay in Detergent Composition 1 or 4 at pH 8 and 16°C, the variant comprising an amino acid sequence having at least 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% identity to SEQ ID NO:2, wherein the variant comprises at least one substitution selected from the group of X024G, X025G, X053G, X061P, X062Q, X078N, X097A, X100D/N/Q, X101N, X102A, X111V, X123A/Q/V, X124I/V, X128A/S, X129S, X210S, X217Q, and optionally at least one substitution selected from the group of
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' variants were determined to have a PI value equal to or greater than 0.5 and less than 0.9 relative to BPN'-v3 in a BMI microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of G097A-N123A- Y217Q, G097A-N123V-Y217Q, N061P-G102A-G128S-Y217Q, N061P-S101N-G102A- G128S-Y217Q, Y217Q, S078N-G097A-I111V-N123Q-Y217Q, and G102A-N123Q-Y217Q, wherein positions of the variant are numbered by correspondence with positions of the SEQ ID NO:2 sequence.
- the invention includes a protease variant having proteolytic activity, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and at least one set of amino acid substitutions selected from said group above, wherein positions of the variant are numbered by correspondence with positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' variants were determined to have a PI value greater than 1.0, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2, from greater than 1.0 to about 10, from greater than 1.0 to about 8, or from greater than 1.0 to about 5 relative to BPN'-v3 in a BMI microswatch cleaning assay in Detergent Composition 1 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of N061P-G097A-G128S- Y217Q, N061P-G097A-S101N-G128A-P210S-Y217Q, N061P-N062Q-G097A-S101N-I111V- Y217Q, S024G-N025G-N061P-G097A
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of greater than 1.0 to about 5 relative to BPN'-v3 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein
- BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of G097A-G128A-Y217Q, G097A-G128A- P210S-Y217Q, G097A-G128S-P210S-Y217Q, G097A-I111V-M124I-Y217Q, G097A-I111V- M124V-P210S-Y217Q, G097A-N123Q-P210S-Y217Q, G097A-N123Q-Y217Q, N061P- G097A-G128A-P210S-Y217Q, N061P-G097A-I111V-M124V-Y217Q, N061P-G097A-I111V-M124V-Y217Q, N061P-G097A-I111V-M124V-Y217Q, N061P-
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of 1.0 relative to BPN'-v3 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of N061P-G097A-M124I-Y217Q, N061P- G097A-S101N-N123Q-Y217Q, N061P-N062Q-G097A-G100N-Y217Q, N061P-N062Q- G097A-G100Q-P210S-Y217Q, N061P-N062Q-G097A-G100Q-S101N-Y217Q, N061P- N062Q-G100N-G102A-Y217Q, S024G-N025G-S053G-N061P-G097A-
- the invention includes a protease variant having proteolytic activity, a PI value of 0.9 relative to BPN'-v3, and/or an enhanced proteolytic activity compared to BPN' in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' variants were determined to have a PI value equal to or greater than 0.5 and less than 0.9 relative to BPN'-v3 in a BMI microswatch cleaning assay in Detergent Composition 1 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of G097A-N123A- Y217Q, G097A-N123V-Y217Q, N061P-N062Q-G097A-G100D-Y217Q, N061P-S101N- G102A-G128S-Y217Q, Y217Q, N061P-G102A-G128S-Y217Q, S078N-G097A-I111V-N123Q- Y217Q, and G102A-N123Q-Y217Q, wherein positions of the variant are numbered by correspondence with positions of the SEQ ID NO: 2 sequence.
- the invention includes a protease variant having proteolytic activity, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and at least one set of amino acid substitutions selected from said group above, wherein positions of the variant are numbered by correspondence with positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' variants were determined to have a PI value greater than 1.0 to about 5 relative to BPN'-v3 in an egg microswatch cleaning assay in Detergent Composition 4 at 16°C and pH 8: BPN' amino acid sequence (SEQ ID NO:2) comprising the set of amino acid substitutions N061P-G097A-S101N-G128A-P210S-Y217Q, wherein amino acid positions of the variant are numbered by correspondence with the sequence of SEQ ID NO:2.
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of greater than 1.0 to about 5 relative to BPN'-v3 in this egg microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and comprising amino acid substitutions N061P- G097A-S101N-G128A-P210S-Y217Q, wherein amino acid positions of the variant are numbered by correspondence with the sequence of SEQ ID NO: 2.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of G097A-G128A-Y217Q, N061P-G102A- P129S-Y217Q, N062Q-G097A-I111V-P210S-Y217Q, S024G-N025G-S053G-N061P-G097A- S101N-G128A-P210S-Y217Q, S024G-N025G-N061P-G097A-S101N-G128A-P210S-Y217Q, N061P-G097A-G128A-P210S-Y217Q, G097A-G128S-Y217Q, G097A-G128S-
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of 1.0 relative to BPN'-v3 in this egg microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' variants were determined to have a PI value equal to or greater than 0.5 and equal to or less than 0.9 relative to BPN'-v3 in an egg microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of N061P-G097A-M124I-Y217Q, S053G-N061P-G097A-S101N-N123Q-Y217Q, S053G-N061P- G102A-P129S-P210S-Y217Q, G097A-I111V-M124V-P210S-Y217Q, G097A-N123Q-P210S- Y Y
- the invention includes a protease variant having proteolytic activity and/or a PI value of equal to or greater than 0.5 and equal to or less than 0.9 relative to BPN'-v3 in this egg microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- subtilisin protease variant having enhanced proteolytic activity compared to BPN' and/or a PI value of greater than 1.0 and to about 5 compared to BPN'-v3 in this egg microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C, the variant comprising an amino acid sequence having at least 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% identity to SEQ ID NO:2, wherein the variant comprises at least one substitution selected from the group of X024G, X025G, X053G, X061P, X062Q, X078N, X097A, X100D/N/Q, X101N, X102A, X111V, X123A/Q/V, X124I/V, X128A/S, X129S, X210S, and X217Q, and optionally at least one substitution selected from the group
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' combinatorial library based on BPN' parent was made by DNA2.0 and delivered as a ligation reaction.
- DNA from the ligation reaction mixtures was amplified before transformation and transformants grown as described in Example 2.
- These variants were tested for cleaning performance using BMI microswatch assay of Test Method 3 in Detergent Composition 1 and Detergent Composition 4 at 16°C and pH 8 as well as egg microswatch assay in Detergent Composition 4 at 16°C and pH 8.
- Protein content was determined using the TCA assay and protease activity was assayed using the AAPF assay.
- the assays were performed as described in Example 1 and the Performance Indices were calculated relative to BPN'-v3 (with a PI value of 1.0).
- BPN' variants were determined to have a PI value greater than 1.0, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2, from greater than 1.0 to about 10, from greater than 1.0 to about 8, or from greater than 1.0 to about 5 relative to BPN'-v3 in a BMI microswatch cleaning assay in Detergent Composition 1 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of S024G-N025G-S053G- T055P-N061P-G097A-S101N-G128A-Y217Q, N025G-G097A-S101N-G128A-Y217Q, N025G-S038G-S053G-N061P-S078N-G097A
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of greater than 1.0 to about 5 relative to BPN'-v3 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of G097A-G128S-Y217Q, G097A-G128A- Y217Q, N025G-S078N-G097A-G128A-Y217Q, N025G-T055P-G097A-G128A-Y217Q, S024G-G097A-S101N-G128A-Y217Q, S024G-I035V-T055P-N061P-S078N-G097A-Y217Q, S024G-N025G-N061P-S078N-G097A-S101N-
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of 1.0 relative to BPN'-v3 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- subtilisin protease variant having enhanced proteolytic activity compared to BPN' and/or a PI value of greater than 1.0 compared to BPN'-v3 in this BMI microswatch cleaning assay in Detergent Composition 1 at pH 8 and 16°C, the variant comprising an amino acid sequence having at least 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% identity to SEQ ID NO:2, wherein the variant comprises at least one substitution selected from the group of X024G, X025G, X035V, X038G, X053G, X055P, X061P, X078N, X097A, X101N, X116S, X128A/S, X130G, X216Q, X217Q, and X249N, and optionally at least one substitution selected from the group of S024G, N025G, I035V
- BPN' variants were determined to have a PI value greater than 1.0, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2, from greater than 1.0 to about 10, from greater than 1.0 to about 8, or from greater than 1.0 to about 5 relative to BPN'-v3 in a BMI microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of S024G-N025G-N061P- S078N-G097A-S101N-G128A-Y217Q, S024G-N025G-S053G-N061P-S078N-S101N-G128A- Y217Q, S024G-N025G-S053G-T055
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of greater than 1.0 to about 5 relative to BPN'-v3 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of G097A-G128S-Y217Q, G097A-G128A-Y217Q, N025G-G097A-S101N-G128A-Y217Q, N025G-S038G-S053G- N061P-S078N-G097A-S101N-G128A-Y217Q, N025G-S053G-N061P-S078N-G128A-Y217Q, N025G-S053G-N061P-S078N-G128A-Y217Q, N025G-S053G-N061P-S078N-G128A-Y217Q, N025G-S053G-N061P-S078N-S101N-G128A-Y217Q, N
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of 1.0 relative to BPN'-v3 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' variants were determined to have a PI value of about 0.9 relative to BPN'-v3 in a BMI microswatch cleaning assay of Tets Method 3 in Detergent Composition 4 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of T055P-N061P-G097A-A116S-G128A, S024G-N025G-T055P-N061P-S078N-G097A-Y217Q, wherein positions of the variant are numbered by correspondence with the sequence of SEQ ID NO: 2.
- Such variants have proteolytic activity and may have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) in this assay.
- the invention includes a protease variant having proteolytic activity, a PI value of 0.9 relative to BPN'-v3, and/or an enhanced proteolytic activity compared to BPN' in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' variants were determined to have a PI value greater than 1.0, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2, from greater than 1.0 to about 10, from greater than 1.0 to about 8, or from greater than 1.0 to about 5 relative to BPN'-v3 in an egg microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of N025G-T055P-N061P- S078N-G097A-S101N-G128A-Y217Q, N061P-S101N-G128A-Y217Q, S024G-N025G-S053G- N061P-S078N-S101N-G128A-Y217Q, S024
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of greater than 1.0 to about 5 relative to BPN'-v3 in this egg microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by
- BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of G097A-G128S-Y217Q, G097A-G128A- Y217Q, S024G-G097A-S101N-G128A-Y217Q, N025G-T055P-N061P-S078N-S101N-G128A- Y217Q, S053G-T055P-N061P-S101N-G128A-Y217Q, S053G-T055P-S078N-G097A-S101N- G128A-Y217Q, N025G-S053G-N061P-S078N-G097A-S101N- G128A-Y217Q, N025G-S053G-N061P-S078N-G097A-S101N- G1
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of 1.0 relative to BPN'-v3 in this egg microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning comprising utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' variants were determined to have a PI value of about 0.9 relative to BPN'-v3 in an egg microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of S101N-G128A-Y217Q, S024G-T055P- N061P-G097A-S101N-G128A, S024G-N025G-N061P-S078N-G097A-S101N-G128A, S024G- T055P-N061P-S078N-S101N-G128A-Y217Q, S024G-N025G
- the invention includes a protease variant having proteolytic activity, a PI value of 0.9 relative to BPN'-v3, and/or an enhanced proteolytic activity compared to BPN' in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' variant was determined to have a PI value of about 0.8 relative to BPN'-v3 in an egg microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN' amino acid sequence (SEQ ID NO:2) comprising amino acid substitutions S024G-S053G- S078N-G097A-S101N-G128A-Y217Q, wherein positions of the variant are numbered by correspondence with the sequence of SEQ ID NO: 2.
- the invention includes a protease variant having proteolytic activity, a PI value of 0.8 relative to BPN'-v3, and/or an enhanced proteolytic activity compared to BPN' in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and comprising amino acid substitutions S024G-S053G-S078N- G097A-S101N-G128A-Y217Q, wherein amino acid positions of the variant are numbered by correspondence with positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN' variants were determined to have a PI value greater than 1.0, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2, from greater than 1.0 to about 10, from greater than 1 to about 12, from greater than 4 to about 12, from greater than 1.0 to about 8, or from greater than 1.0 to about 5 relative to BPN'-v3 in an AAPF proteolytic assay: BPN' amino acid sequence (SEQ ID NO:2) comprising at least one set of amino acid substitutions selected from the group consisting of S024G-G097A-S101N-G128A-Y217Q, S101N-G128A-Y217Q, N025G-T055P-N061P-S078N- S101N-G128A-Y217Q, S053G-T055P-N061P-S101N-G128A-Y217
- Such variants have enhanced proteolytic activity compared to BPN' protease (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of greater than 1.0 to about 5 relative to BPN'-v3 in this AAPF assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- BPN' variant was determined to have a PI value equal to about 1.0 relative to BPN'-v3 in an AAPF proteolytic assay: BPN' amino acid sequence (SEQ ID NO:2) comprising amino acid substitutions G097A-G128A-Y217Q, wherein amino acid positions of the variant are numbered by correspondence with the sequence of SEQ ID NO: 2.
- BPN' amino acid sequence SEQ ID NO:2
- Such variants have enhanced proteolytic activity compared to BPN' protease (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a PI value of 1.0 relative to BPN'- v3 in this AAPF assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 and comprising amino acid substitutions G097A-G128A-Y217Q, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- the amino acid sequence of BPN'-v36 is that of SEQ ID NO:6 and the nucleic acid sequence encoding the BPN'-v36 protease variant is that of SEQ ID NO:5.
- the amino acid sequence of BPN'-v36 may be represented by reference to the subtilisin BPN' amino acid sequence of SEQ ID NO:2. That is, BPN'-v36 may be represented as the subtilisin BPN' sequence of SEQ ID NO:2 with the six amino acid substitutions S024G-S053G- S078N-S101N-G128A-Y217Q.
- the BPN'-v36 amino acid sequence may be conveniently designated as BPN'-S024G-S053G-S078N-S101N-G128A-Y217Q or
- each amino acid position of an amino acid sequence is numbered according to the numbering of a corresponding amino acid position in the amino acid sequence of Bacillus amyloliquefaciens subtilisin BPN' shown in SEQ ID NO:2 as determined by alignment of the variant amino acid sequence with the Bacillus amyloliquefaciens subtilisin BPN' amino acid sequence.
- SELs Site evaluation libraries
- each codon to be mutated in the BPN'-v36 protease a pair of partially overlapping, complementary (mutagenic forward and reverse) primers were designed.
- two PCR reactions were carried out using either a common forward gene-flanking primer (P4974, SEQ ID NO:60) and a mutagenic NNS reverse primer, or the common reverse gene-flanking primer (P4976, SEQ ID NO:61) and a mutagenic NNS forward primer.
- P4974 common forward gene-flanking primer
- P4976 SEQ ID NO:61
- PCR reactions generated two PCR fragments, one encoding the 5' half of the mutant BPN'-v36 gene (5' gene fragment) and the other encoding the 3' half of the mutant BPN'-v36
- Each PCR amplification reaction contained 30 pmol of each primer and 100 ng of the BPN'-v36 parent template DNA (plasmid pHPLT-BPN'-v36, see Figure 4). Amplifications were carried out using Vent DNA polymerase (NEB). The PCR reaction (20 ⁇ ) was initially heated at 95°C for 2.5 min followed by 30 cycles of denaturation at 94°C for 15 sec, annealing at 55°C for 15 sec. and extension at 72°C for 40 sec.
- NEB Vent DNA polymerase
- the 5' and 3' gene fragments were gel-purified by the QIAGEN® gel-band purification kit, mixed (50 ng of each fragment), mixed and amplified by PCR once again using the primers P4973 (SEQ ID NO:62) and P4950 (SEQ ID NO:63) to generate the full-length gene fragment.
- the PCR conditions were same as described above, except the extension phase, which was carried out at 72°C for 2 min.
- the full-length DNA fragment was gel-purified by the QIAGEN® gel-band purification kit, digested by the BamHI and HmdIII restriction enzymes and ligated with the pHPLT-BPN' partial opt vector that also was digested with the same restriction enzymes.
- Ligation mixtures were amplified using rolling circle amplification in an Illustra Templiphi kit according to the manufacturer' s recommendation (GE Healthcare) to generate multimeric DNA for
- the colonies with halos were inoculated in 150 ⁇ of LB media containing 10 ⁇ g/mL neomycin. The next day, cultures were either frozen with 15% glycerol or grown in MBD medium for biochemical analysis as described in Example 2.
- Protein variants from BPN'-v36 SEL were tested for cleaning performance using a BMI microswatch assay in Detergent Composition 4 at 16°C and pH 8 and egg microswatch assay in Detergent Composition 4 at 16°C and pH 8. Protein content was determined using the TCA assay. The assays were performed as described in Example 1 and the Performance Indices were calculated relative to BPN'-v36 (i.e., BPN'-S24G-S53G-S78N-S101N-G128A-Y217Q).
- BPN'-v36 variants were determined to have a PI value greater than 1.0, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2, from greater than 1.0 to about 10, from greater than 1.0 to about 8, or from greater than 1.0 to about 5 relative to BPN'-v36 in a BMI microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN'-S024G-S053G-S078N-S101N-G128A- Y217Q (SEQ ID NO:6) (i.e., BPN'-v36) comprising at least one amino acid substitution selected from the group consisting of A116V, G160S, I111L, II 15V, N109S, N117M, P005G, Q059V, T164S, Y262M, A015Q, A015S, A098
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2), enhanced proteolytic activity compared to BPN'-v3 and BPN'-v36, a PI value greater than that of BPN'-v3, and/or a PI value greater than 1 to about 5 relative to BPN'-v36 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one, two, three, four, five, six or more amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ
- BPN'-v36 variants were determined to have a PI value equal to about 1.0 relative to BPN'-v36 in a BMI microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN'-S024G-S053G-S078N-S101N-G128A-Y217Q amino acid sequence (SEQ ID NO: 6) comprising at least one amino acid substitution selected from the group consisting of BPN'-v36, A001G, A001Y, A013G, A013V, A015F, A015G, A015K, A015M, A015P, A015T, A015W, A015Y, A029G, A073S, A088C, A088I, A088L, A088T, A088V, A098D, A098K, A098P, A098R, A098W, A116D, A116E, A116R, A1
- the invention includes BPN'-S024G-S053G-S078N- S101N-G128A-Y217Q amino acid sequence (SEQ ID NO:6) comprising substitution A128S, e.g., BPN'-S024G-S053G-S078N-S101N-G128S-Y217Q.
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2), a PI value of about 1.0 relative to BPN'-v3, and/or a PI value of 1.0 relative to BPN'-v36 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one, two, three, four, five, six or more amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN'-v36 variants were determined using Test Method 3 to have a PI value equal to about 0.9 relative to BPN'-v36 in a BMI microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN'-S024G-S053G-S078N-S101N-G128A-Y217Q amino acid sequence (SEQ ID NO: 6) comprising at least one amino acid substitution selected from the group consisting of A001F, A001K, A001L, A001M, A001Q, A001R, A001S, A001T, A001V, A013C, A013S, A015D, A015E, A015L, A015R, A048S, A073N, A073T, A074G, A074S, A085C, A085G, A085S, A085V, A088M, A088S, A092S, A098G, A114G,
- Such variants may have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and/or a greater PI value than BPN' in this assay.
- the invention includes a protease variant having proteolytic activity and/or a PI value of 0.9 relative to BPN'-v36 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one, two, three, four, five, six or more amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere here
- BPN'-v36 variants were determined to have a PI value equal to or greater than 0.5 and less than 0.9 relative to BPN'-v36 in the BMI microswatch cleaning assay of Test Method 3 in Detergent Composition 4 at pH 8 and 16°C: BPN'-S24G-S53G-S78N-S101N- G128A-Y217Q amino acid sequence (SEQ ID NO:6) comprising at least one amino acid substitution selected from the group consisting ofAOOlD, A001H, A001N, A015C, A048C, A048E, A085T, A133R, A137R, A142C, A144D, A144R, A152S, A153G, A187P, A187Q, A187T, A187V, A216R, A230S, A272R, A273H, A273T, A274H, D036N, D036S, D181H, D181T, D259N, D259
- the invention includes a protease variant having proteolytic activity and/or a PI value equal to or greater than 0.5 and less than 0.9 relative to BPN'-v36 in this BMI microswatch cleaning assay(Test Method 3), the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one, two, three, four, five, six or more amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN'-v36 variants were determined to have a PI value greater than 1.0, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2, from greater than 1.0 to about 10, from greater than 1.0 to about 8, or from greater than 1.0 to about 5 relative to BPN'-v36 in an egg microswatch cleaning assay in Detergent Composition 4 at 16°C and pH 8: BPN'-S024G-S053G-S078N-S101N-G128A- Y217Q amino acid sequence (SEQ ID NO: 6) comprising at least one amino acid substitution selected from the group consisting of A216E, L090I, A098R, A098W, A098Y, A116G, A116R, A116S, A133M, I107L, I115V, M124L, N101I, N109H, N109S, N109T,
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2), enhanced proteolytic activity compared to BPN'-v3 and BPN'-v36, a PI value greater than that of BPN'-v3, and/or a PI value of greater than 1.0 to about 5 relative to BPN'-v36 in this egg microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one, two, three, four, five, six or more amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the S
- BPN'-v36 variants were determined to have a PI value equal to about 1.0 relative to BPN'-v36 in an egg microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN'-S024G-S053G-S078N-S101N-G128A-Y217Q amino acid sequence (SEQ ID NO: 6) comprising at least one amino acid substitution selected from the group consisting of BPN'-v36, A001D, A001M, A001N, A001R, A001T, A001V, A013C, A013G, A013S, A015D, A015F, A015L, A015M, A015P, A015Q, A074G, A074S, A085S, A085T, A085V, A088C, A088L, A088S, A088T, A088V, A133E, A133G, A133R, A137E
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2), a PI value of about 1.0 relative to BPN'-v3, and/or a PI value of 1.0 relative to BPN'-v36 in this egg microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one, two, three, four, five, six or more amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- the following BPN'-v36 variants were determined to have a PI value equal to about 0.9 relative to BPN'-v36 in an egg microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN'-S024G-S053G-S078N-S101N-G128A-Y217Q amino acid sequence (SEQ ID NO: 6) comprising at least one amino acid substitution selected from the group consisting of A001E, A015C, A015E, A048C, A048E, A073T, A085C, A085G, A088I, A088M, A114G, A137R, A187L, A187N, A187P, A187W, A216C, A230S, A273D, A273H,
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2), and/or a PI value of 0.9 relative to BPN'-v36 in this egg microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one, two, three, four, five, six or more amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN'-v36 variants were determined to have a PI value equal to or greater than 0.5 and less than 0.9 relative to BPN'-v36 in an egg microswatch cleaning assay in
- Detergent Composition 4 at pH 8 and 16°C BPN'-S024G-S053G-S078N-S101N-G128A- Y217Q amino acid sequence (SEQ ID NO:6) comprising at least one amino acid substitution selected from the group consisting of AOOIC, A142C, A187C, A216H, A273Q, A274H, D036Q, D036S, D099S, D197T, E156L, F189A, F189L, G053L, G053R, G157P, G178A, G258P, H039S, H238Y, K012C, K012E, K012L, K012W, K136E, K265Y, L075G, L075V, L082E, L126W, L257D, L257P, M050L, M222A, M222F, M222L, N056S, N062C, N062L, N062
- the invention includes a protease variant having proteolytic activity and/or a PI value of equal to or greater than 0.5 and less than 0.9 relative to BPN'-v36 in this egg microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one, two, three, four, five, six or more amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN'-S24G-S53G-S78N- S101N-G128A-Y217Q BPN'-S24G-S53G-S78N- S101N-G128A-Y217Q
- DNA 2.0 DNA 2.0.
- BMI microswatch assay in Detergent Composition 4 at 16°C and pH 7 Egg microswatch assay in Detergent Composition 4 at 16°C and pH 8
- Protein content was determined using TCA assay and protease activity was assayed using AAPF assay. All assays were performed as described in Example 1 and the Performance Indices were calculated relative to BPN'-v36.
- BPN'-v36 variants were determined to have a PI value greater than 1.0, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2, from greater than 1.0 to about 10, from greater than 1.0 to about 8, or from greater than 1.0 to about 5 relative to BPN'-v36 in a BMI microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN'-S024G-S053G-S078N-S101N-G128A- Y217Q amino acid sequence (SEQ ID NO: 6) comprising at least one set of amino acid substitutions selected from the group consisting of A088T-L257G, A116T-A128S, N061S- N109G-A128S-N243V-S260P, S009T-N109G-A128S-K141R-N243V,
- variants have enhanced proteolytic activity compared to BPN', BPN'-v3, and BPN'-v36, and a greater PI value than BPN', BPN'-v3 and BPN'-v36 in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN', BPN'-v3, and BPN'-v36, a PI value of greater than 1.0 to about 5 relative to BPN'-v3, and/or a PI value of greater than 1.0 to about 5 relative to BPN'-v36 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions
- BPN'-v36 variants were determined to have a PI value equal to about 1.0 relative to BPN'-v36 in a BMI microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN'-S024G-S053G-S078N-S101N-G128A-Y217Q amino acid sequence (SEQ ID NO: 6) comprising at least one set of amino acid substitutions selected from the group consisting of BPN'-v36, A088T, A088T-A116T, A088T-G131H, A088T-K256R, A088T-N109G, A088T- N243V, A088T-Q103H, A088T-S162G, A088T-S248N, A088T-S249A, A088T-T158S, A116T, A116T-G131H, A116T-K256R, A116T-L257G, A116
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2), a PI value of 1.0 relative to BPN'-v3, and a PI value of 1.0 relative to BPN'-v36 in this BMI microswatch cleaning assay Test Method 3), the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such
- BPN'-v36 variants were determined to have a PI value equal to about 0.9 relative to BPN'-v36 in a BMI microswatch cleaning assay(test Method 3) in Detergent Composition 4 at pH 8 and 16°C: BPN'-S024G-S053G-S078N-S101N-G128A-Y217Q amino acid sequence (SEQ ID NO: 6) comprising at least one set of amino acid substitutions selected from the group consisting of A001E-A088T, A001E-A116T, A001E-A128S-G131H-N243V, A001E-G131H-G169A-N243V, A001E-K256R, A001E-N109G, A001E-N243V, A001E- S033T, A001E-S033T-N109G-N218S, A001E-S033T-N109G-N243V, A001E-S162G, A001E-S
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2), and/or a PI value of 0.9 relative to BPN'-v36 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN'-v36 variants were determined to have a PI value equal to or greater than 0.5 and less than 0.9 relative to BPN'-v36 in a BMI microswatch cleaning assay (Test Method 3) in Detergent Composition 4 at pH 8 and 16°C: BPN'-S024G-S053G-S078N-S101N- G128A-Y217Q amino acid sequence (SEQ ID NO:6) comprising at least one set of amino acid substitutions selected from the group consisting of A001E, A001E-A128S, A001E-G024E, A001E-G131H, A001E-G169A, A001E-L257G, A001E-N218S, A001E-Q103H, A001E- S063G, A001E-S248N, A001E-S249A, G024E-N076D, K043Y-N076D, K043Y-Q206D, N076D
- the invention includes a protease variant having proteolytic activity and/or a PI value equal to or greater than 0.5 and less than 0.9 relative to BPN'-v36 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO: 6 and comprising at least one set of acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- the following BPN'-v36 variants were determined to have a PI value greater than 1.0, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2, from greater than 1.0 to about 10, from greater than 1.0 to about 8, or from greater than 1.0 to about 5 relative to BPN'-v36 in a BMI microswatch cleaning assay (test Method 3) in Detergent Composition 4 at pH 7 and 16°C: BPN'-S024G-S053G-S078N-S101N- G128A-Y217Q amino acid sequence (SEQ ID NO:6) comprising at least one set of amino acid substitutions selected from the group consisting of A116T, A088T-N
- Such variants have enhanced proteolytic activity compared to BPN', BPN'-v3, and BPN'-v36, and a greater PI value than BPN', BPN'-v3 and BPN'-v36 in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2), enhanced proteolytic activity compared to BPN', BPN'-v3, and BPN'-v36, a PI value of greater than 1.0 to about 5 relative to BPN'-v3, and/or a PI value of greater than 1.0 to about 5 relative to BPN'-v36 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of amino acid substitutions selected from said
- BPN'-v36 variants were determined to have a PI value equal to about 1.0 relative to BPN'-v36 in a BMI microswatch cleaning assay(Test Method 3) in Detergent Composition 4 at pH 7 and 16°C: BPN'-S024G-S053G-S078N-S101N-G128A-Y217Q amino acid sequence (SEQ ID NO: 6) comprising at least one set of amino acid substitutions selected from the group consisting of BPN'-v36, A001E-A128S, A001E-G131H, A001E-K256R, A001E-N218S, A001E-N243V, A001E-S033T, A001E-S063G, A001E-S162G, A088T, A088T- K256R, A088T-N218S, A088T-Q103H, A088T-S162G, A088T-T158S, A116
- Such variants have enhanced proteolytic activity compared to BPN' protease (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2), a PI value of 1.0 relative to BPN'-v3, and a PI value of 1.0 relative to BPN'-v36 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one
- BPN'-v36 variants were determined to have a PI value equal to about 0.9 relative to BPN'-v36 in a BMI microswatch cleaning assay (Test Method 3) in Detergent Composition 4 at pH 7 and 16°C: BPN'-S024G-S053G-S078N-S101N-G128A-Y217Q amino acid sequence (SEQ ID NO: 6) comprising at least one set of amino acid substitutions selected from the group consisting of A001E, A001E-A088T, A001E-A116T, A001E-G169A, A001E- L257G, A001E-N109G, A001E-S033T-N109G-N243V, A001E-T158S, A088T-G169A, A088T-Q206D, A116T-N218S, A128S-G131H, A128S-N243V-S248N-K256R, A128S-
- the invention includes a protease variant having proteolytic activity and/or a PI value of 0.9 relative to BPN'-v36 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN'-v36 variants were determined to have a PI value equal to or greater than 0.5 and less than 0.9 relative to BPN'-v36 in a BMI microswatch cleaning assay in
- Detergent Composition 4 at pH 7 and 16°C BPN'-S024G-S053G-S078N-S101N-G128A- Y217Q amino acid sequence (SEQ ID NO: 6) comprising at least one set of amino acid substitutions selected from the group consisting of A001E-A128S-G131H-N243V, A001E- G024E, A001E-G131H-G169A-N243V, A001E-Q103H, A001E-S033T-N109G-N218S, A001E-S248N, A116T-G169A, A116T-Q206D, G169A-S249A, K043Y-G169A, N109G- G169A, P040E-N109G-A128S-G131H, Q206D-L257G, S033T-A128S-G131H-N243P, S033T- A128S-G131H-N
- the invention includes a protease variant having proteolytic activity and/or a PI value equal to or greater than 0.5 and less than 0.9 relative to BPN'-v36 in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN'-v36 variants were determined to have a PI value greater than 1.0, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2, from greater than 1.0 to about 10, from greater than 1.0 to about 8, or from greater than 1.0 to about 5 relative to BPN'-v36 in an egg microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN'-S024G-S053G-S078N-S101N-G128A- Y217Q amino acid sequence (SEQ ID NO: 6) comprising at least one set of amino acid substitutions selected from the group consisting of A088T-L257G, G024E-K256R, G024E- L257G, N109G-A116T, N109G-L257G, N243V-K256R, S033T-N109G, S03
- Such variants have enhanced proteolytic activity compared to BPN', BPN'-v3, and BPN'-v36, and a greater PI value than BPN', BPN'-v3 and BPN'-v36 in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2), enhanced proteolytic activity compared to BPN', BPN'-v3, and BPN'-v36, a PI value of greater than 1.0 to about 5 relative to BPN'-v3, and/or a PI value of greater than 1.0 to about 5 relative to BPN'-v36 in this egg microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of amino acid substitutions selected from said group
- BPN'-v36 variants were determined to have a PI value equal to about 1.0 relative to BPN'-v36 in an egg microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN'-S024G-S053G-S078N-S101N-G128A-Y217Q amino acid sequence (SEQ ID NO: 6) comprising at least one set of amino acid substitutions selected from the group consisting of BPN'-v36, A001E, A001E-A116T, A001E-G131H, A001E-G169A, A001E-K256R, A001E- N109G, A001E-S033T-N109G-N243V, A001E-S063G, A001E-S248N, A001E-S249A, A001E-T158S, A088T, A088T-A116T, A088T-G131H, A088T-Q103H, A088
- Such variants have enhanced proteolytic activity compared to BPN' protease (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2), a PI value of 1.0 relative to BPN'-v3, and a PI value of 1.0 relative to BPN'-v36 in this egg microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such
- BPN'-v36 variants were determined to have a PI value equal to or greater than 0.5 and less than 0.9 relative to BPN'-v36 in an egg microswatch cleaning assay in
- Detergent Composition 4 at pH 8 and 16°C BPN'-S024G-S053G-S078N-S101N-G128A- Y217Q amino acid sequence (SEQ ID NO: 6) comprising at least one set of amino acid substitutions selected from the group consisting of A001E-A088T, A001E-A128S, A001E- A128S-G131H-N243V, A001E-G024E, A001E-G024E-S204E-Q206D, A001E-G131H- G169A-N243V, A001E-K043Y, A001E-N076D, A001E-N076D-N109G-A128S, A001E- N218S, A001E-N243V, A001E-Q103H, A001E-Q206D, A001E-S033T, A001E-S033T- N109G-N218S, A001E-S16
- the invention includes a protease variant having proteolytic activity and/or a PI value equal to or greater than 0.5 and less than 0.9 relative to BPN'-v36 in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- the following BPN'-v36 variants were determined to have a PI value greater than 1.0, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2, from greater than 1.0 to about 10, from greater than 1.0 to about 8, or from greater than 1.0 to about 5 relative to BPN'-v36 in a grass microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN'-S024G-S053G-S078N-S101N-G128A- Y217Q amino acid sequence (SEQ ID NO: 6) comprising at least one set of amino acid substitutions selected from the group consisting of T158S-L257G, K256R, L
- Such variants have enhanced proteolytic activity compared to BPN', BPN'-v3, and BPN'-v36, and a greater PI value than BPN', BPN'-v3 and BPN'-v36 in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2), enhanced proteolytic activity compared to BPN', BPN'-v3, and BPN'-v36, a PI value of greater than 1.0 to about 5 relative to BPN'-v3, and/or a PI value of greater than 1.0 to about 5 relative to BPN'-v36 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of amino acid substitutions selected from said
- BPN'-v36 variants were determined to have a PI value equal to about 1.0 relative to BPN'-v36 in a grass microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN'-S024G-S053G-S078N-S101N-G128A-Y217Q amino acid sequence (SEQ ID NO: 6) comprising at least one set of amino acid substitutions selected from the group consisting of BPN'-v36, A001E-A088T, A001E-A116T, A088T-A128S, A088T-N243V, A088T-Q103H, A088T-S248N, A088T-S249A, A116T, A116T-G169A, A116T-N218S, A116T-S162G, A116T-S249A, A116T-T158S, A128S-G169A, A128S-K256R,
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2), a PI value of 1.0 relative to BPN'-v3, and a PI value of 1.0 relative to BPN'-v36 in this BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO: 6 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods
- BPN'-v36 variants were determined to have a PI value equal to or greater than 0.5 and less than 0.9 relative to BPN'-v36 in a grass microswatch cleaning assay in
- Detergent Composition 4 at pH 8 and 16°C BPN'-S024G-S053G-S078N-S101N-G128A- Y217Q amino acid sequence (SEQ ID NO: 6) comprising at least one set of amino acid substitutions selected from the group consisting of A001E-G169A, A001E-K256R, A001E- N109G, A001E-N218S, A088T-A116T, A088T-G131H, A088T-N109G, A088T-N218S, A116T-A128S, A116T-G131H, A116T-S248N, A128S, A128S-G131H, G024E, G024E- N109G, G131H, G131H-L257G, G169A-K256R, G169A-Q206D, K043Y, K043Y-A088T, K043Y-L257G, K
- the invention includes a protease variant having proteolytic activity and/or a PI value equal to or greater than 0.5 and less than 0.9 relative to BPN'-v36 in this grass microswatch cleaning assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- the following BPN'-v36 variants were determined to have a PI value greater than 1.0, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2, from greater than 1.0 to about 10, from greater than 1.0 to about 8, or from greater than 1.0 to about 5 relative to BPN'-v36 in an AAPF proteolytic assay: BPN'-S024G- S053G-S078N-S101N-G128A-Y217Q amino acid sequence (SEQ ID NO:6) comprising at least one set of amino acid substitutions selected from the group consisting of S033T-N076D-A128S- N218S, A001E-S033T-N
- Such variants have enhanced proteolytic activity compared to BPN', BPN'-v3, and BPN'-v36, and a greater PI value than ⁇ ', BPN'- v3 and BPN'-v36 in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2), enhanced proteolytic activity compared to BPN', BPN'-v3, and BPN'-v36, a PI value of greater than 1.0 to about 5 relative to BPN'-v3, and/or a PI value of greater than 1.0 to about 5 relative to BPN'-v36 in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of amino acid substitutions selected from said group above, wherein
- BPN'-v36 variants were determined to have a PI value equal to about 1.0 relative to BPN'-v36 in an AAPF proteolytic assay: BPN'-S024G-S053G-S078N-S101N- G128A-Y217Q amino acid sequence (SEQ ID NO:6) comprising at least one set of amino acid substitutions selected from the group consisting of BPN'-v36, A001E-G131H, A001E-S063G, A088T-G131H, A088T-T158S, A116T-G131H, A116T-S162G, A116T-T158S, G024E-S063G, G131H-N243V, G131H-N243V-K256R, G131H-Q206D, G131H-S249A, K043Y, K043Y- S063G, K043Y-S248N, K043Y-S249A, K043
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2), a PI value of 1.0 relative to BPN'-v3, and a PI value of 1.0 relative to BPN'-v36 in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN'-v36 variants were determined to have a PI value equal to about 0.9 relative to BPN'-v36 in an AAPF proteolytic assay: BPN'-S024G-S053G-S078N-S101N- G128A-Y217Q amino acid sequence (SEQ ID NO:6) comprising at least one set of amino acid substitutions selected from the group consisting of G131H-S162G, G131H-S248N, G131H- T158S, K043Y-G131H, K043Y-S162G, S063G-A088T, S063G-G131H, S063G-S248N, T158S-S162G, Q103H-N218S, S033T-Q103H, and
- the invention includes a protease variant having proteolytic activity and/or a PI value of 0.9 relative to BPN'-v36 in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- subtilisin protease variant having proteolytic activity, enhanced proteolytic activity compared to BPN', or a PI value greater than that of BPN' (SEQ ID NO:2) in a BMI microswatch cleaning assay, the variant comprising an amino acid sequence having at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% identity to SEQ ID NO:2, wherein the variant comprises at least one substitution selected from the group of X001E, X009T, X018T, X021N, X024G, X033T, X040A, X043Y, X061G/P/S, X063G, X076D, X088T, X103H, X109A/G/Q/S, X116T, X128S, X131H, X141R, X158S, X162G, X169A, X204E,
- a BPN' combinatorial library based on the BPN'-v36 parent molecule was made by DNA 2.0 and delivered as a ligation reaction.
- DNA from the ligation reaction mixture was amplified before transformation and transformants grown as described in Example 2.
- the variants were tested for cleaning performance using BMI microswatch assay in Detergent Composition 4 at 16°C and pH 8 and egg microswatch assay in Detergent Composition 4 at 16°C and pH 8. Protein content was determined using the TCA assay. Assays were performed as in Example 1 and Performance Indices were calculated relative to BPN'-v36 (i.e., BPN'-S24G-S53G-S78N-S101N-G128A-Y217Q).
- BPN'-v36 variants were determined to have a PI value greater than 1.0, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2, from greater than 1.0 to about 10, from greater than 1.0 to about 8, or from greater than 1.0 to about 5 relative to BPN'-v36 in a BMI microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN'-S024G-S053G-S078N-S 101N-G128A- Y217Q amino acid sequence (SEQ ID NO:6) comprising at least one set of amino acid substitutions selected from the group consisting of A088T-A116T-N243V-K256R-L257G, A088T-A116T-N243V-L257G, A088T-T158S-N218S-K256R, A088T-T-
- Such variants have enhanced proteolytic activity compared to BPN', BPN'-v3, and BPN'-v36, and a greater PI value than BPN', BPN'-v3 and BPN'-v36 in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2), enhanced proteolytic activity compared to BPN', BPN'-v3, and BPN'-v36, a PI value of greater than 1.0 to about 5 relative to BPN'-v3, and/or a PI value of greater than 1.0 to about 5 relative to BPN'-v36 in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino
- BPN'-v36 variants were determined to have a PI value equal to about 1.0 relative to BPN'-v36 in a BMI microswatch cleaning assay (Test Method 3) in Detergent Composition 4 at pH 8 and 16°C: BPN'-S024G-S053G-S078N-S101N-G128A-Y217Q amino acid sequence (SEQ ID NO: 6) comprising at least one set of amino acid substitutions selected from the group consisting of BPN'-v36, A088T, A088T-A116T-G131H-L257G, A088T- A116T-G131H-N218S-A274T, A088T-A116T-G131H-N218S-K256R, A088T-A116T-G131H- N218S-K256R-L257G, A088T-A116T-G131H-N218S-N243V, A088T-A
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2), a PI value of 1.0 relative to BPN'-v3, and a PI value of 1.0 relative to BPN'-v36 in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN'-v36 variants were determined to have a PI value equal to about 0.9 relative to BPN'-v36 in a BMI microswatch cleaning assay (Test Method 3) in Detergent Composition 4 at H 8 and 16°C: BPN'-S024G-S053G-S078N-S101N-G128A-Y217Q amino acid sequence (SEQ ID NO: 6) comprising at least one set of amino acid substitutions selected from the group consisting of A088T-A098S-N218S-K256R, A088T-A116T-G131H-K256R, A088T-A116T-G131H-K256R-L257G-L267M, A088T-A116T-G131H-N218S
- the invention includes a protease variant having proteolytic activity and/or a PI value of 0.9 relative to BPN'-v36 in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN'-v36 variants were determined to have a PI value equal to or greater than 0.5 and less than 0.9 relative to BPN'-v36 in a BMI microswatch cleaning assay (Test Method 3) in Detergent Composition 4 at pH 8 and 16°C: BPN'-S024G-S053G-S078N-S101N- G128A-Y217Q amino acid sequence (SEQ ID NO:6) comprising at least one set of amino acid substitutions selected from the group consisting of A015S-A088T-N109G-G131H-T158S- N218S-S248N, A088T-A098S-G131H-S248N-K256R-L257G, A088T-A116T-G131H-N218S- N243V-K256R-L257G, A088T-A116T-G131H-T158S-L257G, A088T-A116T-G131H
- the invention includes a protease variant having proteolytic activity and/or a PI value equal to or greater than 0.5 and less than 0.9 relative to BPN'-v36 in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- BPN'-v36 variants were determined to have a PI value greater than 1.0, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2, from greater than 1.0 to about 10, from greater than 1.0 to about 8, or from greater than 1.0 to about 5 relative to BPN'-v36 in an egg microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN'-S024G-S053G-S078N-S101N-G128A- Y217Q amino acid sequence (SEQ ID NO:6) comprising at least one set of amino acid substitutions selected from the group consisting of A088T-N109G-A116T-T158S-N243V- L257G, A116T-N218S-N243V-L257G-N269S, A088T-A116T-K256R, A088T
- Such variants have enhanced proteolytic activity compared to BPN', BPN'-v3, and BPN'-v36, and a greater PI value than BPN', BPN'-v3 and BPN'-v36 in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2), enhanced proteolytic activity compared to BPN', BPN'-v3, and BPN'-v36, a PI value of greater than 1.0 to about 5 relative to BPN'-v3, and/or a PI value of greater than 1.0 to about 5 relative to BPN'-v36 in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino
- BPN'-v36 variants were determined to have a PI value equal to about 1.0 relative to BPN'-v36 in an egg microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN'-S024G-S053G-S078N-S101N-G128A-Y217Q amino acid sequence (SEQ ID NO: 6) comprising at least one set of amino acid substitutions selected from the group consisting of BPN'-v36, A015S-A088T-N109G-G131H-T158S-N218S-S248N, A088T, A088T-A116T- G131H-N218S-N243V-S248N, A088T-A116T-G131H-N218S-S248N, A088T-A116T-G131H- N218S-S248N, A088T-A116T-G131H- N218S-S248N
- Such variants have enhanced proteolytic activity compared to BPN' (SEQ ID NO:2) and a greater PI value than BPN' in this assay.
- the invention includes a protease variant having enhanced proteolytic activity compared to BPN' (SEQ ID NO:2), a PI value of 1.0 relative to BPN'-v3, and a PI value of 1.0 relative to BPN'-v36 in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of amino acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least
- BPN'-v36 variants were determined to have a PI value equal to or greater than 0.5 and less than 0.9 relative to BPN'-v36 in an egg microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C: BPN'-S024G-S053G-S078N-S101N-G128A- Y217Q amino acid sequence (SEQ ID NO:6) comprising at least one set of amino acid substitutions selected from the group consisting of A088T-A098S-G131H-S248N-K256R- L257G, A088T-A116T-G131H-K256R, A088T-A116T-G131H-N218S-S248N-K256R, A088T- A116T-G131H-N243V-S248N-L257G, A088T-A116T-G131H-S248N, A088T-A116T-G131H-S2
- the invention includes a protease variant having proteolytic activity and/or a PI value equal to or greater than 0.5 and less than 0.9 relative to BPN'-v36 in this assay, the variant comprising an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% or 99% identity to SEQ ID NO:2 or SEQ ID NO:6 and comprising at least one set of acid substitutions selected from said group above, wherein amino acid positions of the variant are numbered by correspondence with amino acid positions of the SEQ ID NO:2 sequence.
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- subtilisin protease variant having enhanced proteolytic activity compared to BPN'-v36 and/or BPN-'v3 and/or a PI value of greater than 1.0 compared to BPN'- v36 in a BMI microswatch or egg microswatch cleaning assay in Detergent Composition 4 at pH 8 and 16°C, the variant comprising an amino acid sequence having at least 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, or 98% identity to SEQ ID NO:2, wherein the variant comprises at least one substitution selected from the group of X001R/T, X002R, X003F/P, X004A/L/M/P, X005S, X006H, X014L, X015L/S, X016C, X017T, X018L, X019K, X020A, X021T, X022L,
- compositions including, but not limited to, e.g., cleaning compositions, comprising at least one such variant and methods for cleaning utilizing at least one such variant as described in greater detail elsewhere herein.
- the DNA from the site evaluation libraries of the BPN'-v36 was further mutagenized by error-prone PCR. These libraries were amplified with primers P4973 and P4950 (described in Example 7) using Taq DNA polymerase (Promega). Each PCR amplification reaction contained 30 pmol of each primer, 100 ng of the template DNA (SELs of the BPN'-v36) and various amount of MnC .
- the PCR reaction (20 iL) was initially heated at 95°C for 2.5 min followed by 30 cycles of denaturation at 94°C for 15 sec, annealing at 55°C for 15 sec. and extension at 72°C for 2 min.
- the DNA fragment was gel -purified by the QIAGEN® gel-band purification kit, digested by the BamHI and HzVidlll restriction enzymes and ligated with the pHPLT-BPN' partial opt vector that also was digested with the same restriction enzymes.
- Ligation mixtures were amplified using rolling circle amplification in an Illustra Templiphi kit according to the manufacturer's recommendation (GE Healthcare) to generate multimeric DNA for transformation into Bacillus subtilis. For this purpose, ⁇ of the ligation mixture was mixed with 5 ⁇ of the sample buffer, heated to 95°C for 3 min and cooled on ice.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Detergent Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Materials For Photolithography (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18181021.9A EP3434764A3 (en) | 2009-12-09 | 2010-12-09 | Fabric and home care products |
EP10796231A EP2510092A1 (en) | 2009-12-09 | 2010-12-09 | Fabric and home care products |
CA2782613A CA2782613C (en) | 2009-12-09 | 2010-12-09 | Fabric and home care products |
CN201080055885.5A CN102652175B (en) | 2009-12-09 | 2010-12-09 | Fabric and household care product |
MX2012006616A MX2012006616A (en) | 2009-12-09 | 2010-12-09 | Fabric and home care products. |
EP22182416.2A EP4159833A3 (en) | 2009-12-09 | 2010-12-09 | Fabric and home care products |
JP2012543280A JP5882904B2 (en) | 2009-12-09 | 2010-12-09 | Fabric care products and home care products |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26787809P | 2009-12-09 | 2009-12-09 | |
US61/267,878 | 2009-12-09 | ||
US39217510P | 2010-10-12 | 2010-10-12 | |
US61/392,175 | 2010-10-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011072117A1 true WO2011072117A1 (en) | 2011-06-16 |
Family
ID=43530401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/059669 WO2011072117A1 (en) | 2009-12-09 | 2010-12-09 | Fabric and home care products |
Country Status (7)
Country | Link |
---|---|
US (4) | US8785171B2 (en) |
EP (3) | EP4159833A3 (en) |
JP (1) | JP5882904B2 (en) |
CN (1) | CN102652175B (en) |
CA (1) | CA2782613C (en) |
MX (1) | MX2012006616A (en) |
WO (1) | WO2011072117A1 (en) |
Cited By (113)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2551336A1 (en) | 2011-07-25 | 2013-01-30 | The Procter & Gamble Company | Detergent compositions |
WO2013060621A1 (en) * | 2011-10-28 | 2013-05-02 | Henkel Ag & Co. Kgaa | Performance-enhanced and temperature-resistant protease variants |
EP2607468A1 (en) * | 2011-12-20 | 2013-06-26 | Henkel AG & Co. KGaA | Detergent compositions comprising subtilase variants |
EP2628785A1 (en) * | 2012-02-17 | 2013-08-21 | Henkel AG & Co. KGaA | Detergent compositions comprising subtilase variants |
US8785171B2 (en) | 2009-12-09 | 2014-07-22 | The Procter & Gamble Company | Fabric and home care products comprising cold water proteases |
CN103958657A (en) * | 2011-11-25 | 2014-07-30 | 诺维信公司 | Subtilase variants and polynucleotides encoding same |
EP2794874A1 (en) * | 2011-12-20 | 2014-10-29 | Novozymes A/S | Subtilase variants and polynucleotides encoding same |
WO2014177430A1 (en) * | 2013-04-30 | 2014-11-06 | Henkel Ag & Co. Kgaa | Cleaning agent containing proteases |
WO2014200656A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from streptomyces umbrinus |
WO2014200657A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from streptomyces xiamenensis |
WO2014200658A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from promicromonospora vindobonensis |
WO2014204596A1 (en) | 2013-06-17 | 2014-12-24 | Danisco Us Inc. | Alpha-amylase from bacillaceae family member |
WO2015050724A1 (en) | 2013-10-03 | 2015-04-09 | Danisco Us Inc. | Alpha-amylases from a subset of exiguobacterium, and methods of use, thereof |
WO2015050723A1 (en) | 2013-10-03 | 2015-04-09 | Danisco Us Inc. | Alpha-amylases from exiguobacterium, and methods of use, thereof |
WO2015077126A1 (en) | 2013-11-20 | 2015-05-28 | Danisco Us Inc. | Variant alpha-amylases having reduced susceptibility to protease cleavage, and methods of use, thereof |
WO2015112338A1 (en) | 2014-01-22 | 2015-07-30 | The Procter & Gamble Company | Method of treating textile fabrics |
WO2015112340A1 (en) | 2014-01-22 | 2015-07-30 | The Procter & Gamble Company | Method of treating textile fabrics |
WO2015112339A1 (en) | 2014-01-22 | 2015-07-30 | The Procter & Gamble Company | Fabric treatment composition |
WO2015112341A1 (en) | 2014-01-22 | 2015-07-30 | The Procter & Gamble Company | Fabric treatment composition |
US9157052B2 (en) | 2009-12-09 | 2015-10-13 | Danisco Us Inc. | Methods for cleaning using a variant protease derived from subtilisin |
WO2016081437A1 (en) | 2014-11-17 | 2016-05-26 | The Procter & Gamble Company | Benefit agent delivery compositions |
WO2016096714A1 (en) * | 2014-12-15 | 2016-06-23 | Henkel Ag & Co. Kgaa | Detergent composition comprising subtilase variants |
EP3075824A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075826A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075831A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075829A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075834A1 (en) | 2015-04-02 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075828A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075827A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075833A2 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075825A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075823A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | A spray-dried laundry detergent base particle |
EP3075830A2 (en) | 2015-04-02 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016161219A1 (en) | 2015-04-02 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3088502A1 (en) | 2015-04-29 | 2016-11-02 | The Procter and Gamble Company | Method of treating a fabric |
EP3088505A1 (en) | 2015-04-29 | 2016-11-02 | The Procter and Gamble Company | Method of treating a fabric |
EP3088506A1 (en) | 2015-04-29 | 2016-11-02 | The Procter and Gamble Company | Detergent composition |
EP3088503A1 (en) | 2015-04-29 | 2016-11-02 | The Procter and Gamble Company | Method of treating a fabric |
EP3088504A1 (en) | 2015-04-29 | 2016-11-02 | The Procter and Gamble Company | Method of treating a fabric |
EP3153425A1 (en) | 2015-10-06 | 2017-04-12 | The Procter and Gamble Company | Flexible box bag comprising detergent powder and a scoop |
US9758286B2 (en) | 2015-10-06 | 2017-09-12 | The Procter & Gamble Company | Flexible box bag comprising soluble unit dose detergent pouch |
WO2017162429A1 (en) * | 2016-03-23 | 2017-09-28 | Henkel Ag & Co. Kgaa | Proteases with improved enzyme stability in detergents |
WO2017173324A2 (en) | 2016-04-01 | 2017-10-05 | Danisco Us Inc. | Alpha-amylases, compositions & methods |
WO2017173190A2 (en) | 2016-04-01 | 2017-10-05 | Danisco Us Inc. | Alpha-amylases, compositions & methods |
EP3227425A1 (en) * | 2014-12-04 | 2017-10-11 | Novozymes A/S | Liquid cleaning compositions comprising protease variants |
EP3243896A1 (en) | 2016-05-09 | 2017-11-15 | The Procter and Gamble Company | Detergent composition comprising a fatty acid decarboxylase |
EP3243897A1 (en) | 2016-05-09 | 2017-11-15 | The Procter & Gamble Company | Detergent composition comprising a fatty acid-transforming enzyme |
EP3243898A2 (en) | 2016-05-09 | 2017-11-15 | The Procter & Gamble Company | Detergent composition comprising an oleic acid-transforming enzyme |
EP2365055B1 (en) | 2010-03-01 | 2017-12-20 | The Procter and Gamble Company | Composition comprising substituted cellulosic polymer and amylase |
WO2017215925A1 (en) * | 2016-06-15 | 2017-12-21 | Henkel Ag & Co. Kgaa | Bacillus gibsonii protease and variants thereof |
EP3269729A1 (en) | 2016-07-14 | 2018-01-17 | The Procter and Gamble Company | Detergent composition |
WO2018067493A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Spray-dried base detergent particle giving rise to a low ph in the wash |
WO2018067484A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Laundry detergent composition |
WO2018067481A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Laundry detergent composition |
WO2018067486A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Low ph laundry detergent composition |
WO2018067487A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Low ph laundry detergent composition |
WO2018067488A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Low ph laundry detergent composition |
WO2018067485A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Low ph laundry detergent composition |
WO2018067482A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Laundry detergent composition |
WO2018067483A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Laundry detergent composition |
EP3330348A1 (en) | 2016-12-02 | 2018-06-06 | The Procter & Gamble Company | Cleaning compositions including enzymes |
WO2018102479A1 (en) | 2016-12-02 | 2018-06-07 | The Procter & Gamble Company | Cleaning compositions including enzymes |
EP3339419A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339413A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339407A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339417A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339420A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339416A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339415A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339418A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339414A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
WO2018118825A1 (en) | 2016-12-22 | 2018-06-28 | The Procter & Gamble Company | Laundry detergent composition |
WO2018118917A1 (en) * | 2016-12-21 | 2018-06-28 | Danisco Us Inc. | Protease variants and uses thereof |
EP3546557A1 (en) | 2018-03-28 | 2019-10-02 | The Procter & Gamble Company | Catalase inhibition during a laundering process |
EP3546558A1 (en) | 2018-03-28 | 2019-10-02 | The Procter & Gamble Company | Laundry detergent composition |
EP3546554A1 (en) | 2018-03-28 | 2019-10-02 | The Procter & Gamble Company | Spray-drying process |
EP3546559A1 (en) | 2018-03-28 | 2019-10-02 | The Procter & Gamble Company | Laundry detergent composition |
WO2019191173A1 (en) | 2018-03-28 | 2019-10-03 | The Procter & Gamble Company | Process for preparing a spray-dried laundry detergent particle |
WO2019191172A1 (en) | 2018-03-28 | 2019-10-03 | The Procter & Gamble Company | Process for preparing a spray-dried laundry detergent particle |
WO2019191171A1 (en) | 2018-03-28 | 2019-10-03 | The Procter & Gamble Company | Laundry detergent composition |
EP3594319A1 (en) | 2018-07-12 | 2020-01-15 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
US10731111B2 (en) | 2015-11-25 | 2020-08-04 | Conopco, Inc. | Liquid laundry detergent composition |
WO2020222996A1 (en) | 2019-04-29 | 2020-11-05 | The Procter & Gamble Company | A process for making a laundry detergent composition |
EP3754010A1 (en) | 2019-06-17 | 2020-12-23 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition comprises a detersive surfactant and a linear polyamine salt |
EP3798290A1 (en) | 2019-09-30 | 2021-03-31 | The Procter & Gamble Company | Use of an anionically-modified cellulosic polymer as a dye transfer inhibitor during a textile laundering process |
EP3936595A1 (en) | 2020-07-06 | 2022-01-12 | The Procter & Gamble Company | A process for making a particulate laundry detergent composition |
EP3943603A1 (en) * | 2020-07-22 | 2022-01-26 | Technische Universität Darmstadt | Rapid transformation method for gram-positive bacteria |
WO2022077022A1 (en) | 2020-10-09 | 2022-04-14 | The Procter & Gamble Company | Packaged laundry detergent product |
WO2022106400A1 (en) * | 2020-11-18 | 2022-05-27 | Novozymes A/S | Combination of immunochemically different proteases |
EP4108756A1 (en) | 2021-06-25 | 2022-12-28 | The Procter & Gamble Company | A laundry detergent powder |
EP4108754A1 (en) | 2021-06-25 | 2022-12-28 | The Procter & Gamble Company | A process for making a packaged laundry detergent powder |
EP4123005A1 (en) | 2021-07-19 | 2023-01-25 | The Procter & Gamble Company | Cleaning composition comprising bacterial spores |
EP4212608A1 (en) | 2022-01-14 | 2023-07-19 | The Procter & Gamble Company | A method of making a spray-dried laundry detergent particle |
WO2023150905A1 (en) | 2022-02-08 | 2023-08-17 | The Procter & Gamble Company | A method of laundering fabric |
WO2023150903A1 (en) | 2022-02-08 | 2023-08-17 | The Procter & Gamble Company | A method of laundering fabric |
EP4234666A1 (en) | 2022-02-24 | 2023-08-30 | The Procter & Gamble Company | Water-soluble unit dose article comprising a fibrous non-woven sheet and a surfactant system |
EP4234672A1 (en) | 2022-02-24 | 2023-08-30 | The Procter & Gamble Company | Water-soluble unit dose article comprising a fibrous non-woven sheet and a hueing dye particle |
EP4279570A1 (en) | 2022-05-19 | 2023-11-22 | The Procter & Gamble Company | A process for making a particulate laundry detergent composition |
WO2023225459A2 (en) | 2022-05-14 | 2023-11-23 | Novozymes A/S | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
EP4299702A1 (en) | 2022-06-27 | 2024-01-03 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
EP4299701A1 (en) | 2022-06-27 | 2024-01-03 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
EP4299704A1 (en) | 2022-06-27 | 2024-01-03 | The Procter & Gamble Company | A method of laundering and drying fabric |
EP4299703A1 (en) | 2022-06-27 | 2024-01-03 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
EP4342969A1 (en) | 2022-09-21 | 2024-03-27 | The Procter & Gamble Company | A solid detergent cleaning composition |
EP4342970A1 (en) | 2022-09-21 | 2024-03-27 | Milliken & Company | Coloured fabric hueing dye agent particles |
EP4364930A1 (en) | 2022-11-01 | 2024-05-08 | The Procter & Gamble Company | Sealing jaws and water-soluble unit dose article comprising a fibrous non-woven sheet |
EP4364929A1 (en) | 2022-11-01 | 2024-05-08 | The Procter & Gamble Company | Sealing jaws and water-soluble unit dose article comprising a fibrous non-woven sheet |
EP4382592A1 (en) | 2022-12-06 | 2024-06-12 | The Procter & Gamble Company | Water-soluble unit dose article comprising a fibrous non-woven sheet and a surfactant system |
EP4389867A1 (en) | 2022-12-23 | 2024-06-26 | The Procter & Gamble Company | A process of making a laundry detergent article |
EP4389866A1 (en) | 2022-12-23 | 2024-06-26 | The Procter & Gamble Company | A process of making a water-soluble detergent unit dose article |
WO2024163584A1 (en) * | 2023-02-01 | 2024-08-08 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2024163600A1 (en) * | 2023-02-01 | 2024-08-08 | Danisco Us Inc. | Subtilisin variants and methods of use |
EP4403631A3 (en) * | 2014-10-27 | 2024-10-30 | Danisco US Inc. | Serine proteases |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090060933A1 (en) * | 2004-06-14 | 2009-03-05 | Estell David A | Proteases producing an altered immunogenic response and methods of making and using the same |
US9828597B2 (en) | 2006-11-22 | 2017-11-28 | Toyota Motor Engineering & Manufacturing North America, Inc. | Biofunctional materials |
US20110256610A1 (en) * | 2008-06-06 | 2011-10-20 | Viktor Yuryevich Alekseyev | Compositions And Methods Comprising Variant Microbial Proteases |
EP3031894A1 (en) | 2008-11-11 | 2016-06-15 | Danisco US Inc. | Proteases comprising one or more combinable mutations |
US20100192985A1 (en) * | 2008-11-11 | 2010-08-05 | Wolfgang Aehle | Compositions and methods comprising serine protease variants |
CN102858970B (en) * | 2010-04-15 | 2017-07-21 | 丹尼斯科美国公司 | Composition and method comprising misfolded proteins enzyme |
JP5813753B2 (en) * | 2010-05-06 | 2015-11-17 | ザ プロクター アンド ギャンブルカンパニー | Consumer products with protease variants |
US9388370B2 (en) * | 2010-06-21 | 2016-07-12 | Toyota Motor Engineering & Manufacturing North America, Inc. | Thermolysin-like protease for cleaning insect body stains |
US9121016B2 (en) | 2011-09-09 | 2015-09-01 | Toyota Motor Engineering & Manufacturing North America, Inc. | Coatings containing polymer modified enzyme for stable self-cleaning of organic stains |
US10988714B2 (en) | 2010-06-21 | 2021-04-27 | Regents Of The University Of Minnesota | Methods of facilitating removal of a fingerprint from a substrate or a coating |
US8796009B2 (en) | 2010-06-21 | 2014-08-05 | Toyota Motor Engineering & Manufacturing North America, Inc. | Clearcoat containing thermolysin-like protease from Bacillus stearothermophilus for cleaning of insect body stains |
US11015149B2 (en) | 2010-06-21 | 2021-05-25 | Toyota Motor Corporation | Methods of facilitating removal of a fingerprint |
TR201901382T4 (en) * | 2011-05-05 | 2019-02-21 | Danisco Inc | Compositions and methods comprising serine protease variants. |
BR112013028440A2 (en) * | 2011-05-05 | 2016-11-29 | Procter & Gamble | compositions and methods comprising serine protease variants |
US20130123162A1 (en) * | 2011-11-10 | 2013-05-16 | The Procter & Gamble Company | Consumer products |
WO2013142486A1 (en) * | 2012-03-19 | 2013-09-26 | The Procter & Gamble Company | Laundry care compositions containing dyes |
MX349739B (en) * | 2012-03-20 | 2017-08-10 | Firmenich & Cie | Compounds for a controlled release of active perfuming molecules. |
FI3013956T3 (en) * | 2013-06-27 | 2023-05-23 | Novozymes As | Subtilase variants and polynucleotides encoding same |
EP3116982B2 (en) * | 2014-03-12 | 2022-03-02 | The Procter & Gamble Company | Detergent composition |
JP2018501374A (en) | 2014-12-23 | 2018-01-18 | ルブリゾル アドバンスド マテリアルズ, インコーポレイテッド | Laundry detergent composition |
KR20170098306A (en) | 2014-12-23 | 2017-08-29 | 루브리졸 어드밴스드 머티어리얼스, 인코포레이티드 | A laundry detergent composition stabilized with an amphiphilic rheology modifier crosslinked with an amphiphilic crosslinking agent |
EP3316973B1 (en) * | 2015-06-30 | 2019-08-07 | Firmenich SA | Delivery system with improved deposition |
EP3173467A1 (en) | 2015-11-26 | 2017-05-31 | The Procter & Gamble Company | Cleaning compositions comprising enzymes |
CA3018865A1 (en) | 2016-03-31 | 2017-10-05 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
WO2017173241A1 (en) | 2016-03-31 | 2017-10-05 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
WO2017192692A1 (en) * | 2016-05-03 | 2017-11-09 | Danisco Us Inc | Protease variants and uses thereof |
US10494592B2 (en) * | 2016-05-20 | 2019-12-03 | The Procter & Gamble Company | Detergent composition comprising anionic/nonionic/cationic surfactant system and encapsulates |
US10457900B2 (en) * | 2016-05-20 | 2019-10-29 | The Proctor & Gamble Company | Detergent composition comprising an alkyl ether sulfate-rich surfactant system and coated encapsulates |
CN106120333A (en) * | 2016-06-27 | 2016-11-16 | 苏州宇希新材料科技有限公司 | A kind of preparation method of Graphene/Caulis et Folium Lini composite fibre |
CN106120024A (en) * | 2016-06-27 | 2016-11-16 | 苏州宇希新材料科技有限公司 | A kind of preparation method of graphene fiber |
CN105887244B (en) * | 2016-06-27 | 2018-02-27 | 苏州宇希新材料科技有限公司 | A kind of graphene fiber |
US20180119066A1 (en) * | 2016-11-01 | 2018-05-03 | The Procter & Gamble Company | Leuco polymers as bluing agents in laundry care compositions |
AU2017365019A1 (en) | 2016-11-23 | 2019-07-11 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
US10550443B2 (en) | 2016-12-02 | 2020-02-04 | The Procter & Gamble Company | Cleaning compositions including enzymes |
CN107980060B (en) * | 2017-01-09 | 2021-05-25 | 深圳市邦泰绿色生物合成研究院 | Preparation method of 3 alpha-hydroxy-7 oxo-5 beta-cholanic acid and enzyme 2 for preparation |
WO2018204812A1 (en) | 2017-05-04 | 2018-11-08 | Lubrizol Advanced Materials, Inc. | Dual activated microgel |
CA3068144A1 (en) | 2017-06-30 | 2019-01-03 | Flemming Skou | Membrane cleaning solution and method of accelerated membrane cleaning using the same |
EP3810658A1 (en) | 2018-06-20 | 2021-04-28 | The Procter & Gamble Company | A product comprising polysaccharide derivatives |
EP3976775A1 (en) | 2019-05-24 | 2022-04-06 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
EP4061917A1 (en) | 2019-11-19 | 2022-09-28 | Lubrizol Advanced Materials, Inc. | Redeposition inhibiting polymers and detergent compositions containing same |
JP2023507573A (en) | 2019-12-19 | 2023-02-24 | ルブリゾル アドバンスド マテリアルズ, インコーポレイテッド | REDEPOSITION INHIBITING POLYMERS AND DETERGENT COMPOSITIONS CONTAINING THEM |
CN112908417A (en) * | 2020-12-30 | 2021-06-04 | 浙江工业大学 | Gene mining method combining functional sequence and structure simulation, NADH (nicotinamide adenine dinucleotide) preference type glufosinate dehydrogenase mutant and application |
US20230242850A1 (en) * | 2022-01-28 | 2023-08-03 | The Procter & Gamble Company | Container systems with water-soluble pouches |
US11464384B1 (en) | 2022-03-31 | 2022-10-11 | Techtronic Cordless Gp | Water soluable package for a floor cleaner |
CN116926049B (en) * | 2022-04-24 | 2024-07-23 | 南京百斯杰生物工程有限公司 | Subtilase mutants and uses thereof |
US20240263162A1 (en) * | 2023-02-01 | 2024-08-08 | The Procter & Gamble Company | Detergent compositions containing enzymes |
Citations (140)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3594328A (en) | 1965-08-02 | 1971-07-20 | Ciba Ltd | Process for the encapsulation of dispersible materials |
US3812011A (en) | 1971-09-30 | 1974-05-21 | Hayashibara Biochem Lab | Method of converting starch to beta-cyclodextrin |
US4234627A (en) | 1977-02-04 | 1980-11-18 | The Procter & Gamble Company | Fabric conditioning compositions |
US4317881A (en) | 1979-04-07 | 1982-03-02 | Sanraku-Ocean Co., Ltd. | Process for producing cyclodextrins |
US4378923A (en) | 1981-07-09 | 1983-04-05 | Nippon Kokan Kabushiki Kaisha | Binding device for elongated pipes |
US4418144A (en) | 1981-03-06 | 1983-11-29 | Nihon Shokuhin Kako Co., Ltd. | Process for producing gamma-cyclodextrins |
US4430243A (en) | 1981-08-08 | 1984-02-07 | The Procter & Gamble Company | Bleach catalyst compositions and use thereof in laundry bleaching and detergent compositions |
US4514461A (en) | 1981-08-10 | 1985-04-30 | Woo Yen Kong | Fragrance impregnated fabric |
US4539135A (en) | 1983-06-01 | 1985-09-03 | Colgate Palmolive Co. | Perfume-containing carrier for laundry compositions |
US4540721A (en) | 1983-03-10 | 1985-09-10 | The Procter & Gamble Company | Method of providing odor to product container |
USRE32713E (en) | 1980-03-17 | 1988-07-12 | Capsule impregnated fabric | |
US4760025A (en) | 1984-05-29 | 1988-07-26 | Genencor, Inc. | Modified enzymes and methods for making same |
US4762636A (en) | 1986-02-28 | 1988-08-09 | Ciba-Geigy Corporation | Process for the preparation of granules containing an active substance and to the use thereof as speckles for treating substrates |
WO1989006270A1 (en) | 1988-01-07 | 1989-07-13 | Novo-Nordisk A/S | Enzymatic detergent |
US4882220A (en) | 1988-02-02 | 1989-11-21 | Kanebo, Ltd. | Fibrous structures having a durable fragrance |
US4911852A (en) | 1988-10-07 | 1990-03-27 | The Procter & Gamble Company | Liquid laundry detergent with curable amine functional silicone for fabric wrinkle reduction |
US4973422A (en) | 1989-01-17 | 1990-11-27 | The Procter & Gamble Company | Perfume particles for use in cleaning and conditioning compositions |
US4990280A (en) | 1988-03-14 | 1991-02-05 | Danochemo A/S | Photoactivator dye composition for detergent use |
WO1994002597A1 (en) | 1992-07-23 | 1994-02-03 | Novo Nordisk A/S | MUTANT α-AMYLASE, DETERGENT, DISH WASHING AGENT, AND LIQUEFACTION AGENT |
WO1994018314A1 (en) | 1993-02-11 | 1994-08-18 | Genencor International, Inc. | Oxidatively stable alpha-amylase |
US5352604A (en) | 1989-08-25 | 1994-10-04 | Henkel Research Corporation | Alkaline proteolytic enzyme and method of production |
US5486303A (en) | 1993-08-27 | 1996-01-23 | The Procter & Gamble Company | Process for making high density detergent agglomerates using an anhydrous powder additive |
US5489392A (en) | 1994-09-20 | 1996-02-06 | The Procter & Gamble Company | Process for making a high density detergent composition in a single mixer/densifier with selected recycle streams for improved agglomerate properties |
US5500137A (en) | 1994-10-20 | 1996-03-19 | The Procter & Gamble Company | Fabric softening bar compositions containing fabric softener and enduring perfume |
US5500154A (en) | 1994-10-20 | 1996-03-19 | The Procter & Gamble Company | Detergent compositions containing enduring perfume |
US5500138A (en) | 1994-10-20 | 1996-03-19 | The Procter & Gamble Company | Fabric softener compositions with improved environmental impact |
US5506201A (en) | 1994-04-29 | 1996-04-09 | International Flavors & Fragrances Inc. | Formulation of a fat surfactant vehicle containing a fragrance |
US5516448A (en) | 1994-09-20 | 1996-05-14 | The Procter & Gamble Company | Process for making a high density detergent composition which includes selected recycle streams for improved agglomerate |
WO1996023873A1 (en) | 1995-02-03 | 1996-08-08 | Novo Nordisk A/S | Amylase variants |
WO1996023874A1 (en) | 1995-02-03 | 1996-08-08 | Novo Nordisk A/S | A method of designing alpha-amylase mutants with predetermined properties |
US5552378A (en) | 1990-03-06 | 1996-09-03 | The Procter & Gamble Company | Solid consumer product compositions containing small particle cyclodextrin complexes |
US5565422A (en) | 1995-06-23 | 1996-10-15 | The Procter & Gamble Company | Process for preparing a free-flowing particulate detergent composition having improved solubility |
US5569645A (en) | 1995-04-24 | 1996-10-29 | The Procter & Gamble Company | Low dosage detergent composition containing optimum proportions of agglomerates and spray dried granules for improved flow properties |
US5574005A (en) | 1995-03-07 | 1996-11-12 | The Procter & Gamble Company | Process for producing detergent agglomerates from high active surfactant pastes having non-linear viscoelastic properties |
US5576282A (en) | 1995-09-11 | 1996-11-19 | The Procter & Gamble Company | Color-safe bleach boosters, compositions and laundry methods employing same |
WO1997000324A1 (en) | 1995-06-14 | 1997-01-03 | Kao Corporation | Gene encoding alkaline liquefying alpha-amylase |
US5595967A (en) | 1995-02-03 | 1997-01-21 | The Procter & Gamble Company | Detergent compositions comprising multiperacid-forming bleach activators |
US5597936A (en) | 1995-06-16 | 1997-01-28 | The Procter & Gamble Company | Method for manufacturing cobalt catalysts |
US5651976A (en) | 1993-06-17 | 1997-07-29 | The United States Of America As Represented By The Secretary Of The Navy | Controlled release of active agents using inorganic tubules |
US5679630A (en) | 1993-10-14 | 1997-10-21 | The Procter & Gamble Company | Protease-containing cleaning compositions |
WO1997043424A1 (en) | 1996-05-14 | 1997-11-20 | Genencor International, Inc. | MODIFIED α-AMYLASES HAVING ALTERED CALCIUM BINDING PROPERTIES |
US5691297A (en) | 1994-09-20 | 1997-11-25 | The Procter & Gamble Company | Process for making a high density detergent composition by controlling agglomeration within a dispersion index |
WO1998017767A1 (en) | 1996-10-18 | 1998-04-30 | The Procter & Gamble Company | Detergent compositions |
US5780404A (en) | 1996-02-26 | 1998-07-14 | The Procter & Gamble Company | Detergent compositions containing enduring perfume |
US5856164A (en) | 1994-03-29 | 1999-01-05 | Novo Nordisk A/S | Alkaline bacillus amylase |
US5858959A (en) | 1997-02-28 | 1999-01-12 | Procter & Gamble Company | Delivery systems comprising zeolites and a starch hydrolysate glass |
US5879584A (en) | 1994-09-10 | 1999-03-09 | The Procter & Gamble Company | Process for manufacturing aqueous compositions comprising peracids |
WO1999023211A1 (en) | 1997-10-30 | 1999-05-14 | Novo Nordisk A/S | α-AMYLASE MUTANTS |
US5958870A (en) | 1996-04-01 | 1999-09-28 | The Procter & Gamble Company | Betaine ester compounds of active alcohols |
WO1999053038A2 (en) * | 1998-04-15 | 1999-10-21 | Genencor International, Inc. | Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
US6024943A (en) | 1996-12-23 | 2000-02-15 | Ness; Jeremy Nicholas | Particles containing absorbed liquids and methods of making them |
US6042792A (en) | 1997-09-18 | 2000-03-28 | International Flavors & Fragrances Inc. | Apparatus for preparing a solid phase microparticulate composition |
US6048830A (en) | 1996-03-22 | 2000-04-11 | The Procter & Gamble Company | Delivery system having release barrier loaded zeolite |
US6051540A (en) | 1998-11-05 | 2000-04-18 | International Flavors & Fragrances Inc. | Method employing drum chilling and apparatus therefor for producing fragrance-containing long lasting solid particle |
WO2000032601A2 (en) | 1998-11-30 | 2000-06-08 | The Procter & Gamble Company | Process for preparing cross-bridged tetraaza macrocycles |
US6093562A (en) | 1996-02-05 | 2000-07-25 | Novo Nordisk A/S | Amylase variants |
US6093691A (en) | 1996-08-19 | 2000-07-25 | The Procter & Gamble Company | Rinse added fabric softening compositions and method of use for the delivery of fragrance derivatives |
EP1022334A2 (en) | 1998-12-21 | 2000-07-26 | Kao Corporation | Novel amylases |
US6096918A (en) | 1998-02-13 | 2000-08-01 | Givaudan Roure (International) Sa | Aryl-acrylic acid esters |
US6103678A (en) | 1996-11-07 | 2000-08-15 | The Procter & Gamble Company | Compositions comprising a perfume and an amino-functional polymer |
US6106875A (en) | 1997-10-08 | 2000-08-22 | Givaudan Roure (International) Sa | Method of encapsulating flavors and fragrances by controlled water transport into microcapsules |
WO2000060060A2 (en) | 1999-03-31 | 2000-10-12 | Novozymes A/S | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
US6133228A (en) | 1998-05-28 | 2000-10-17 | Firmenich Sa | Slow release of fragrant compounds in perfumery using 2-benzoyl benzoates, 2-alkanoyl benzoates or α-keto esters |
US6147037A (en) | 1996-08-19 | 2000-11-14 | The Procter & Gamble Company | Fragrance delivery systems |
US6165953A (en) | 1996-12-19 | 2000-12-26 | The Procter & Gamble Company | Dryer added fabric softening compositions and method of use for the delivery of fragrance derivatives |
EP1070115A2 (en) | 1998-04-07 | 2001-01-24 | Unilever Plc | Coloured granular composition for use in particulate detergent compositions |
US6200949B1 (en) | 1999-12-21 | 2001-03-13 | International Flavors And Fragrances Inc. | Process for forming solid phase controllably releasable fragrance-containing consumable articles |
US6225464B1 (en) | 1997-03-07 | 2001-05-01 | The Procter & Gamble Company | Methods of making cross-bridged macropolycycles |
US6245732B1 (en) | 1996-03-22 | 2001-06-12 | The Procter Gamble Co. | Delivery system having release inhibitor loaded zeolite and method for making same |
US6277796B1 (en) | 1996-12-19 | 2001-08-21 | The Procter & Gamble Company | Dryer-activated fabric conditioning and antistatic compositions with improved perfume longevity |
US6291412B1 (en) | 1998-05-18 | 2001-09-18 | Ciba Specialty Chemicals Corporation | Water-soluble granules of phthalocyanine compounds |
US6306812B1 (en) | 1997-03-07 | 2001-10-23 | Procter & Gamble Company, The | Bleach compositions containing metal bleach catalyst, and bleach activators and/or organic percarboxylic acids |
US6312936B1 (en) | 1997-10-23 | 2001-11-06 | Genencor International, Inc. | Multiply-substituted protease variants |
US6316397B1 (en) | 1997-06-27 | 2001-11-13 | The Procter & Gamble Co. | Pro-fragrance linear acetals and ketals |
US6326348B1 (en) | 1996-04-16 | 2001-12-04 | The Procter & Gamble Co. | Detergent compositions containing selected mid-chain branched surfactants |
US6413920B1 (en) | 1998-07-10 | 2002-07-02 | Procter & Gamble Company | Amine reaction compounds comprising one or more active ingredient |
US6437150B1 (en) | 1998-04-20 | 2002-08-20 | Givaudan Sa | Compounds having protected hydroxy groups |
US6458754B1 (en) | 1998-04-23 | 2002-10-01 | The Procter & Gamble Company | Encapsulated perfume particles and detergent compositions containing said particles |
US6479682B1 (en) | 1998-04-20 | 2002-11-12 | Givaudan Sa | Compounds having protected hydroxy groups |
US6491728B2 (en) | 1994-10-20 | 2002-12-10 | The Procter & Gamble Company | Detergent compositions containing enduring perfume |
US20030036489A1 (en) | 2001-05-04 | 2003-02-20 | The Procter & Gamble Company | Consumable composition comprising perfumed particles and article containing the same |
WO2003015736A2 (en) | 2001-08-16 | 2003-02-27 | Quest International B.V. | Perfume-containing composition |
US6531444B1 (en) | 2000-11-09 | 2003-03-11 | Salvona, Llc | Controlled delivery system for fabric care products |
US6544945B1 (en) | 1998-02-24 | 2003-04-08 | The Procter & Gamble Company | Cyclic pro-perfumes having modifiable fragrance raw material alcohol release rates |
US20030087790A1 (en) | 2001-08-20 | 2003-05-08 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Photobleach speckle and laundry detergent compositions containing it |
US20030087791A1 (en) | 2001-08-20 | 2003-05-08 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Photobleach speckle and laundry detergent compositions containing it |
US6566112B2 (en) | 1997-11-19 | 2003-05-20 | Genencor International, Inc. | Cellulase producing actinomycetes, cellulase produced therefrom and method of producing same |
US20030125222A1 (en) | 2000-01-05 | 2003-07-03 | Ekkehard Jahns | Microcapsule preparations and detergents and cleaning agents containing microcapsules |
WO2003062381A2 (en) * | 2002-01-16 | 2003-07-31 | Genencor International, Inc. | Multiply-substituted protease variants |
US20030158344A1 (en) | 2002-02-08 | 2003-08-21 | Rodriques Klein A. | Hydrophobe-amine graft copolymer |
US6610646B2 (en) | 2000-06-01 | 2003-08-26 | The Procter & Gamble Company | Enhanced duration fragrance delivery system having a non-distorted initial fragrance impression |
US20030165692A1 (en) | 2002-01-24 | 2003-09-04 | Friedrich Koch | Coagulates containing microcapsules |
US20030195133A1 (en) | 2002-04-10 | 2003-10-16 | Adi Shefer | Targeted controlled delivery compositions activated by changes in pH or salt concentration |
US20030199422A1 (en) | 2000-06-02 | 2003-10-23 | Birkbeck Anthony Alexander | Perfumes |
US20030203829A1 (en) | 2002-04-26 | 2003-10-30 | Adi Shefer | Multi component controlled delivery system for fabric care products |
US6645479B1 (en) | 1997-09-18 | 2003-11-11 | International Flavors & Fragrances Inc. | Targeted delivery of active/bioactive and perfuming compositions |
US20030216488A1 (en) | 2002-04-18 | 2003-11-20 | The Procter & Gamble Company | Compositions comprising a dispersant and microcapsules containing an active material |
US20030215417A1 (en) | 2002-04-18 | 2003-11-20 | The Procter & Gamble Company | Malodor-controlling compositions comprising odor control agents and microcapsules containing an active material |
US20040048764A1 (en) | 2002-09-11 | 2004-03-11 | Kim Dong Gyu | Complex salt for anti-spotting detergents |
US20040058845A1 (en) | 2002-09-05 | 2004-03-25 | Metrot Veronique Sylvie | Structured liquid fabric treatment compositions |
US20040071742A1 (en) | 2002-10-10 | 2004-04-15 | Popplewell Lewis Michael | Encapsulated fragrance chemicals |
US20040072719A1 (en) | 2002-10-10 | 2004-04-15 | Bennett Sydney William | Encapsulated fragrance chemicals |
US20040071746A1 (en) | 2002-10-10 | 2004-04-15 | Popplewell Lewis Michael | Encapsulated fragrance chemicals |
US20040087477A1 (en) | 2001-03-16 | 2004-05-06 | Ness Jeremy Nicholas | Perfume encapsulates |
US20040087476A1 (en) | 2002-11-01 | 2004-05-06 | Dykstra Robert Richard | Polymeric assisted delivery using separate addition |
US20040091445A1 (en) | 2002-11-01 | 2004-05-13 | The Procter & Gamble Company | Rinse-off personal care compositions comprising cationic perfume polymeric particles |
US20040092425A1 (en) | 2002-11-04 | 2004-05-13 | The Procter & Gamble Company | Liquid laundry detergent |
US20040092414A1 (en) | 2002-11-01 | 2004-05-13 | Clapp Mannie Lee | Rinse-off personal care compositions comprising anionic and/or nonionic perfume polymeric particles |
US20040106536A1 (en) | 2000-03-20 | 2004-06-03 | Jean Mane | Solid perfumed preparation in the form of microbeads and the use thereof |
US20040110648A1 (en) | 2002-11-01 | 2004-06-10 | Jordan Glenn Thomas | Perfume polymeric particles |
US20040220074A1 (en) | 2001-12-13 | 2004-11-04 | Charles Fehr | Compounds for a controlled release of active molecules |
US20050003980A1 (en) | 2003-06-27 | 2005-01-06 | The Procter & Gamble Company | Lipophilic fluid cleaning compositions capable of delivering scent |
US6861402B1 (en) | 1999-06-01 | 2005-03-01 | The Procter & Gamble Company | Pro-fragrances |
WO2005042532A1 (en) | 2003-10-31 | 2005-05-12 | Unilever Plc | Bispidon-derivated ligands and complex for catalytically bleaching a substrate |
WO2005052161A2 (en) | 2003-11-19 | 2005-06-09 | Genencor International, Inc. | Serine proteases, nucleic acids encoding serine enzymes and vectors and host cells incorporating same |
US6939702B1 (en) | 1999-03-31 | 2005-09-06 | Novozymes A/S | Lipase variant |
US20050227891A1 (en) | 2002-09-04 | 2005-10-13 | Pierre Dreyer | Formulations comprising water-soluble granulates |
US6956013B2 (en) | 2001-04-10 | 2005-10-18 | The Procter & Gamble Company | Photo-activated pro-fragrances |
WO2005102261A1 (en) | 2004-03-26 | 2005-11-03 | Dow Corning Corporation | Controlled release compositions |
US20060003913A1 (en) | 2004-06-30 | 2006-01-05 | The Procter & Gamble Company | Perfumed liquid laundry detergent compositions with functionalized silicone fabric care agents |
WO2006002643A2 (en) | 2004-07-05 | 2006-01-12 | Novozymes A/S | Alpha-amylase variants with altered properties |
US6987084B2 (en) | 2000-11-08 | 2006-01-17 | The Procter & Gamble Co. | Photo-labile pro-fragrance conjugates |
US20060020459A1 (en) | 2004-07-21 | 2006-01-26 | Carter John A | System and method for immigration tracking and intelligence |
US20060039934A1 (en) | 2002-08-14 | 2006-02-23 | Ness Jeremy N | Compositions comprising encapsulated material |
US7018978B2 (en) | 1998-10-23 | 2006-03-28 | Procter & Gamble Company | Fragrance pro-accords and aldehyde and ketone fragrance libraries |
US7071151B2 (en) | 2001-09-11 | 2006-07-04 | Procter & Gamble Company | Compositions comprising photo-labile perfume delivery |
US20060263313A1 (en) | 2005-05-19 | 2006-11-23 | Scavone Timothy A | Consumer noticeable improvement in wetness protection |
US7153818B2 (en) | 2000-07-28 | 2006-12-26 | Henkel Kgaa | Amylolytic enzyme extracted from bacillus sp. A 7-7 (DSM 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
WO2007044993A2 (en) | 2005-10-12 | 2007-04-19 | Genencor International, Inc. | Use and production of storage-stable neutral metalloprotease |
US7208459B2 (en) | 2004-06-29 | 2007-04-24 | The Procter & Gamble Company | Laundry detergent compositions with efficient hueing dye |
US7262042B2 (en) | 2001-12-20 | 2007-08-28 | Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) | Alkaline protease from Bacillus gibsonii (DSM 14393) and washing and cleaning products comprising said alkaline protease |
US20070275866A1 (en) | 2006-05-23 | 2007-11-29 | Robert Richard Dykstra | Perfume delivery systems for consumer goods |
WO2008002472A2 (en) * | 2006-06-23 | 2008-01-03 | Danisco Us Inc., Genencor Division | Systematic evaluation of sequence and activity relationships using site evaluation libraries for engineering multiple properties |
US20080305982A1 (en) | 2007-06-11 | 2008-12-11 | Johan Smets | Benefit agent containing delivery particle |
WO2008153925A2 (en) * | 2007-06-06 | 2008-12-18 | Danisco Us, Inc., Genencor Division | Methods for improving multiple protein properties |
WO2009021867A2 (en) | 2007-08-10 | 2009-02-19 | Henkel Ag & Co. Kgaa | Agents containing proteases |
US20090217464A1 (en) | 2008-02-29 | 2009-09-03 | Philip Frank Souter | Detergent composition comprising lipase |
US20090247449A1 (en) | 2008-03-26 | 2009-10-01 | John Allen Burdis | Delivery particle |
WO2009149145A2 (en) * | 2008-06-06 | 2009-12-10 | Danisco Us Inc., Genencor Division | Compositions and methods comprising variant microbial proteases |
WO2010056640A2 (en) * | 2008-11-11 | 2010-05-20 | Danisco Us Inc. | Compositions and methods comprising serine protease variants |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6093A (en) | 1849-02-06 | Horatio allen | ||
US562A (en) | 1838-01-09 | Scale beam and weight | ||
ATE217346T1 (en) * | 1992-09-24 | 2002-05-15 | Genencor Int | NEW CLEANING AGENT COMPOSITIONS CONTAINING ALKALINE PROTEASES |
ES2364776T3 (en) * | 1994-02-24 | 2011-09-14 | HENKEL AG & CO. KGAA | IMPROVED AND DETERGENT ENZYMES THAT CONTAIN THEM. |
GB0207647D0 (en) | 2002-04-03 | 2002-05-15 | Dow Corning | Emulsions |
US7985569B2 (en) * | 2003-11-19 | 2011-07-26 | Danisco Us Inc. | Cellulomonas 69B4 serine protease variants |
US7999035B2 (en) * | 2005-04-15 | 2011-08-16 | Basf Aktiengesellschaft | Amphiphilic water-soluble alkoxylated polyalkylenimines with an internal polyethylene oxide block and an external polypropylene oxide block |
EP2100948A1 (en) * | 2008-03-14 | 2009-09-16 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP2100947A1 (en) * | 2008-03-14 | 2009-09-16 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
WO2011072117A1 (en) | 2009-12-09 | 2011-06-16 | The Procter & Gamble Company | Fabric and home care products |
-
2010
- 2010-12-09 WO PCT/US2010/059669 patent/WO2011072117A1/en active Application Filing
- 2010-12-09 CA CA2782613A patent/CA2782613C/en active Active
- 2010-12-09 CN CN201080055885.5A patent/CN102652175B/en active Active
- 2010-12-09 JP JP2012543280A patent/JP5882904B2/en active Active
- 2010-12-09 EP EP22182416.2A patent/EP4159833A3/en active Pending
- 2010-12-09 EP EP10796231A patent/EP2510092A1/en not_active Withdrawn
- 2010-12-09 US US12/963,681 patent/US8785171B2/en active Active
- 2010-12-09 EP EP18181021.9A patent/EP3434764A3/en active Pending
- 2010-12-09 MX MX2012006616A patent/MX2012006616A/en active IP Right Grant
-
2014
- 2014-03-12 US US14/205,835 patent/US20140193888A1/en not_active Abandoned
-
2017
- 2017-12-13 US US15/839,900 patent/US10900000B2/en active Active
-
2020
- 2020-11-18 US US16/951,344 patent/US20210071113A1/en active Pending
Patent Citations (149)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3594328A (en) | 1965-08-02 | 1971-07-20 | Ciba Ltd | Process for the encapsulation of dispersible materials |
US3812011A (en) | 1971-09-30 | 1974-05-21 | Hayashibara Biochem Lab | Method of converting starch to beta-cyclodextrin |
US4234627A (en) | 1977-02-04 | 1980-11-18 | The Procter & Gamble Company | Fabric conditioning compositions |
US4317881A (en) | 1979-04-07 | 1982-03-02 | Sanraku-Ocean Co., Ltd. | Process for producing cyclodextrins |
USRE32713E (en) | 1980-03-17 | 1988-07-12 | Capsule impregnated fabric | |
US4418144A (en) | 1981-03-06 | 1983-11-29 | Nihon Shokuhin Kako Co., Ltd. | Process for producing gamma-cyclodextrins |
US4378923A (en) | 1981-07-09 | 1983-04-05 | Nippon Kokan Kabushiki Kaisha | Binding device for elongated pipes |
US4430243A (en) | 1981-08-08 | 1984-02-07 | The Procter & Gamble Company | Bleach catalyst compositions and use thereof in laundry bleaching and detergent compositions |
US4514461A (en) | 1981-08-10 | 1985-04-30 | Woo Yen Kong | Fragrance impregnated fabric |
US4540721A (en) | 1983-03-10 | 1985-09-10 | The Procter & Gamble Company | Method of providing odor to product container |
US4539135A (en) | 1983-06-01 | 1985-09-03 | Colgate Palmolive Co. | Perfume-containing carrier for laundry compositions |
US4760025A (en) | 1984-05-29 | 1988-07-26 | Genencor, Inc. | Modified enzymes and methods for making same |
US4762636A (en) | 1986-02-28 | 1988-08-09 | Ciba-Geigy Corporation | Process for the preparation of granules containing an active substance and to the use thereof as speckles for treating substrates |
WO1989006270A1 (en) | 1988-01-07 | 1989-07-13 | Novo-Nordisk A/S | Enzymatic detergent |
US4882220A (en) | 1988-02-02 | 1989-11-21 | Kanebo, Ltd. | Fibrous structures having a durable fragrance |
US4917920A (en) | 1988-02-02 | 1990-04-17 | Kanebo, Ltd. | Fibrous structures having a durable fragrance and a process for preparing the same |
US4990280A (en) | 1988-03-14 | 1991-02-05 | Danochemo A/S | Photoactivator dye composition for detergent use |
US4911852A (en) | 1988-10-07 | 1990-03-27 | The Procter & Gamble Company | Liquid laundry detergent with curable amine functional silicone for fabric wrinkle reduction |
US4973422A (en) | 1989-01-17 | 1990-11-27 | The Procter & Gamble Company | Perfume particles for use in cleaning and conditioning compositions |
US5352604A (en) | 1989-08-25 | 1994-10-04 | Henkel Research Corporation | Alkaline proteolytic enzyme and method of production |
US5552378A (en) | 1990-03-06 | 1996-09-03 | The Procter & Gamble Company | Solid consumer product compositions containing small particle cyclodextrin complexes |
WO1994002597A1 (en) | 1992-07-23 | 1994-02-03 | Novo Nordisk A/S | MUTANT α-AMYLASE, DETERGENT, DISH WASHING AGENT, AND LIQUEFACTION AGENT |
WO1994018314A1 (en) | 1993-02-11 | 1994-08-18 | Genencor International, Inc. | Oxidatively stable alpha-amylase |
US5651976A (en) | 1993-06-17 | 1997-07-29 | The United States Of America As Represented By The Secretary Of The Navy | Controlled release of active agents using inorganic tubules |
US5486303A (en) | 1993-08-27 | 1996-01-23 | The Procter & Gamble Company | Process for making high density detergent agglomerates using an anhydrous powder additive |
US5679630A (en) | 1993-10-14 | 1997-10-21 | The Procter & Gamble Company | Protease-containing cleaning compositions |
US5856164A (en) | 1994-03-29 | 1999-01-05 | Novo Nordisk A/S | Alkaline bacillus amylase |
US5506201A (en) | 1994-04-29 | 1996-04-09 | International Flavors & Fragrances Inc. | Formulation of a fat surfactant vehicle containing a fragrance |
US5879584A (en) | 1994-09-10 | 1999-03-09 | The Procter & Gamble Company | Process for manufacturing aqueous compositions comprising peracids |
US5516448A (en) | 1994-09-20 | 1996-05-14 | The Procter & Gamble Company | Process for making a high density detergent composition which includes selected recycle streams for improved agglomerate |
US5691297A (en) | 1994-09-20 | 1997-11-25 | The Procter & Gamble Company | Process for making a high density detergent composition by controlling agglomeration within a dispersion index |
US5489392A (en) | 1994-09-20 | 1996-02-06 | The Procter & Gamble Company | Process for making a high density detergent composition in a single mixer/densifier with selected recycle streams for improved agglomerate properties |
US6491728B2 (en) | 1994-10-20 | 2002-12-10 | The Procter & Gamble Company | Detergent compositions containing enduring perfume |
US5500138A (en) | 1994-10-20 | 1996-03-19 | The Procter & Gamble Company | Fabric softener compositions with improved environmental impact |
US5500154A (en) | 1994-10-20 | 1996-03-19 | The Procter & Gamble Company | Detergent compositions containing enduring perfume |
US5500137A (en) | 1994-10-20 | 1996-03-19 | The Procter & Gamble Company | Fabric softening bar compositions containing fabric softener and enduring perfume |
WO1996023873A1 (en) | 1995-02-03 | 1996-08-08 | Novo Nordisk A/S | Amylase variants |
US5595967A (en) | 1995-02-03 | 1997-01-21 | The Procter & Gamble Company | Detergent compositions comprising multiperacid-forming bleach activators |
WO1996023874A1 (en) | 1995-02-03 | 1996-08-08 | Novo Nordisk A/S | A method of designing alpha-amylase mutants with predetermined properties |
US5574005A (en) | 1995-03-07 | 1996-11-12 | The Procter & Gamble Company | Process for producing detergent agglomerates from high active surfactant pastes having non-linear viscoelastic properties |
US5569645A (en) | 1995-04-24 | 1996-10-29 | The Procter & Gamble Company | Low dosage detergent composition containing optimum proportions of agglomerates and spray dried granules for improved flow properties |
WO1997000324A1 (en) | 1995-06-14 | 1997-01-03 | Kao Corporation | Gene encoding alkaline liquefying alpha-amylase |
US5597936A (en) | 1995-06-16 | 1997-01-28 | The Procter & Gamble Company | Method for manufacturing cobalt catalysts |
US5565422A (en) | 1995-06-23 | 1996-10-15 | The Procter & Gamble Company | Process for preparing a free-flowing particulate detergent composition having improved solubility |
US5576282A (en) | 1995-09-11 | 1996-11-19 | The Procter & Gamble Company | Color-safe bleach boosters, compositions and laundry methods employing same |
US6093562A (en) | 1996-02-05 | 2000-07-25 | Novo Nordisk A/S | Amylase variants |
US5780404A (en) | 1996-02-26 | 1998-07-14 | The Procter & Gamble Company | Detergent compositions containing enduring perfume |
US6048830A (en) | 1996-03-22 | 2000-04-11 | The Procter & Gamble Company | Delivery system having release barrier loaded zeolite |
US6245732B1 (en) | 1996-03-22 | 2001-06-12 | The Procter Gamble Co. | Delivery system having release inhibitor loaded zeolite and method for making same |
US5958870A (en) | 1996-04-01 | 1999-09-28 | The Procter & Gamble Company | Betaine ester compounds of active alcohols |
US6326348B1 (en) | 1996-04-16 | 2001-12-04 | The Procter & Gamble Co. | Detergent compositions containing selected mid-chain branched surfactants |
WO1997043424A1 (en) | 1996-05-14 | 1997-11-20 | Genencor International, Inc. | MODIFIED α-AMYLASES HAVING ALTERED CALCIUM BINDING PROPERTIES |
US6093691A (en) | 1996-08-19 | 2000-07-25 | The Procter & Gamble Company | Rinse added fabric softening compositions and method of use for the delivery of fragrance derivatives |
US6147037A (en) | 1996-08-19 | 2000-11-14 | The Procter & Gamble Company | Fragrance delivery systems |
WO1998017767A1 (en) | 1996-10-18 | 1998-04-30 | The Procter & Gamble Company | Detergent compositions |
US6103678A (en) | 1996-11-07 | 2000-08-15 | The Procter & Gamble Company | Compositions comprising a perfume and an amino-functional polymer |
US6277796B1 (en) | 1996-12-19 | 2001-08-21 | The Procter & Gamble Company | Dryer-activated fabric conditioning and antistatic compositions with improved perfume longevity |
US6165953A (en) | 1996-12-19 | 2000-12-26 | The Procter & Gamble Company | Dryer added fabric softening compositions and method of use for the delivery of fragrance derivatives |
US6024943A (en) | 1996-12-23 | 2000-02-15 | Ness; Jeremy Nicholas | Particles containing absorbed liquids and methods of making them |
US5858959A (en) | 1997-02-28 | 1999-01-12 | Procter & Gamble Company | Delivery systems comprising zeolites and a starch hydrolysate glass |
US6306812B1 (en) | 1997-03-07 | 2001-10-23 | Procter & Gamble Company, The | Bleach compositions containing metal bleach catalyst, and bleach activators and/or organic percarboxylic acids |
US6225464B1 (en) | 1997-03-07 | 2001-05-01 | The Procter & Gamble Company | Methods of making cross-bridged macropolycycles |
US6316397B1 (en) | 1997-06-27 | 2001-11-13 | The Procter & Gamble Co. | Pro-fragrance linear acetals and ketals |
US6042792A (en) | 1997-09-18 | 2000-03-28 | International Flavors & Fragrances Inc. | Apparatus for preparing a solid phase microparticulate composition |
US6645479B1 (en) | 1997-09-18 | 2003-11-11 | International Flavors & Fragrances Inc. | Targeted delivery of active/bioactive and perfuming compositions |
US6106875A (en) | 1997-10-08 | 2000-08-22 | Givaudan Roure (International) Sa | Method of encapsulating flavors and fragrances by controlled water transport into microcapsules |
US6312936B1 (en) | 1997-10-23 | 2001-11-06 | Genencor International, Inc. | Multiply-substituted protease variants |
WO1999023211A1 (en) | 1997-10-30 | 1999-05-14 | Novo Nordisk A/S | α-AMYLASE MUTANTS |
US6566112B2 (en) | 1997-11-19 | 2003-05-20 | Genencor International, Inc. | Cellulase producing actinomycetes, cellulase produced therefrom and method of producing same |
US6096918A (en) | 1998-02-13 | 2000-08-01 | Givaudan Roure (International) Sa | Aryl-acrylic acid esters |
US6544945B1 (en) | 1998-02-24 | 2003-04-08 | The Procter & Gamble Company | Cyclic pro-perfumes having modifiable fragrance raw material alcohol release rates |
EP1070115A2 (en) | 1998-04-07 | 2001-01-24 | Unilever Plc | Coloured granular composition for use in particulate detergent compositions |
WO1999053038A2 (en) * | 1998-04-15 | 1999-10-21 | Genencor International, Inc. | Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
US6437150B1 (en) | 1998-04-20 | 2002-08-20 | Givaudan Sa | Compounds having protected hydroxy groups |
US6479682B1 (en) | 1998-04-20 | 2002-11-12 | Givaudan Sa | Compounds having protected hydroxy groups |
US6458754B1 (en) | 1998-04-23 | 2002-10-01 | The Procter & Gamble Company | Encapsulated perfume particles and detergent compositions containing said particles |
US6291412B1 (en) | 1998-05-18 | 2001-09-18 | Ciba Specialty Chemicals Corporation | Water-soluble granules of phthalocyanine compounds |
US6218355B1 (en) | 1998-05-28 | 2001-04-17 | Firmenich Sa | Slow release of fragrant compounds in perfumery using a keto esters |
US6133228A (en) | 1998-05-28 | 2000-10-17 | Firmenich Sa | Slow release of fragrant compounds in perfumery using 2-benzoyl benzoates, 2-alkanoyl benzoates or α-keto esters |
US6413920B1 (en) | 1998-07-10 | 2002-07-02 | Procter & Gamble Company | Amine reaction compounds comprising one or more active ingredient |
US7018978B2 (en) | 1998-10-23 | 2006-03-28 | Procter & Gamble Company | Fragrance pro-accords and aldehyde and ketone fragrance libraries |
US6051540A (en) | 1998-11-05 | 2000-04-18 | International Flavors & Fragrances Inc. | Method employing drum chilling and apparatus therefor for producing fragrance-containing long lasting solid particle |
WO2000032601A2 (en) | 1998-11-30 | 2000-06-08 | The Procter & Gamble Company | Process for preparing cross-bridged tetraaza macrocycles |
EP1022334A2 (en) | 1998-12-21 | 2000-07-26 | Kao Corporation | Novel amylases |
WO2000060060A2 (en) | 1999-03-31 | 2000-10-12 | Novozymes A/S | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
US6939702B1 (en) | 1999-03-31 | 2005-09-06 | Novozymes A/S | Lipase variant |
US6861402B1 (en) | 1999-06-01 | 2005-03-01 | The Procter & Gamble Company | Pro-fragrances |
US6200949B1 (en) | 1999-12-21 | 2001-03-13 | International Flavors And Fragrances Inc. | Process for forming solid phase controllably releasable fragrance-containing consumable articles |
US20030125222A1 (en) | 2000-01-05 | 2003-07-03 | Ekkehard Jahns | Microcapsule preparations and detergents and cleaning agents containing microcapsules |
US20040106536A1 (en) | 2000-03-20 | 2004-06-03 | Jean Mane | Solid perfumed preparation in the form of microbeads and the use thereof |
US6610646B2 (en) | 2000-06-01 | 2003-08-26 | The Procter & Gamble Company | Enhanced duration fragrance delivery system having a non-distorted initial fragrance impression |
US20030199422A1 (en) | 2000-06-02 | 2003-10-23 | Birkbeck Anthony Alexander | Perfumes |
US7153818B2 (en) | 2000-07-28 | 2006-12-26 | Henkel Kgaa | Amylolytic enzyme extracted from bacillus sp. A 7-7 (DSM 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
US6987084B2 (en) | 2000-11-08 | 2006-01-17 | The Procter & Gamble Co. | Photo-labile pro-fragrance conjugates |
US20060223726A1 (en) | 2000-11-08 | 2006-10-05 | Dykstra Robert R | Photo-labile pro-fragrance conjugates |
US7109153B2 (en) | 2000-11-08 | 2006-09-19 | Procter & Gamble Company | Photo-labile pro-fragrance conjugates |
US7119060B2 (en) | 2000-11-09 | 2006-10-10 | Salvona Ip, Llc | Controlled delivery system for fabric care products |
US6531444B1 (en) | 2000-11-09 | 2003-03-11 | Salvona, Llc | Controlled delivery system for fabric care products |
US20040087477A1 (en) | 2001-03-16 | 2004-05-06 | Ness Jeremy Nicholas | Perfume encapsulates |
US6956013B2 (en) | 2001-04-10 | 2005-10-18 | The Procter & Gamble Company | Photo-activated pro-fragrances |
US20030036489A1 (en) | 2001-05-04 | 2003-02-20 | The Procter & Gamble Company | Consumable composition comprising perfumed particles and article containing the same |
WO2003015736A2 (en) | 2001-08-16 | 2003-02-27 | Quest International B.V. | Perfume-containing composition |
US20030087791A1 (en) | 2001-08-20 | 2003-05-08 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Photobleach speckle and laundry detergent compositions containing it |
US20030087790A1 (en) | 2001-08-20 | 2003-05-08 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Photobleach speckle and laundry detergent compositions containing it |
US7071151B2 (en) | 2001-09-11 | 2006-07-04 | Procter & Gamble Company | Compositions comprising photo-labile perfume delivery |
US20040220074A1 (en) | 2001-12-13 | 2004-11-04 | Charles Fehr | Compounds for a controlled release of active molecules |
US7262042B2 (en) | 2001-12-20 | 2007-08-28 | Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) | Alkaline protease from Bacillus gibsonii (DSM 14393) and washing and cleaning products comprising said alkaline protease |
WO2003062381A2 (en) * | 2002-01-16 | 2003-07-31 | Genencor International, Inc. | Multiply-substituted protease variants |
US20030165692A1 (en) | 2002-01-24 | 2003-09-04 | Friedrich Koch | Coagulates containing microcapsules |
US20030158344A1 (en) | 2002-02-08 | 2003-08-21 | Rodriques Klein A. | Hydrophobe-amine graft copolymer |
US20030195133A1 (en) | 2002-04-10 | 2003-10-16 | Adi Shefer | Targeted controlled delivery compositions activated by changes in pH or salt concentration |
US20030215417A1 (en) | 2002-04-18 | 2003-11-20 | The Procter & Gamble Company | Malodor-controlling compositions comprising odor control agents and microcapsules containing an active material |
US20030216488A1 (en) | 2002-04-18 | 2003-11-20 | The Procter & Gamble Company | Compositions comprising a dispersant and microcapsules containing an active material |
US20030203829A1 (en) | 2002-04-26 | 2003-10-30 | Adi Shefer | Multi component controlled delivery system for fabric care products |
US20060039934A1 (en) | 2002-08-14 | 2006-02-23 | Ness Jeremy N | Compositions comprising encapsulated material |
US20050227891A1 (en) | 2002-09-04 | 2005-10-13 | Pierre Dreyer | Formulations comprising water-soluble granulates |
US20040058845A1 (en) | 2002-09-05 | 2004-03-25 | Metrot Veronique Sylvie | Structured liquid fabric treatment compositions |
US20040048764A1 (en) | 2002-09-11 | 2004-03-11 | Kim Dong Gyu | Complex salt for anti-spotting detergents |
US20050003983A1 (en) | 2002-09-11 | 2005-01-06 | Kim Dong Gyu | Complex salt for anti-spotting detergents |
US20040072720A1 (en) | 2002-10-10 | 2004-04-15 | Joseph Brain | Encapsulated fragrance chemicals |
US20040071746A1 (en) | 2002-10-10 | 2004-04-15 | Popplewell Lewis Michael | Encapsulated fragrance chemicals |
US20040071742A1 (en) | 2002-10-10 | 2004-04-15 | Popplewell Lewis Michael | Encapsulated fragrance chemicals |
US20040072719A1 (en) | 2002-10-10 | 2004-04-15 | Bennett Sydney William | Encapsulated fragrance chemicals |
US20040087476A1 (en) | 2002-11-01 | 2004-05-06 | Dykstra Robert Richard | Polymeric assisted delivery using separate addition |
US20040110648A1 (en) | 2002-11-01 | 2004-06-10 | Jordan Glenn Thomas | Perfume polymeric particles |
US20040092414A1 (en) | 2002-11-01 | 2004-05-13 | Clapp Mannie Lee | Rinse-off personal care compositions comprising anionic and/or nonionic perfume polymeric particles |
US20040091445A1 (en) | 2002-11-01 | 2004-05-13 | The Procter & Gamble Company | Rinse-off personal care compositions comprising cationic perfume polymeric particles |
US20040092425A1 (en) | 2002-11-04 | 2004-05-13 | The Procter & Gamble Company | Liquid laundry detergent |
US20050003980A1 (en) | 2003-06-27 | 2005-01-06 | The Procter & Gamble Company | Lipophilic fluid cleaning compositions capable of delivering scent |
WO2005042532A1 (en) | 2003-10-31 | 2005-05-12 | Unilever Plc | Bispidon-derivated ligands and complex for catalytically bleaching a substrate |
WO2005052146A2 (en) | 2003-11-19 | 2005-06-09 | Genencor International, Inc. | Serine proteases, nucleic acids encoding serine enzymes and vectors and host cells incorporating same |
WO2005052161A2 (en) | 2003-11-19 | 2005-06-09 | Genencor International, Inc. | Serine proteases, nucleic acids encoding serine enzymes and vectors and host cells incorporating same |
WO2005102261A1 (en) | 2004-03-26 | 2005-11-03 | Dow Corning Corporation | Controlled release compositions |
US7208459B2 (en) | 2004-06-29 | 2007-04-24 | The Procter & Gamble Company | Laundry detergent compositions with efficient hueing dye |
US20060003913A1 (en) | 2004-06-30 | 2006-01-05 | The Procter & Gamble Company | Perfumed liquid laundry detergent compositions with functionalized silicone fabric care agents |
WO2006002643A2 (en) | 2004-07-05 | 2006-01-12 | Novozymes A/S | Alpha-amylase variants with altered properties |
US20060020459A1 (en) | 2004-07-21 | 2006-01-26 | Carter John A | System and method for immigration tracking and intelligence |
US20060263313A1 (en) | 2005-05-19 | 2006-11-23 | Scavone Timothy A | Consumer noticeable improvement in wetness protection |
WO2007044993A2 (en) | 2005-10-12 | 2007-04-19 | Genencor International, Inc. | Use and production of storage-stable neutral metalloprotease |
US20070275866A1 (en) | 2006-05-23 | 2007-11-29 | Robert Richard Dykstra | Perfume delivery systems for consumer goods |
WO2008002472A2 (en) * | 2006-06-23 | 2008-01-03 | Danisco Us Inc., Genencor Division | Systematic evaluation of sequence and activity relationships using site evaluation libraries for engineering multiple properties |
WO2008153925A2 (en) * | 2007-06-06 | 2008-12-18 | Danisco Us, Inc., Genencor Division | Methods for improving multiple protein properties |
US20080305982A1 (en) | 2007-06-11 | 2008-12-11 | Johan Smets | Benefit agent containing delivery particle |
WO2009021867A2 (en) | 2007-08-10 | 2009-02-19 | Henkel Ag & Co. Kgaa | Agents containing proteases |
US20090217464A1 (en) | 2008-02-29 | 2009-09-03 | Philip Frank Souter | Detergent composition comprising lipase |
US20090247449A1 (en) | 2008-03-26 | 2009-10-01 | John Allen Burdis | Delivery particle |
WO2009149145A2 (en) * | 2008-06-06 | 2009-12-10 | Danisco Us Inc., Genencor Division | Compositions and methods comprising variant microbial proteases |
WO2009149144A2 (en) | 2008-06-06 | 2009-12-10 | Danisco Us Inc. | Compositions and methods comprising variant microbial proteases |
WO2010056640A2 (en) * | 2008-11-11 | 2010-05-20 | Danisco Us Inc. | Compositions and methods comprising serine protease variants |
Non-Patent Citations (28)
Title |
---|
ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 410 |
ALTSCHUL ET AL., METH. ENZYMOL., vol. 266, 1996, pages 460 - 480 |
ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, no. 17, 1997, pages 3389 - 3402 |
ARKIN; YOUVAN, BIOTECHNOLOGY, vol. 10, 1992, pages 297 - 300 |
BITTKER ET AL., NAT. BIOTECHNOL., vol. 20, 2001, pages 1024 - 9 |
BITTKER ET AL., PROC NATL. ACAD. SCI. USA, vol. 101, 2004, pages 7011 - 6 |
COCO ET AL., NAT. BIOTECHNOL., vol. 20, 2002, pages 1246 - 50 |
DEVEREUX ET AL., NUCL. ACID RES., vol. 12, 1984, pages 387 - 395 |
DOOLITTLE, J. MOL. EVOL., vol. 35, 1987, pages 351 - 360 |
GLASE ET AL., J. IMMUNOL., vol. 149, 1992, pages 3903 - 13 |
HENIKOFF, PROC. NATL. ACAD. SCI. USA, vol. 89, 1992, pages 10915 |
HIGGINS; SHARP, CABIOS, vol. 5, 1989, pages 151 - 153 |
KARLIN; ALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 5873 - 5787 |
LUTZ ET AL., PROC. NATL. ACAD. SCI. USA, vol. 98, 2001, pages 11248 - 53 |
MCKENZIE ET AL., PLASMID, vol. 15, no. 2, 1986, pages 93 - 103 |
NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 |
NEIDHARDT ET AL., J. BACTERIOL., vol. 119, 1974, pages 736 - 747 |
NESS ET AL., NAT. BIOTECHNOL., vol. 20, 2002, pages 1251 - 5 |
OSTERMEIE ET AL., BIOORG. MED. CHEM., vol. 7, 1999, pages 2139 - 44 |
PEARSON; LIPMAN, PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 2444 |
PISARCHIK ET AL., PROT. ENG. DES. SELECT., vol. 20, 2007, pages 257 - 265 |
REIDHAAR-OLSON ET AL., METHODS ENZYMOL., vol. 208, 1991, pages 564 - 86 |
RUBINGH D N ET AL: "Wild type subtilisin BPN'", GENESEQ,, 30 September 1999 (1999-09-30), XP002544118 * |
SIEBER ET AL., NAT. BIOTECHNO, vol. 1, no. 19, 2001, pages 456 - 60 |
SMITH; WATERMAN, ADV. APPL. MATH, vol. 2, 1981, pages 482 |
STEMMER WP, PROC. NATL. ACAD. SCI. USA, vol. 91, no. 22, 1994, pages 10747 - 51 |
W. NOLL: "Chemistry and Technology of Silicone", vol. 106, 1998, ACADEMIC PRESS INC., pages: 209 |
ZHA ET AL., CHEMBIOCHEM, vol. 4, 2003, pages 34 - 9 |
Cited By (186)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8785171B2 (en) | 2009-12-09 | 2014-07-22 | The Procter & Gamble Company | Fabric and home care products comprising cold water proteases |
US20160083710A1 (en) * | 2009-12-09 | 2016-03-24 | Danisco Us Inc. | Compositions and methods comprising protease variants |
US9157052B2 (en) | 2009-12-09 | 2015-10-13 | Danisco Us Inc. | Methods for cleaning using a variant protease derived from subtilisin |
EP2365055B1 (en) | 2010-03-01 | 2017-12-20 | The Procter and Gamble Company | Composition comprising substituted cellulosic polymer and amylase |
JP2014523474A (en) * | 2011-07-25 | 2014-09-11 | ザ プロクター アンド ギャンブル カンパニー | Detergent composition |
EP2551336A1 (en) | 2011-07-25 | 2013-01-30 | The Procter & Gamble Company | Detergent compositions |
EP2551335A1 (en) | 2011-07-25 | 2013-01-30 | The Procter & Gamble Company | Enzyme stabilized liquid detergent composition |
WO2013016368A1 (en) | 2011-07-25 | 2013-01-31 | The Procter & Gamble Company | Detergent compositions |
CN108384772A (en) * | 2011-10-28 | 2018-08-10 | 汉高股份有限及两合公司 | Performance enhancement and temperature-resistant ease variants |
CN103906836A (en) * | 2011-10-28 | 2014-07-02 | 汉高股份有限及两合公司 | Performance-enhanced and temperature-resistant protease variants |
WO2013060621A1 (en) * | 2011-10-28 | 2013-05-02 | Henkel Ag & Co. Kgaa | Performance-enhanced and temperature-resistant protease variants |
CN103958657A (en) * | 2011-11-25 | 2014-07-30 | 诺维信公司 | Subtilase variants and polynucleotides encoding same |
EP3323875A1 (en) * | 2011-12-20 | 2018-05-23 | Henkel AG & Co. KGaA | Detergent compositions comprising subtilase variants |
WO2013092582A3 (en) * | 2011-12-20 | 2014-01-30 | Henkel Ag & Co. Kgaa | Detergent compositions comprising subtilase variants |
WO2013092582A2 (en) * | 2011-12-20 | 2013-06-27 | Henkel Ag & Co. Kgaa | Detergent compositions comprising subtilase variants |
EP2607468A1 (en) * | 2011-12-20 | 2013-06-26 | Henkel AG & Co. KGaA | Detergent compositions comprising subtilase variants |
EP2794874A1 (en) * | 2011-12-20 | 2014-10-29 | Novozymes A/S | Subtilase variants and polynucleotides encoding same |
WO2013120952A3 (en) * | 2012-02-17 | 2014-02-06 | Henkel Ag & Co. Kgaa | Detergent compositions comprising subtilase variants |
EP2628785A1 (en) * | 2012-02-17 | 2013-08-21 | Henkel AG & Co. KGaA | Detergent compositions comprising subtilase variants |
WO2014177430A1 (en) * | 2013-04-30 | 2014-11-06 | Henkel Ag & Co. Kgaa | Cleaning agent containing proteases |
US10421928B2 (en) | 2013-04-30 | 2019-09-24 | Henkel Ag & Co. Kgaa | Cleaning agent containing proteases |
WO2014200656A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from streptomyces umbrinus |
WO2014200658A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from promicromonospora vindobonensis |
WO2014200657A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from streptomyces xiamenensis |
WO2014204596A1 (en) | 2013-06-17 | 2014-12-24 | Danisco Us Inc. | Alpha-amylase from bacillaceae family member |
WO2015050723A1 (en) | 2013-10-03 | 2015-04-09 | Danisco Us Inc. | Alpha-amylases from exiguobacterium, and methods of use, thereof |
WO2015050724A1 (en) | 2013-10-03 | 2015-04-09 | Danisco Us Inc. | Alpha-amylases from a subset of exiguobacterium, and methods of use, thereof |
WO2015077126A1 (en) | 2013-11-20 | 2015-05-28 | Danisco Us Inc. | Variant alpha-amylases having reduced susceptibility to protease cleavage, and methods of use, thereof |
WO2015112339A1 (en) | 2014-01-22 | 2015-07-30 | The Procter & Gamble Company | Fabric treatment composition |
WO2015112341A1 (en) | 2014-01-22 | 2015-07-30 | The Procter & Gamble Company | Fabric treatment composition |
WO2015112340A1 (en) | 2014-01-22 | 2015-07-30 | The Procter & Gamble Company | Method of treating textile fabrics |
WO2015112338A1 (en) | 2014-01-22 | 2015-07-30 | The Procter & Gamble Company | Method of treating textile fabrics |
EP4403631A3 (en) * | 2014-10-27 | 2024-10-30 | Danisco US Inc. | Serine proteases |
WO2016081437A1 (en) | 2014-11-17 | 2016-05-26 | The Procter & Gamble Company | Benefit agent delivery compositions |
US11174452B2 (en) | 2014-12-04 | 2021-11-16 | Novozymes A/S | Liquid cleaning compositions comprising protease variants |
EP3227425A1 (en) * | 2014-12-04 | 2017-10-11 | Novozymes A/S | Liquid cleaning compositions comprising protease variants |
US11851639B2 (en) | 2014-12-04 | 2023-12-26 | Novozymes A/S | Liquid cleaning compositions comprising protease variants |
US11597894B2 (en) | 2014-12-15 | 2023-03-07 | Henkel Ag & Co. Kgaa | Detergent composition comprising subtilase variants |
US10760036B2 (en) | 2014-12-15 | 2020-09-01 | Henkel Ag & Co. Kgaa | Detergent composition comprising subtilase variants |
EP3608403A3 (en) * | 2014-12-15 | 2020-03-25 | Henkel AG & Co. KGaA | Detergent composition comprising subtilase variants |
WO2016096714A1 (en) * | 2014-12-15 | 2016-06-23 | Henkel Ag & Co. Kgaa | Detergent composition comprising subtilase variants |
EP3399031A1 (en) * | 2014-12-15 | 2018-11-07 | Henkel AG & Co. KGaA | Detergent composition comprising subtilase variants |
EP3075831A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075833A2 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016160870A1 (en) | 2015-03-30 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075824A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016160863A1 (en) | 2015-03-30 | 2016-10-06 | The Procter & Gamble Company | A spray-dried laundry detergent base particle |
WO2016160865A1 (en) | 2015-03-30 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016160867A1 (en) | 2015-03-30 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075826A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016160866A1 (en) | 2015-03-30 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016160869A1 (en) | 2015-03-30 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075829A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075828A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016160868A1 (en) | 2015-03-30 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075827A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075823A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | A spray-dried laundry detergent base particle |
EP3075825A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016160351A1 (en) | 2015-03-30 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075830A2 (en) | 2015-04-02 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016161219A1 (en) | 2015-04-02 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075834A1 (en) | 2015-04-02 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3081625A1 (en) | 2015-04-02 | 2016-10-19 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016161217A1 (en) | 2015-04-02 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016161218A1 (en) | 2015-04-02 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3088503A1 (en) | 2015-04-29 | 2016-11-02 | The Procter and Gamble Company | Method of treating a fabric |
WO2016176296A1 (en) | 2015-04-29 | 2016-11-03 | The Procter & Gamble Company | Method of laundering a fabric |
EP3088502A1 (en) | 2015-04-29 | 2016-11-02 | The Procter and Gamble Company | Method of treating a fabric |
EP3088505A1 (en) | 2015-04-29 | 2016-11-02 | The Procter and Gamble Company | Method of treating a fabric |
EP3088506A1 (en) | 2015-04-29 | 2016-11-02 | The Procter and Gamble Company | Detergent composition |
EP3674387A1 (en) | 2015-04-29 | 2020-07-01 | The Procter & Gamble Company | Method of treating a fabric |
EP3088504A1 (en) | 2015-04-29 | 2016-11-02 | The Procter and Gamble Company | Method of treating a fabric |
WO2016176282A1 (en) | 2015-04-29 | 2016-11-03 | The Procter & Gamble Company | Method of treating a fabric |
WO2016176241A1 (en) | 2015-04-29 | 2016-11-03 | The Procter & Gamble Company | Detergent composition |
WO2016176280A1 (en) | 2015-04-29 | 2016-11-03 | The Procter & Gamble Company | Method of treating a fabric |
WO2016176240A1 (en) | 2015-04-29 | 2016-11-03 | The Procter & Gamble Company | Method of treating a fabric |
EP3153425A1 (en) | 2015-10-06 | 2017-04-12 | The Procter and Gamble Company | Flexible box bag comprising detergent powder and a scoop |
WO2017062560A1 (en) | 2015-10-06 | 2017-04-13 | The Procter & Gamble Company | Flexible box bag comprising detergent powder and a scoop |
US9758286B2 (en) | 2015-10-06 | 2017-09-12 | The Procter & Gamble Company | Flexible box bag comprising soluble unit dose detergent pouch |
US10731111B2 (en) | 2015-11-25 | 2020-08-04 | Conopco, Inc. | Liquid laundry detergent composition |
WO2017162429A1 (en) * | 2016-03-23 | 2017-09-28 | Henkel Ag & Co. Kgaa | Proteases with improved enzyme stability in detergents |
WO2017173190A2 (en) | 2016-04-01 | 2017-10-05 | Danisco Us Inc. | Alpha-amylases, compositions & methods |
WO2017173324A2 (en) | 2016-04-01 | 2017-10-05 | Danisco Us Inc. | Alpha-amylases, compositions & methods |
EP3556835A1 (en) | 2016-05-09 | 2019-10-23 | The Procter & Gamble Company | Detergent composition comprising a fatty acid decarboxylase |
EP3511403A1 (en) | 2016-05-09 | 2019-07-17 | The Procter & Gamble Company | Detergent composition |
EP3243896A1 (en) | 2016-05-09 | 2017-11-15 | The Procter and Gamble Company | Detergent composition comprising a fatty acid decarboxylase |
EP3540037A1 (en) | 2016-05-09 | 2019-09-18 | The Procter & Gamble Company | Detergent composition comprising a oleate 10s lipoxygenase |
EP3540036A1 (en) | 2016-05-09 | 2019-09-18 | The Procter & Gamble Company | Detergent composition comprising a fatty acid lipoxygenase |
EP3243897A1 (en) | 2016-05-09 | 2017-11-15 | The Procter & Gamble Company | Detergent composition comprising a fatty acid-transforming enzyme |
EP3243898A2 (en) | 2016-05-09 | 2017-11-15 | The Procter & Gamble Company | Detergent composition comprising an oleic acid-transforming enzyme |
EP3556834A1 (en) | 2016-05-09 | 2019-10-23 | The Procter & Gamble Company | Detergent composition comprising a fatty acid decarboxylase |
WO2017215925A1 (en) * | 2016-06-15 | 2017-12-21 | Henkel Ag & Co. Kgaa | Bacillus gibsonii protease and variants thereof |
US10941371B2 (en) | 2016-06-15 | 2021-03-09 | Henkel Ag & Co. Kgaa | Bacillus gibsonii protease and variants thereof |
EP3269729A1 (en) | 2016-07-14 | 2018-01-17 | The Procter and Gamble Company | Detergent composition |
WO2018013395A1 (en) | 2016-07-14 | 2018-01-18 | The Procter & Gamble Company | Detergent composition |
WO2018067487A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Low ph laundry detergent composition |
WO2018067494A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Low ph laundry detergent composition |
WO2018067484A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Laundry detergent composition |
WO2018067493A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Spray-dried base detergent particle giving rise to a low ph in the wash |
WO2018067481A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Laundry detergent composition |
WO2018067483A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Laundry detergent composition |
WO2018067482A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Laundry detergent composition |
WO2018067486A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Low ph laundry detergent composition |
WO2018067485A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Low ph laundry detergent composition |
WO2018067489A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Low ph laundry detergent composition |
WO2018067488A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Low ph laundry detergent composition |
WO2018102478A1 (en) | 2016-12-02 | 2018-06-07 | The Procter & Gamble Company | Cleaning compositions including enzymes |
EP3330348A1 (en) | 2016-12-02 | 2018-06-06 | The Procter & Gamble Company | Cleaning compositions including enzymes |
WO2018102479A1 (en) | 2016-12-02 | 2018-06-07 | The Procter & Gamble Company | Cleaning compositions including enzymes |
EP4001389A1 (en) | 2016-12-02 | 2022-05-25 | The Procter & Gamble Company | Cleaning compositions including enzymes |
WO2018118917A1 (en) * | 2016-12-21 | 2018-06-28 | Danisco Us Inc. | Protease variants and uses thereof |
CN110312795A (en) * | 2016-12-21 | 2019-10-08 | 丹尼斯科美国公司 | Ease variants and application thereof |
EP3339419A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
WO2018118824A1 (en) | 2016-12-22 | 2018-06-28 | The Procter & Gamble Company | Laundry detergent composition |
EP3339417A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339416A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339413A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339415A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339407A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339420A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339418A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339421A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339414A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
WO2018118825A1 (en) | 2016-12-22 | 2018-06-28 | The Procter & Gamble Company | Laundry detergent composition |
WO2019191171A1 (en) | 2018-03-28 | 2019-10-03 | The Procter & Gamble Company | Laundry detergent composition |
WO2019190794A1 (en) | 2018-03-28 | 2019-10-03 | The Procter & Gamble Company | Spray-drying process |
US11505768B2 (en) | 2018-03-28 | 2022-11-22 | The Procter & Gamble Company | Process for preparing a spray-dried laundry detergent particle |
EP3546557A1 (en) | 2018-03-28 | 2019-10-02 | The Procter & Gamble Company | Catalase inhibition during a laundering process |
EP3546558A1 (en) | 2018-03-28 | 2019-10-02 | The Procter & Gamble Company | Laundry detergent composition |
WO2019191174A1 (en) | 2018-03-28 | 2019-10-03 | The Procter & Gamble Company | Laundry detergent composition |
EP3546559A1 (en) | 2018-03-28 | 2019-10-02 | The Procter & Gamble Company | Laundry detergent composition |
EP3546554A1 (en) | 2018-03-28 | 2019-10-02 | The Procter & Gamble Company | Spray-drying process |
WO2019191172A1 (en) | 2018-03-28 | 2019-10-03 | The Procter & Gamble Company | Process for preparing a spray-dried laundry detergent particle |
WO2019191173A1 (en) | 2018-03-28 | 2019-10-03 | The Procter & Gamble Company | Process for preparing a spray-dried laundry detergent particle |
WO2019191170A1 (en) | 2018-03-28 | 2019-10-03 | The Procter & Gamble Company | Laundry detergent composition |
WO2020013959A1 (en) | 2018-07-12 | 2020-01-16 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
EP3594319A1 (en) | 2018-07-12 | 2020-01-15 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
WO2020222996A1 (en) | 2019-04-29 | 2020-11-05 | The Procter & Gamble Company | A process for making a laundry detergent composition |
EP3754010A1 (en) | 2019-06-17 | 2020-12-23 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition comprises a detersive surfactant and a linear polyamine salt |
EP3798290A1 (en) | 2019-09-30 | 2021-03-31 | The Procter & Gamble Company | Use of an anionically-modified cellulosic polymer as a dye transfer inhibitor during a textile laundering process |
WO2022010753A1 (en) | 2020-07-06 | 2022-01-13 | The Procter & Gamble Company | A process for making a particulate laundry detergent composition |
EP3936595A1 (en) | 2020-07-06 | 2022-01-12 | The Procter & Gamble Company | A process for making a particulate laundry detergent composition |
EP3943603A1 (en) * | 2020-07-22 | 2022-01-26 | Technische Universität Darmstadt | Rapid transformation method for gram-positive bacteria |
WO2022077022A1 (en) | 2020-10-09 | 2022-04-14 | The Procter & Gamble Company | Packaged laundry detergent product |
WO2022106400A1 (en) * | 2020-11-18 | 2022-05-27 | Novozymes A/S | Combination of immunochemically different proteases |
EP4108756A1 (en) | 2021-06-25 | 2022-12-28 | The Procter & Gamble Company | A laundry detergent powder |
EP4108754A1 (en) | 2021-06-25 | 2022-12-28 | The Procter & Gamble Company | A process for making a packaged laundry detergent powder |
WO2022271931A1 (en) | 2021-06-25 | 2022-12-29 | The Procter & Gamble Company | A laundry detergent powder |
WO2022271930A1 (en) | 2021-06-25 | 2022-12-29 | The Procter & Gamble Company | A process for making a packaged laundry detergent powder |
EP4123005A1 (en) | 2021-07-19 | 2023-01-25 | The Procter & Gamble Company | Cleaning composition comprising bacterial spores |
WO2023004213A1 (en) | 2021-07-19 | 2023-01-26 | The Procter & Gamble Company | Cleaning composition comprising bacterial spores |
EP4212608A1 (en) | 2022-01-14 | 2023-07-19 | The Procter & Gamble Company | A method of making a spray-dried laundry detergent particle |
WO2023137306A1 (en) | 2022-01-14 | 2023-07-20 | The Procter & Gamble Company | A method of making a spray-dried laundry detergent particle |
WO2023150903A1 (en) | 2022-02-08 | 2023-08-17 | The Procter & Gamble Company | A method of laundering fabric |
WO2023150905A1 (en) | 2022-02-08 | 2023-08-17 | The Procter & Gamble Company | A method of laundering fabric |
EP4234666A1 (en) | 2022-02-24 | 2023-08-30 | The Procter & Gamble Company | Water-soluble unit dose article comprising a fibrous non-woven sheet and a surfactant system |
EP4234672A1 (en) | 2022-02-24 | 2023-08-30 | The Procter & Gamble Company | Water-soluble unit dose article comprising a fibrous non-woven sheet and a hueing dye particle |
WO2023164353A1 (en) | 2022-02-24 | 2023-08-31 | The Procter & Gamble Company | Water-soluble unit dose article comprising a fibrous non-woven sheet and a hueing dye particle |
WO2023164354A1 (en) | 2022-02-24 | 2023-08-31 | The Procter & Gamble Company | Water-soluble unit dose article comprising a fibrous non-woven sheet and a surfactant system |
WO2023225459A2 (en) | 2022-05-14 | 2023-11-23 | Novozymes A/S | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
EP4279570A1 (en) | 2022-05-19 | 2023-11-22 | The Procter & Gamble Company | A process for making a particulate laundry detergent composition |
WO2023224761A1 (en) | 2022-05-19 | 2023-11-23 | The Procter & Gamble Company | A process for making a particulate laundry detergent composition |
WO2024006655A1 (en) | 2022-06-27 | 2024-01-04 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
EP4299702A1 (en) | 2022-06-27 | 2024-01-03 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
EP4299703A1 (en) | 2022-06-27 | 2024-01-03 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
WO2024006656A1 (en) | 2022-06-27 | 2024-01-04 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
WO2024006654A1 (en) | 2022-06-27 | 2024-01-04 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
WO2024006658A1 (en) | 2022-06-27 | 2024-01-04 | The Procter & Gamble Company | A method of laundering and drying fabric |
EP4299701A1 (en) | 2022-06-27 | 2024-01-03 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
EP4299704A1 (en) | 2022-06-27 | 2024-01-03 | The Procter & Gamble Company | A method of laundering and drying fabric |
EP4342969A1 (en) | 2022-09-21 | 2024-03-27 | The Procter & Gamble Company | A solid detergent cleaning composition |
EP4342970A1 (en) | 2022-09-21 | 2024-03-27 | Milliken & Company | Coloured fabric hueing dye agent particles |
WO2024064711A1 (en) | 2022-09-21 | 2024-03-28 | The Procter & Gamble Company | A solid detergent cleaning composition |
WO2024064184A1 (en) | 2022-09-21 | 2024-03-28 | Milliken & Company | Coloured fabric hueing dye agent particles |
EP4364930A1 (en) | 2022-11-01 | 2024-05-08 | The Procter & Gamble Company | Sealing jaws and water-soluble unit dose article comprising a fibrous non-woven sheet |
WO2024097149A1 (en) | 2022-11-01 | 2024-05-10 | The Procter & Gamble Company | Sealing jaws and water-soluble unit dose article comprising a fibrous non-woven sheet |
WO2024097150A1 (en) | 2022-11-01 | 2024-05-10 | The Procter & Gamble Company | Sealing jaws and water-soluble unit dose article comprising a fibrous non-woven sheet |
EP4364929A1 (en) | 2022-11-01 | 2024-05-08 | The Procter & Gamble Company | Sealing jaws and water-soluble unit dose article comprising a fibrous non-woven sheet |
EP4382592A1 (en) | 2022-12-06 | 2024-06-12 | The Procter & Gamble Company | Water-soluble unit dose article comprising a fibrous non-woven sheet and a surfactant system |
WO2024123757A1 (en) | 2022-12-06 | 2024-06-13 | The Procter & Gamble Company | Water-soluble unit dose article comprising a fibrous non-woven sheet and a surfactant system |
EP4389867A1 (en) | 2022-12-23 | 2024-06-26 | The Procter & Gamble Company | A process of making a laundry detergent article |
EP4389866A1 (en) | 2022-12-23 | 2024-06-26 | The Procter & Gamble Company | A process of making a water-soluble detergent unit dose article |
WO2024137568A1 (en) | 2022-12-23 | 2024-06-27 | The Procter & Gamble Company | A process of making a water-soluble detergent unit dose article |
WO2024137571A1 (en) | 2022-12-23 | 2024-06-27 | The Procter & Gamble Company | A process of making a laundry detergent article |
WO2024163584A1 (en) * | 2023-02-01 | 2024-08-08 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2024163600A1 (en) * | 2023-02-01 | 2024-08-08 | Danisco Us Inc. | Subtilisin variants and methods of use |
Also Published As
Publication number | Publication date |
---|---|
US20140193888A1 (en) | 2014-07-10 |
EP2510092A1 (en) | 2012-10-17 |
CN102652175B (en) | 2016-02-10 |
MX2012006616A (en) | 2012-06-21 |
US20180171268A1 (en) | 2018-06-21 |
JP2013513386A (en) | 2013-04-22 |
US20110237487A1 (en) | 2011-09-29 |
US20210071113A1 (en) | 2021-03-11 |
US8785171B2 (en) | 2014-07-22 |
CA2782613A1 (en) | 2011-06-16 |
US10900000B2 (en) | 2021-01-26 |
EP4159833A2 (en) | 2023-04-05 |
CA2782613C (en) | 2016-08-23 |
EP4159833A3 (en) | 2023-07-26 |
CN102652175A (en) | 2012-08-29 |
EP3434764A3 (en) | 2019-04-03 |
EP3434764A2 (en) | 2019-01-30 |
JP5882904B2 (en) | 2016-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210071113A1 (en) | Fabric and home care products | |
CA2834865C (en) | Compositions and methods comprising serine protease variants | |
RU2598717C2 (en) | Consumer goods with protease versions | |
US10647947B2 (en) | Detergent composition | |
US20200299618A1 (en) | Compositions and methods comprising serine protease variants | |
EP2705145B1 (en) | Compositions and methods comprising serine protease variants | |
US20130123162A1 (en) | Consumer products |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080055885.5 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10796231 Country of ref document: EP Kind code of ref document: A1 |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10796231 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2782613 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2012/006616 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012543280 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010796231 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112012014083 Country of ref document: BR |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01E Ref document number: 112012014083 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112012014083 Country of ref document: BR Kind code of ref document: A2 Effective date: 20120611 |